ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count,
GO:0050900,leukocyte migration,Dec-60,304/15833,1.24E-09,1.73E-06,1.20E-06,Spp1/Ccl3/Ccl4/Cd74/Cxcl2/Dusp1/Tlr2/Cx3cr1/Selplg/P2ry12/Il1b/Cxcl10,12,
GO:0097529,myeloid leukocyte migration,Oct-60,184/15833,1.60E-09,1.73E-06,1.20E-06,Spp1/Ccl3/Ccl4/Cd74/Cxcl2/Dusp1/Cx3cr1/P2ry12/Il1b/Cxcl10,10,
GO:0009617,response to bacterium,14/60,500/15833,3.75E-09,2.69E-06,1.87E-06,Lyz2/Cxcl2/Nfkbia/Cd52/Junb/Lpl/H2-K1/Axl/Zfp36/Tlr2/Cx3cr1/Il1b/Cxcl10/Rgs1,14,
GO:1902107,positive regulation of leukocyte differentiation,Sep-60,155/15833,6.31E-09,3.41E-06,2.36E-06,Ccl3/Cd74/Cd83/Fos/Axl/Vsir/Il1b/Id2/Hsp90aa1,9,
GO:0030593,neutrophil chemotaxis,Jul-60,87/15833,3.61E-08,1.15E-05,7.97E-06,Spp1/Ccl3/Ccl4/Cd74/Cxcl2/Il1b/Cxcl10,7,
GO:0030595,leukocyte chemotaxis,Sep-60,190/15833,3.72E-08,1.15E-05,7.97E-06,Spp1/Ccl3/Ccl4/Cd74/Cxcl2/Dusp1/Cx3cr1/Il1b/Cxcl10,9,
GO:0060326,cell chemotaxis,Oct-60,259/15833,4.24E-08,1.15E-05,7.97E-06,Spp1/Ccl3/Ccl4/Cd74/Cxcl2/Dusp1/Ccrl2/Cx3cr1/Il1b/Cxcl10,10,
GO:1903708,positive regulation of hemopoiesis,Sep-60,193/15833,4.26E-08,1.15E-05,7.97E-06,Ccl3/Cd74/Cd83/Fos/Axl/Vsir/Il1b/Id2/Hsp90aa1,9,
GO:0032680,regulation of tumor necrosis factor production,Aug-60,151/15833,9.56E-08,1.99E-05,1.38E-05,Ccl3/Ccl4/Lpl/Axl/Zfp36/Tlr2/Cx3cr1/Vsir,8,
GO:0019221,cytokine-mediated signaling pathway,Oct-60,283/15833,9.74E-08,1.99E-05,1.38E-05,Ccl3/Ccl4/Cd74/Cxcl2/Nfkbia/Axl/Cx3cr1/Il1b/Cxcl10/Klf6,10,
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,Aug-60,153/15833,1.06E-07,1.99E-05,1.38E-05,Ccl3/Ccl4/Lpl/Axl/Zfp36/Tlr2/Cx3cr1/Vsir,8,
GO:0032640,tumor necrosis factor production,Aug-60,154/15833,1.11E-07,1.99E-05,1.38E-05,Ccl3/Ccl4/Lpl/Axl/Zfp36/Tlr2/Cx3cr1/Vsir,8,
GO:1990266,neutrophil migration,Jul-60,104/15833,1.25E-07,1.99E-05,1.38E-05,Spp1/Ccl3/Ccl4/Cd74/Cxcl2/Il1b/Cxcl10,7,
GO:0071706,tumor necrosis factor superfamily cytokine production,Aug-60,157/15833,1.29E-07,1.99E-05,1.38E-05,Ccl3/Ccl4/Lpl/Axl/Zfp36/Tlr2/Cx3cr1/Vsir,8,
GO:1903706,regulation of hemopoiesis,Nov-60,376/15833,1.41E-07,2.03E-05,1.41E-05,Ccl3/Cd74/Nfkbia/Cd83/Fos/Axl/Zfp36/Vsir/Il1b/Id2/Hsp90aa1,11,
GO:0071621,granulocyte chemotaxis,Jul-60,108/15833,1.62E-07,2.09E-05,1.45E-05,Spp1/Ccl3/Ccl4/Cd74/Cxcl2/Il1b/Cxcl10,7,
GO:0071219,cellular response to molecule of bacterial origin,Aug-60,162/15833,1.65E-07,2.09E-05,1.45E-05,Cxcl2/Nfkbia/Axl/Zfp36/Tlr2/Cx3cr1/Il1b/Cxcl10,8,
GO:0006875,cellular metal ion homeostasis,Dec-60,493/15833,2.61E-07,3.13E-05,2.17E-05,Apoe/Ccl3/Fth1/Cxcl2/Ccrl2/Cd52/Ftl1/Mt1/Cx3cr1/Il1b/Cxcl10/Hmox1,12,
GO:0050727,regulation of inflammatory response,Oct-60,319/15833,2.96E-07,3.29E-05,2.28E-05,Apoe/Ccl3/Nfkbia/Lpl/Cst7/Ier3/Zfp36/Tlr2/Cx3cr1/Il1b,10,
GO:0002237,response to molecule of bacterial origin,Sep-60,243/15833,3.05E-07,3.29E-05,2.28E-05,Cxcl2/Nfkbia/Junb/Axl/Zfp36/Tlr2/Cx3cr1/Il1b/Cxcl10,9,
GO:0071216,cellular response to biotic stimulus,Aug-60,183/15833,4.19E-07,4.30E-05,2.98E-05,Cxcl2/Nfkbia/Axl/Zfp36/Tlr2/Cx3cr1/Il1b/Cxcl10,8,
GO:0097530,granulocyte migration,Jul-60,128/15833,5.18E-07,5.08E-05,3.52E-05,Spp1/Ccl3/Ccl4/Cd74/Cxcl2/Il1b/Cxcl10,7,
GO:1902105,regulation of leukocyte differentiation,Sep-60,270/15833,7.38E-07,6.92E-05,4.80E-05,Ccl3/Cd74/Cd83/Fos/Axl/Vsir/Il1b/Id2/Hsp90aa1,9,
GO:0032103,positive regulation of response to external stimulus,Sep-60,281/15833,1.03E-06,9.25E-05,6.41E-05,Ccl3/Ccl4/Cd74/Nfkbia/Lpl/Tlr2/P2ry12/Il1b/Cxcl10,9,
GO:0070997,neuron death,Oct-60,376/15833,1.33E-06,0.000114424,7.93E-05,Apoe/Ccl3/Cxcl2/Fos/Btg2/Mt1/Axl/Cx3cr1/Il1b/Hmox1,10,
GO:0071222,cellular response to lipopolysaccharide,Jul-60,154/15833,1.80E-06,0.000149502,0.000103552,Cxcl2/Nfkbia/Axl/Zfp36/Cx3cr1/Il1b/Cxcl10,7,
GO:0032496,response to lipopolysaccharide,Aug-60,226/15833,2.06E-06,0.000159792,0.00011068,Cxcl2/Nfkbia/Junb/Axl/Zfp36/Cx3cr1/Il1b/Cxcl10,8,
GO:0045621,positive regulation of lymphocyte differentiation,Jun-60,100/15833,2.07E-06,0.000159792,0.00011068,Cd74/Cd83/Axl/Vsir/Il1b/Hsp90aa1,6,
GO:0002521,leukocyte differentiation,Nov-60,500/15833,2.36E-06,0.000175476,0.000121544,Ccl3/Cd74/Cd83/Fos/Junb/Axl/Tlr2/Vsir/Il1b/Id2/Hsp90aa1,11,
GO:1990868,response to chemokine,May-60,60/15833,3.07E-06,0.000210308,0.00014567,Ccl3/Ccl4/Cxcl2/Dusp1/Cxcl10,5,
GO:1990869,cellular response to chemokine,May-60,60/15833,3.07E-06,0.000210308,0.00014567,Ccl3/Ccl4/Cxcl2/Dusp1/Cxcl10,5,
GO:0001818,negative regulation of cytokine production,Aug-60,239/15833,3.12E-06,0.000210308,0.00014567,Cd83/Axl/Zfp36/Tlr2/Cx3cr1/Vsir/Klf2/Hmox1,8,
GO:0045619,regulation of lymphocyte differentiation,Jul-60,169/15833,3.34E-06,0.000218742,0.000151511,Cd74/Cd83/Axl/Vsir/Il1b/Id2/Hsp90aa1,7,
GO:0045428,regulation of nitric oxide biosynthetic process,May-60,62/15833,3.62E-06,0.000226633,0.000156977,Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,5,
GO:0009991,response to extracellular stimulus,Sep-60,328/15833,3.68E-06,0.000226633,0.000156977,Apoe/Spp1/Atf3/Fos/Lpl/Axl/Zfp36/P2ry12/Il1b,9,
GO:0043523,regulation of neuron apoptotic process,Aug-60,248/15833,4.10E-06,0.000245775,0.000170236,Apoe/Ccl3/Btg2/Mt1/Axl/Cx3cr1/Il1b/Hmox1,8,
GO:1901214,regulation of neuron death,Sep-60,343/15833,5.29E-06,0.000308328,0.000213563,Apoe/Ccl3/Fos/Btg2/Mt1/Axl/Cx3cr1/Il1b/Hmox1,9,
GO:0002685,regulation of leukocyte migration,Jul-60,184/15833,5.87E-06,0.000333082,0.000230709,Ccl4/Cd74/Dusp1/Tlr2/P2ry12/Il1b/Cxcl10,7,
GO:0050866,negative regulation of cell activation,Jul-60,185/15833,6.08E-06,0.000336315,0.000232948,Apoe/Cd74/Cst7/Axl/Vsir/Id2/Hmox1,7,
GO:0006809,nitric oxide biosynthetic process,May-60,70/15833,6.61E-06,0.000351504,0.000243469,Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,5,
GO:0070372,regulation of ERK1 and ERK2 cascade,Aug-60,265/15833,6.68E-06,0.000351504,0.000243469,Apoe/Ccl3/Ccl4/Atf3/Cd74/Dusp1/Tlr2/Il1b,8,
GO:0046209,nitric oxide metabolic process,May-60,73/15833,8.13E-06,0.000416621,0.000288572,Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,5,
GO:0051402,neuron apoptotic process,Aug-60,273/15833,8.30E-06,0.000416621,0.000288572,Apoe/Ccl3/Btg2/Mt1/Axl/Cx3cr1/Il1b/Hmox1,8,
GO:0030099,myeloid cell differentiation,Sep-60,372/15833,1.02E-05,0.000485361,0.000336185,Ccl3/Cd74/Nfkbia/Fos/Junb/Zfp36/Tlr2/Id2/Klf2,9,
GO:0070371,ERK1 and ERK2 cascade,Aug-60,281/15833,1.02E-05,0.000485361,0.000336185,Apoe/Ccl3/Ccl4/Atf3/Cd74/Dusp1/Tlr2/Il1b,8,
GO:1905954,positive regulation of lipid localization,May-60,77/15833,1.06E-05,0.000485361,0.000336185,Apoe/Spp1/Nfkbia/Lpl/Il1b,5,
GO:2001057,reactive nitrogen species metabolic process,May-60,77/15833,1.06E-05,0.000485361,0.000336185,Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,5,
GO:0002687,positive regulation of leukocyte migration,Jun-60,133/15833,1.08E-05,0.000486798,0.00033718,Ccl4/Cd74/Tlr2/P2ry12/Il1b/Cxcl10,6,
GO:0032611,interleukin-1 beta production,May-60,78/15833,1.13E-05,0.000496,0.000343554,Ccl3/Lpl/Tlr2/Cx3cr1/Il1b,5,
GO:0002718,regulation of cytokine production involved in immune response,May-60,79/15833,1.20E-05,0.000517424,0.000358393,Cd74/Tlr2/Vsir/Il1b/Hmox1,5,
GO:0009896,positive regulation of catabolic process,Sep-60,400/15833,1.81E-05,0.000766612,0.000530993,Apoe/Btg2/Ier3/Zfp36/Tlr2/Vsir/Il1b/Hmox1/Hsp90aa1,9,
GO:0045429,positive regulation of nitric oxide biosynthetic process,Apr-60,42/15833,1.87E-05,0.000777134,0.000538281,Tlr2/Il1b/Klf2/Hsp90aa1,4,
GO:0045582,positive regulation of T cell differentiation,May-60,88/15833,2.03E-05,0.000822776,0.000569895,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:1904407,positive regulation of nitric oxide metabolic process,Apr-60,43/15833,2.06E-05,0.000822776,0.000569895,Tlr2/Il1b/Klf2/Hsp90aa1,4,
GO:0038066,p38MAPK cascade,Apr-60,44/15833,2.26E-05,0.000866311,0.00060005,Dusp1/Gadd45b/Zfp36/Il1b,4,
GO:0042136,neurotransmitter biosynthetic process,May-60,90/15833,2.26E-05,0.000866311,0.00060005,Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,5,
GO:0071396,cellular response to lipid,Sep-60,412/15833,2.29E-05,0.000866311,0.00060005,Spp1/Cxcl2/Nfkbia/Lpl/Axl/Zfp36/Cx3cr1/Il1b/Cxcl10,9,
GO:0002548,monocyte chemotaxis,Apr-60,45/15833,2.47E-05,0.000919631,0.000636982,Ccl3/Ccl4/Dusp1/Cxcl10,4,
GO:0061900,glial cell activation,Apr-60,46/15833,2.70E-05,0.000987349,0.000683886,Cst7/Tlr2/Cx3cr1/Il1b,4,
GO:0032612,interleukin-1 production,May-60,94/15833,2.80E-05,0.000989098,0.000685098,Ccl3/Lpl/Tlr2/Cx3cr1/Il1b,5,
GO:1903426,regulation of reactive oxygen species biosynthetic process,May-60,94/15833,2.80E-05,0.000989098,0.000685098,Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,5,
GO:0002683,negative regulation of immune system process,Sep-60,429/15833,3.14E-05,0.00107674,0.000745803,Cd74/Dusp1/Nfkbia/Cst7/Axl/Zfp36/Vsir/Id2/Hmox1,9,
GO:0072503,cellular divalent inorganic cation homeostasis,Sep-60,429/15833,3.14E-05,0.00107674,0.000745803,Apoe/Ccl3/Cxcl2/Ccrl2/Cd52/Mt1/Cx3cr1/Il1b/Cxcl10,9,
GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,Apr-60,48/15833,3.20E-05,0.00107921,0.000747514,Atf3/Ppp1r15a/Klf2/Hmox1,4,
GO:0002367,cytokine production involved in immune response,May-60,98/15833,3.42E-05,0.001135196,0.000786292,Cd74/Tlr2/Vsir/Il1b/Hmox1,5,
GO:0002695,negative regulation of leukocyte activation,Jun-60,165/15833,3.68E-05,0.00120208,0.00083262,Cd74/Cst7/Axl/Vsir/Id2/Hmox1,6,
GO:0070098,chemokine-mediated signaling pathway,Apr-60,50/15833,3.77E-05,0.001206943,0.000835988,Ccl3/Ccl4/Cxcl2/Cxcl10,4,
GO:0043524,negative regulation of neuron apoptotic process,Jun-60,166/15833,3.80E-05,0.001206943,0.000835988,Apoe/Btg2/Mt1/Axl/Cx3cr1/Hmox1,6,
GO:0002688,regulation of leukocyte chemotaxis,May-60,103/15833,4.34E-05,0.001358722,0.000941117,Ccl4/Cd74/Dusp1/Il1b/Cxcl10,5,
GO:0072507,divalent inorganic cation homeostasis,Sep-60,450/15833,4.56E-05,0.001406384,0.00097413,Apoe/Ccl3/Cxcl2/Ccrl2/Cd52/Mt1/Cx3cr1/Il1b/Cxcl10,9,
GO:0043620,regulation of DNA-templated transcription in response to stress,Apr-60,53/15833,4.75E-05,0.001439111,0.000996799,Atf3/Ppp1r15a/Klf2/Hmox1,4,
GO:0071276,cellular response to cadmium ion,Mar-60,19/15833,4.80E-05,0.001439111,0.000996799,Fos/Mt1/Hmox1,3,
GO:1903428,positive regulation of reactive oxygen species biosynthetic process,Apr-60,55/15833,5.50E-05,0.001625925,0.001126195,Tlr2/Il1b/Klf2/Hsp90aa1,4,
GO:1903409,reactive oxygen species biosynthetic process,May-60,109/15833,5.70E-05,0.001661694,0.001150971,Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,5,
GO:0150076,neuroinflammatory response,Apr-60,56/15833,5.91E-05,0.001699496,0.001177154,Cst7/Tlr2/Cx3cr1/Il1b,4,
GO:0032370,positive regulation of lipid transport,Apr-60,58/15833,6.78E-05,0.001901389,0.001316995,Apoe/Spp1/Nfkbia/Il1b,4,
GO:0032722,positive regulation of chemokine production,Apr-60,58/15833,6.78E-05,0.001901389,0.001316995,Cd74/Lpl/Tlr2/Il1b,4,
GO:0070374,positive regulation of ERK1 and ERK2 cascade,Jun-60,185/15833,6.96E-05,0.001925187,0.001333479,Apoe/Ccl3/Ccl4/Cd74/Tlr2/Il1b,6,
GO:2000377,regulation of reactive oxygen species metabolic process,Jun-60,186/15833,7.17E-05,0.001957648,0.001355963,Ier3/Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,6,
GO:0002763,positive regulation of myeloid leukocyte differentiation,Apr-60,59/15833,7.26E-05,0.001957648,0.001355963,Ccl3/Cd74/Fos/Id2,4,
GO:0007204,positive regulation of cytosolic calcium ion concentration,Jul-60,279/15833,8.51E-05,0.002241427,0.001552523,Ccl3/Cxcl2/Ccrl2/Cd52/Cx3cr1/Il1b/Cxcl10,7,
GO:0002694,regulation of leukocyte activation,Sep-60,488/15833,8.52E-05,0.002241427,0.001552523,Cd74/Cd83/Cst7/Axl/Vsir/Il1b/Id2/Hmox1/Hsp90aa1,9,
GO:0050920,regulation of chemotaxis,Jun-60,194/15833,9.05E-05,0.002352389,0.00162938,Ccl4/Cd74/Dusp1/P2ry12/Il1b/Cxcl10,6,
GO:0019915,lipid storage,Apr-60,63/15833,9.39E-05,0.002412744,0.001671185,Apoe/Nfkbia/Lpl/Il1b,4,
GO:1905952,regulation of lipid localization,May-60,123/15833,0.000101207,0.002521137,0.001746263,Apoe/Spp1/Nfkbia/Lpl/Il1b,5,
GO:0045637,regulation of myeloid cell differentiation,Jun-60,198/15833,0.000101235,0.002521137,0.001746263,Ccl3/Cd74/Nfkbia/Fos/Zfp36/Id2,6,
GO:0045785,positive regulation of cell adhesion,Aug-60,388/15833,0.00010164,0.002521137,0.001746263,Spp1/Cd74/Cd83/Cd63/Vsir/P2ry12/Il1b/Hsp90aa1,8,
GO:0006690,icosanoid metabolic process,Apr-60,65/15833,0.000106145,0.00259404,0.00179676,Cd74/Tlr2/Ltc4s/Il1b,4,
GO:0002573,myeloid leukocyte differentiation,Jun-60,200/15833,0.000106983,0.00259404,0.00179676,Ccl3/Cd74/Fos/Junb/Tlr2/Id2,6,
GO:0051235,maintenance of location,Jul-60,291/15833,0.000110624,0.002652511,0.00183726,Apoe/Fth1/Nfkbia/Lpl/Ftl1/Il1b/Cxcl10,7,
GO:0007159,leukocyte cell-cell adhesion,Jul-60,293/15833,0.000115434,0.002737446,0.00189609,Cd74/Cd83/Cx3cr1/Vsir/Selplg/Il1b/Hsp90aa1,7,
GO:0032651,regulation of interleukin-1 beta production,Apr-60,67/15833,0.000119491,0.00280284,0.001941384,Ccl3/Lpl/Tlr2/Cx3cr1,4,
GO:0042133,neurotransmitter metabolic process,May-60,128/15833,0.000122146,0.002834302,0.001963177,Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,5,
GO:0050729,positive regulation of inflammatory response,May-60,129/15833,0.000126704,0.002908807,0.002014783,Ccl3/Nfkbia/Lpl/Tlr2/Il1b,5,
GO:0050921,positive regulation of chemotaxis,May-60,130/15833,0.000131392,0.002984684,0.002067338,Ccl4/Cd74/P2ry12/Il1b/Cxcl10,5,
GO:0031667,response to nutrient levels,Jul-60,300/15833,0.000133633,0.003003967,0.002080695,Apoe/Spp1/Atf3/Lpl/Zfp36/P2ry12/Il1b,7,
GO:0002703,regulation of leukocyte mediated immunity,Jun-60,210/15833,0.000139745,0.003094367,0.002143311,H2-D1/H2-K1/Tlr2/Vsir/Il1b/Hmox1,6,
GO:0071674,mononuclear cell migration,Apr-60,70/15833,0.000141735,0.003094367,0.002143311,Ccl3/Ccl4/Dusp1/Cxcl10,4,
GO:0006874,cellular calcium ion homeostasis,Aug-60,408/15833,0.000143776,0.003094367,0.002143311,Apoe/Ccl3/Cxcl2/Ccrl2/Cd52/Cx3cr1/Il1b/Cxcl10,8,
GO:0002700,regulation of production of molecular mediator of immune response,May-60,133/15833,0.000146258,0.003094367,0.002143311,Cd74/Tlr2/Vsir/Il1b/Hmox1,5,
GO:0034101,erythrocyte homeostasis,May-60,133/15833,0.000146258,0.003094367,0.002143311,Axl/Zfp36/Id2/Klf2/Hmox1,5,
GO:0050728,negative regulation of inflammatory response,May-60,133/15833,0.000146258,0.003094367,0.002143311,Apoe/Cst7/Ier3/Zfp36/Cx3cr1,5,
GO:0046686,response to cadmium ion,Mar-60,28/15833,0.000158436,0.003287543,0.002277114,Fos/Mt1/Hmox1,3,
GO:2000178,negative regulation of neural precursor cell proliferation,Mar-60,28/15833,0.000158436,0.003287543,0.002277114,Btg2/Il1b/Id2,3,
GO:0002699,positive regulation of immune effector process,Jun-60,218/15833,0.000171304,0.003520696,0.002438607,Cd74/H2-D1/H2-K1/Tlr2/Il1b/Hmox1,6,
GO:0050718,positive regulation of interleukin-1 beta secretion,Mar-60,29/15833,0.000176241,0.003588005,0.002485229,Ccl3/Lpl/Tlr2,3,
GO:0055074,calcium ion homeostasis,Aug-60,421/15833,0.000178229,0.00359456,0.002489769,Apoe/Ccl3/Cxcl2/Ccrl2/Cd52/Cx3cr1/Il1b/Cxcl10,8,
GO:0002709,regulation of T cell mediated immunity,Apr-60,75/15833,0.000185255,0.00370166,0.002563952,H2-D1/H2-K1/Vsir/Il1b,4,
GO:0042326,negative regulation of phosphorylation,Aug-60,425/15833,0.000190106,0.003729646,0.002583336,Apoe/Atf3/Dusp1/Gadd45b/Ier3/Ppp1r15a/Pmepa1/Il1b,8,
GO:0051480,regulation of cytosolic calcium ion concentration,Jul-60,318/15833,0.000191351,0.003729646,0.002583336,Ccl3/Cxcl2/Ccrl2/Cd52/Cx3cr1/Il1b/Cxcl10,7,
GO:0045580,regulation of T cell differentiation,May-60,141/15833,0.00019223,0.003729646,0.002583336,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:1901215,negative regulation of neuron death,Jun-60,223/15833,0.000193728,0.003729646,0.002583336,Apoe/Btg2/Mt1/Axl/Cx3cr1/Hmox1,6,
GO:0061082,myeloid leukocyte cytokine production,Mar-60,30/15833,0.000195297,0.003729646,0.002583336,Cd74/Tlr2/Hmox1,3,
GO:0071248,cellular response to metal ion,May-60,142/15833,0.000198671,0.003760814,0.002604924,Fos/Junb/Mt1/Id2/Hmox1,5,
GO:0046916,cellular transition metal ion homeostasis,Apr-60,77/15833,0.000205101,0.003848769,0.002665846,Fth1/Ftl1/Mt1/Hmox1,4,
GO:0050716,positive regulation of interleukin-1 secretion,Mar-60,31/15833,0.000215639,0.004011635,0.002778656,Ccl3/Lpl/Tlr2,3,
GO:0051348,negative regulation of transferase activity,Jun-60,230/15833,0.000228956,0.004222975,0.00292504,Apoe/Dusp1/Gadd45b/Rpl23/Zfp36/Il1b,6,
GO:0044403,symbiont process,Jul-60,328/15833,0.00023125,0.00422914,0.00292931,Apoe/Ccl4/Cd74/Ctsb/Axl/Zfp36/Tlr2,7,
GO:0002443,leukocyte mediated immunity,Jul-60,332/15833,0.000248982,0.004515146,0.003127412,Cd74/H2-D1/H2-K1/Tlr2/Vsir/Il1b/Hmox1,7,
GO:0002690,positive regulation of leukocyte chemotaxis,Apr-60,82/15833,0.000261375,0.004651863,0.003222109,Ccl4/Cd74/Il1b/Cxcl10,4,
GO:0032652,regulation of interleukin-1 production,Apr-60,82/15833,0.000261375,0.004651863,0.003222109,Ccl3/Lpl/Tlr2/Cx3cr1,4,
GO:0031331,positive regulation of cellular catabolic process,Jul-60,335/15833,0.000262988,0.004651863,0.003222109,Apoe/Btg2/Zfp36/Tlr2/Il1b/Hmox1/Hsp90aa1,7,
GO:0032642,regulation of chemokine production,Apr-60,83/15833,0.000273836,0.004765637,0.003300914,Cd74/Lpl/Tlr2/Il1b,4,
GO:1901568,fatty acid derivative metabolic process,Apr-60,83/15833,0.000273836,0.004765637,0.003300914,Cd74/Tlr2/Ltc4s/Il1b,4,
GO:0044419,interspecies interaction between organisms,Jul-60,342/15833,0.000298151,0.005138627,0.003559266,Apoe/Ccl4/Cd74/Ctsb/Axl/Zfp36/Tlr2,7,
GO:0032602,chemokine production,Apr-60,85/15833,0.000300031,0.005138627,0.003559266,Cd74/Lpl/Tlr2/Il1b,4,
GO:0030098,lymphocyte differentiation,Jul-60,344/15833,0.000308864,0.005236849,0.003627299,Cd74/Cd83/Axl/Vsir/Il1b/Id2/Hsp90aa1,7,
GO:0046456,icosanoid biosynthetic process,Mar-60,35/15833,0.000310619,0.005236849,0.003627299,Cd74/Ltc4s/Il1b,3,
GO:0014015,positive regulation of gliogenesis,Apr-60,88/15833,0.000342629,0.005731727,0.003970076,Tlr2/P2ry12/Il1b/Id2,4,
GO:0072593,reactive oxygen species metabolic process,Jun-60,251/15833,0.000365759,0.006042009,0.004184992,Ier3/Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,6,
GO:1900744,regulation of p38MAPK cascade,Mar-60,37/15833,0.000366776,0.006042009,0.004184992,Dusp1/Gadd45b/Il1b,3,
GO:0007584,response to nutrient,Apr-60,90/15833,0.000373329,0.0060991,0.004224536,Spp1/Lpl/P2ry12/Il1b,4,
GO:0071241,cellular response to inorganic substance,May-60,163/15833,0.000376128,0.0060991,0.004224536,Fos/Junb/Mt1/Id2/Hmox1,5,
GO:0019932,second-messenger-mediated signaling,Jul-60,356/15833,0.00037984,0.0060991,0.004224536,Apoe/Ccl4/Ccrl2/Mt1/Cx3cr1/P2ry12/Cxcl10,7,
GO:0051251,positive regulation of lymphocyte activation,Jun-60,253/15833,0.000381547,0.0060991,0.004224536,Cd74/Cd83/Axl/Vsir/Il1b/Hsp90aa1,6,
GO:0032760,positive regulation of tumor necrosis factor production,Apr-60,91/15833,0.000389395,0.006178781,0.004279728,Ccl3/Ccl4/Lpl/Tlr2,4,
GO:0050706,regulation of interleukin-1 beta secretion,Mar-60,38/15833,0.000397144,0.006255737,0.004333031,Ccl3/Lpl/Tlr2,3,
GO:0045639,positive regulation of myeloid cell differentiation,Apr-60,92/15833,0.00040595,0.006257422,0.004334198,Ccl3/Cd74/Fos/Id2,4,
GO:0051897,positive regulation of protein kinase B signaling,Apr-60,92/15833,0.00040595,0.006257422,0.004334198,Axl/Cx3cr1/P2ry12/Hsp90aa1,4,
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,Apr-60,92/15833,0.00040595,0.006257422,0.004334198,Ccl3/Ccl4/Lpl/Tlr2,4,
GO:0002262,myeloid cell homeostasis,May-60,166/15833,0.000408951,0.006258974,0.004335273,Axl/Zfp36/Id2/Klf2/Hmox1,5,
GO:0002697,regulation of immune effector process,Jul-60,361/15833,0.000413029,0.006276875,0.004347672,Cd74/H2-D1/H2-K1/Tlr2/Vsir/Il1b/Hmox1,7,
GO:0043491,protein kinase B signaling,May-60,167/15833,0.000420358,0.006343591,0.004393883,Axl/Cx3cr1/P2ry12/Il1b/Hsp90aa1,5,
GO:0001774,microglial cell activation,Mar-60,39/15833,0.000429082,0.006385931,0.004423209,Cst7/Tlr2/Cx3cr1,3,
GO:0002269,leukocyte activation involved in inflammatory response,Mar-60,39/15833,0.000429082,0.006385931,0.004423209,Cst7/Tlr2/Cx3cr1,3,
GO:0016032,viral process,Jun-60,259/15833,0.000432135,0.006387313,0.004424167,Apoe/Ccl4/Cd74/Ctsb/Axl/Zfp36,6,
GO:0032368,regulation of lipid transport,Apr-60,96/15833,0.000477225,0.007005794,0.004852557,Apoe/Spp1/Nfkbia/Il1b,4,
GO:0001649,osteoblast differentiation,May-60,173/15833,0.000493938,0.007202152,0.004988564,Spp1/Junb/H3f3b/Tmem119/Id2,5,
GO:0002819,regulation of adaptive immune response,May-60,174/15833,0.000507088,0.0072953,0.005053084,Cd74/H2-D1/H2-K1/Vsir/Il1b,5,
GO:0050870,positive regulation of T cell activation,May-60,174/15833,0.000507088,0.0072953,0.005053084,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:0042035,regulation of cytokine biosynthetic process,Apr-60,98/15833,0.000516018,0.007374609,0.005108016,Zfp36/Tlr2/Cx3cr1/Il1b,4,
GO:0032731,positive regulation of interleukin-1 beta production,Mar-60,42/15833,0.00053466,0.007563335,0.005238737,Ccl3/Lpl/Tlr2,3,
GO:2000379,positive regulation of reactive oxygen species metabolic process,Apr-60,99/15833,0.000536233,0.007563335,0.005238737,Tlr2/Il1b/Klf2/Hsp90aa1,4,
GO:0006879,cellular iron ion homeostasis,Mar-60,43/15833,0.000573216,0.008032465,0.00556368,Fth1/Ftl1/Hmox1,3,
GO:0001933,negative regulation of protein phosphorylation,Jul-60,383/15833,0.000587786,0.008183493,0.00566829,Apoe/Atf3/Dusp1/Gadd45b/Ppp1r15a/Pmepa1/Il1b,7,
GO:0007249,I-kappaB kinase/NF-kappaB signaling,May-60,180/15833,0.000591608,0.008183914,0.005668581,Cd74/Nfkbia/Tlr2/Cx3cr1/Il1b,5,
GO:0009895,negative regulation of catabolic process,Jun-60,276/15833,0.000604355,0.008306991,0.00575383,Ier3/Rpl23/Zfp36/Cst3/Il1b/Hmox1,6,
GO:0050704,regulation of interleukin-1 secretion,Mar-60,44/15833,0.000613506,0.008379404,0.005803987,Ccl3/Lpl/Tlr2,3,
GO:2000177,regulation of neural precursor cell proliferation,Apr-60,103/15833,0.000622756,0.008405423,0.005822009,Btg2/Cx3cr1/Il1b/Id2,4,
GO:0060907,positive regulation of macrophage cytokine production,Feb-60,10/15833,0.000623201,0.008405423,0.005822009,Cd74/Tlr2,2,
GO:0032653,regulation of interleukin-10 production,Mar-60,45/15833,0.000655562,0.008732738,0.006048723,Cd83/Tlr2/Vsir,3,
GO:0050702,interleukin-1 beta secretion,Mar-60,45/15833,0.000655562,0.008732738,0.006048723,Ccl3/Lpl/Tlr2,3,
GO:0055076,transition metal ion homeostasis,Apr-60,105/15833,0.000669537,0.008864176,0.006139764,Fth1/Ftl1/Mt1/Hmox1,4,
GO:0048247,lymphocyte chemotaxis,Mar-60,46/15833,0.000699416,0.00920329,0.006374651,Ccl3/Ccl4/Cxcl10,3,
GO:0001819,positive regulation of cytokine production,Jul-60,396/15833,0.000715976,0.009364097,0.006486034,Ccl3/Ccl4/Cd74/Cd83/Lpl/Tlr2/Il1b,7,
GO:0051249,regulation of lymphocyte activation,Jul-60,397/15833,0.000726689,0.009446955,0.006543425,Cd74/Cd83/Axl/Vsir/Il1b/Id2/Hsp90aa1,7,
GO:1903039,positive regulation of leukocyte cell-cell adhesion,May-60,189/15833,0.000737709,0.009532789,0.006602878,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:1901570,fatty acid derivative biosynthetic process,Mar-60,47/15833,0.000745097,0.009570952,0.006629312,Cd74/Ltc4s/Il1b,3,
GO:0034375,high-density lipoprotein particle remodeling,Feb-60,11/15833,0.000759834,0.009611073,0.006657101,Apoe/Lpl,2,
GO:2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production,Feb-60,11/15833,0.000759834,0.009611073,0.006657101,Cd74/Lpl,2,
GO:0002456,T cell mediated immunity,Apr-60,109/15833,0.000770489,0.009611073,0.006657101,H2-D1/H2-K1/Vsir/Il1b,4,
GO:0042089,cytokine biosynthetic process,Apr-60,109/15833,0.000770489,0.009611073,0.006657101,Zfp36/Tlr2/Cx3cr1/Il1b,4,
GO:0051701,interaction with host,Apr-60,109/15833,0.000770489,0.009611073,0.006657101,Cd74/Ctsb/Axl/Tlr2,4,
GO:0032732,positive regulation of interleukin-1 production,Mar-60,48/15833,0.000792637,0.009718807,0.006731723,Ccl3/Lpl/Tlr2,3,
GO:0046718,viral entry into host cell,Mar-60,48/15833,0.000792637,0.009718807,0.006731723,Cd74/Ctsb/Axl,3,
GO:0060760,positive regulation of response to cytokine stimulus,Mar-60,48/15833,0.000792637,0.009718807,0.006731723,Cd74/Axl/Tlr2,3,
GO:0043903,regulation of symbiosis, encompassing mutualism through parasitism,May-60,193/15833,0.000810666,0.009883707,0.006845941,Apoe/Ccl4/Cd74/Zfp36/Tlr2,5
GO:0031348,negative regulation of defense response,May-60,194/15833,0.000829718,0.010059167,0.006967473,Apoe/Cst7/Ier3/Zfp36/Cx3cr1,5,
GO:0032613,interleukin-10 production,Mar-60,49/15833,0.000842064,0.01015181,0.007031642,Cd83/Tlr2/Vsir,3,
GO:0032102,negative regulation of response to external stimulus,Jun-60,295/15833,0.000855516,0.010256681,0.007104281,Apoe/Dusp1/Cst7/Ier3/Zfp36/Cx3cr1,6,
GO:0002440,production of molecular mediator of immune response,May-60,196/15833,0.000868825,0.010323679,0.007150687,Cd74/Tlr2/Vsir/Il1b/Hmox1,5,
GO:0048872,homeostasis of number of cells,Jun-60,296/15833,0.000870672,0.010323679,0.007150687,Cd74/Axl/Zfp36/Id2/Klf2/Hmox1,6,
GO:0042107,cytokine metabolic process,Apr-60,113/15833,0.000881764,0.01039807,0.007202215,Zfp36/Tlr2/Cx3cr1/Il1b,4,
GO:0002720,positive regulation of cytokine production involved in immune response,Mar-60,50/15833,0.000893408,0.010460123,0.007245196,Cd74/Tlr2/Il1b,3,
GO:0060211,regulation of nuclear-transcribed mRNA poly(A) tail shortening,Feb-60,12/15833,0.000909578,0.010460123,0.007245196,Btg2/Zfp36,2,
GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,Feb-60,12/15833,0.000909578,0.010460123,0.007245196,Btg2/Zfp36,2,
GO:1900272,negative regulation of long-term synaptic potentiation,Feb-60,12/15833,0.000909578,0.010460123,0.007245196,Apoe/Cx3cr1,2,
GO:0002761,regulation of myeloid leukocyte differentiation,Apr-60,114/15833,0.000911262,0.010460123,0.007245196,Ccl3/Cd74/Fos/Id2,4,
GO:1905517,macrophage migration,Mar-60,51/15833,0.000946699,0.010809398,0.00748712,Ccl3/Cx3cr1/P2ry12,3,
GO:0031668,cellular response to extracellular stimulus,May-60,201/15833,0.000972609,0.010975833,0.007602401,Atf3/Fos/Lpl/Axl/P2ry12,5,
GO:0002696,positive regulation of leukocyte activation,Jun-60,303/15833,0.000982664,0.010975833,0.007602401,Cd74/Cd83/Axl/Vsir/Il1b/Hsp90aa1,6,
GO:0030260,entry into host cell,Mar-60,52/15833,0.001001964,0.010975833,0.007602401,Cd74/Ctsb/Axl,3,
GO:0044409,entry into host,Mar-60,52/15833,0.001001964,0.010975833,0.007602401,Cd74/Ctsb/Axl,3,
GO:0048002,antigen processing and presentation of peptide antigen,Mar-60,52/15833,0.001001964,0.010975833,0.007602401,Cd74/H2-D1/H2-K1,3,
GO:0050701,interleukin-1 secretion,Mar-60,52/15833,0.001001964,0.010975833,0.007602401,Ccl3/Lpl/Tlr2,3,
GO:0051806,entry into cell of other organism involved in symbiotic interaction,Mar-60,52/15833,0.001001964,0.010975833,0.007602401,Cd74/Ctsb/Axl,3,
GO:0051828,entry into other organism involved in symbiotic interaction,Mar-60,52/15833,0.001001964,0.010975833,0.007602401,Cd74/Ctsb/Axl,3,
GO:0045687,positive regulation of glial cell differentiation,Mar-60,53/15833,0.001059233,0.011544567,0.007996334,Tlr2/Il1b/Id2,3,
GO:0002821,positive regulation of adaptive immune response,Apr-60,120/15833,0.001103034,0.011961544,0.008285153,Cd74/H2-D1/H2-K1/Il1b,4,
GO:0002711,positive regulation of T cell mediated immunity,Mar-60,54/15833,0.001118532,0.012007048,0.008316671,H2-D1/H2-K1/Il1b,3,
GO:0032663,regulation of interleukin-2 production,Mar-60,54/15833,0.001118532,0.012007048,0.008316671,Cd83/Zfp36/Il1b,3,
GO:0010876,lipid localization,Jun-60,311/15833,0.001123922,0.012007048,0.008316671,Apoe/Spp1/Nfkbia/Lpl/Apoc1/Il1b,6,
GO:0050867,positive regulation of cell activation,Jun-60,317/15833,0.001239739,0.013137626,0.009099765,Cd74/Cd83/Axl/Vsir/Il1b/Hsp90aa1,6,
GO:0010875,positive regulation of cholesterol efflux,Feb-60,14/15833,0.001248014,0.013137626,0.009099765,Apoe/Nfkbia,2,
GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,Feb-60,14/15833,0.001248014,0.013137626,0.009099765,Cd74/Lpl,2,
GO:2001234,negative regulation of apoptotic signaling pathway,May-60,213/15833,0.001259178,0.01319081,0.009136603,Cd74/Ier3/Cx3cr1/Il1b/Hmox1,5,
GO:0006706,steroid catabolic process,Feb-60,15/15833,0.001436509,0.014622582,0.010128319,Apoe/Spp1,2,
GO:0010935,regulation of macrophage cytokine production,Feb-60,15/15833,0.001436509,0.014622582,0.010128319,Cd74/Tlr2,2,
GO:0030730,sequestering of triglyceride,Feb-60,15/15833,0.001436509,0.014622582,0.010128319,Lpl/Il1b,2,
GO:0051044,positive regulation of membrane protein ectodomain proteolysis,Feb-60,15/15833,0.001436509,0.014622582,0.010128319,Apoe/Il1b,2,
GO:0070262,peptidyl-serine dephosphorylation,Feb-60,15/15833,0.001436509,0.014622582,0.010128319,Dusp1/Ppp1r15a,2,
GO:0072567,chemokine (C-X-C motif) ligand 2 production,Feb-60,15/15833,0.001436509,0.014622582,0.010128319,Cd74/Lpl,2,
GO:0045600,positive regulation of fat cell differentiation,Mar-60,59/15833,0.001446438,0.014654525,0.010150444,Lpl/Zfp36/Id2,3,
GO:0071356,cellular response to tumor necrosis factor,Apr-60,131/15833,0.001525404,0.015382343,0.010654567,Ccl3/Ccl4/Nfkbia/Zfp36,4,
GO:0022409,positive regulation of cell-cell adhesion,May-60,224/15833,0.001572889,0.015787415,0.01093514,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:0032623,interleukin-2 production,Mar-60,61/15833,0.001592748,0.015825929,0.010961816,Cd83/Zfp36/Il1b,3,
GO:0051048,negative regulation of secretion,May-60,226/15833,0.001635594,0.015825929,0.010961816,Apoe/Cd74/P2ry12/Il1b/Hmox1,5,
GO:0006691,leukotriene metabolic process,Feb-60,16/15833,0.001637729,0.015825929,0.010961816,Tlr2/Ltc4s,2,
GO:0010832,negative regulation of myotube differentiation,Feb-60,16/15833,0.001637729,0.015825929,0.010961816,Tmem119/Cxcl10,2,
GO:0032700,negative regulation of interleukin-17 production,Feb-60,16/15833,0.001637729,0.015825929,0.010961816,Tlr2/Vsir,2,
GO:0034368,protein-lipid complex remodeling,Feb-60,16/15833,0.001637729,0.015825929,0.010961816,Apoe/Lpl,2,
GO:0034369,plasma lipoprotein particle remodeling,Feb-60,16/15833,0.001637729,0.015825929,0.010961816,Apoe/Lpl,2,
GO:0071498,cellular response to fluid shear stress,Feb-60,16/15833,0.001637729,0.015825929,0.010961816,Spp1/Klf2,2,
GO:0051961,negative regulation of nervous system development,Jun-60,335/15833,0.001642729,0.015825929,0.010961816,Apoe/H2-D1/H2-K1/Tlr2/Il1b/Id2,6,
GO:0031349,positive regulation of defense response,Jun-60,336/15833,0.001667727,0.015995358,0.011079171,Ccl3/Cd74/Nfkbia/Lpl/Tlr2/Il1b,6,
GO:0032675,regulation of interleukin-6 production,Apr-60,135/15833,0.001703557,0.016266709,0.011267122,Lpl/Tlr2/Il1b/Klf2,4,
GO:0043410,positive regulation of MAPK cascade,Jul-60,461/15833,0.001727062,0.016418499,0.011372259,Apoe/Ccl3/Ccl4/Cd74/Gadd45b/Tlr2/Il1b,7,
GO:0051896,regulation of protein kinase B signaling,Apr-60,136/15833,0.001750259,0.016566052,0.011474462,Axl/Cx3cr1/P2ry12/Hsp90aa1,4,
GO:0031330,negative regulation of cellular catabolic process,May-60,230/15833,0.001766503,0.016646787,0.011530383,Ier3/Rpl23/Zfp36/Cst3/Hmox1,5,
GO:0071496,cellular response to external stimulus,May-60,231/15833,0.0018004,0.016788657,0.011628649,Atf3/Fos/Lpl/Axl/P2ry12,5,
GO:0050715,positive regulation of cytokine secretion,Apr-60,138/15833,0.001846322,0.016788657,0.011628649,Ccl3/Lpl/Tlr2/Il1b,4,
GO:0002486,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent,Feb-60,17/15833,0.001851576,0.016788657,0.011628649,H2-D1/H2-K1,2
GO:0007252,I-kappaB phosphorylation,Feb-60,17/15833,0.001851576,0.016788657,0.011628649,Tlr2/Cx3cr1,2,
GO:0010934,macrophage cytokine production,Feb-60,17/15833,0.001851576,0.016788657,0.011628649,Cd74/Tlr2,2,
GO:0034367,protein-containing complex remodeling,Feb-60,17/15833,0.001851576,0.016788657,0.011628649,Apoe/Lpl,2,
GO:0035994,response to muscle stretch,Feb-60,17/15833,0.001851576,0.016788657,0.011628649,Nfkbia/Fos,2,
GO:1900151,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,Feb-60,17/15833,0.001851576,0.016788657,0.011628649,Btg2/Zfp36,2
GO:1900153,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,Feb-60,17/15833,0.001851576,0.016788657,0.011628649,Btg2/Zfp36,2
GO:0051250,negative regulation of lymphocyte activation,Apr-60,139/15833,0.0018957,0.01711682,0.01185595,Cd74/Axl/Vsir/Id2,4,
GO:0043407,negative regulation of MAP kinase activity,Mar-60,65/15833,0.00191244,0.017196022,0.01191081,Apoe/Dusp1/Il1b,3,
GO:0051051,negative regulation of transport,Jul-60,470/15833,0.001927488,0.017259419,0.011954721,Apoe/Cd74/Ier3/Tlr2/P2ry12/Il1b/Hmox1,7,
GO:0032635,interleukin-6 production,Apr-60,142/15833,0.002049322,0.018153347,0.0125739,Lpl/Tlr2/Il1b/Klf2,4,
GO:0002476,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,Feb-60,18/15833,0.002077955,0.018153347,0.0125739,H2-D1/H2-K1,2,
GO:0002484,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,Feb-60,18/15833,0.002077955,0.018153347,0.0125739,H2-D1/H2-K1,2,
GO:0019433,triglyceride catabolic process,Feb-60,18/15833,0.002077955,0.018153347,0.0125739,Apoe/Lpl,2,
GO:0046697,decidualization,Feb-60,18/15833,0.002077955,0.018153347,0.0125739,Junb/Ctsb,2,
GO:0048711,positive regulation of astrocyte differentiation,Feb-60,18/15833,0.002077955,0.018153347,0.0125739,Il1b/Id2,2,
GO:0035914,skeletal muscle cell differentiation,Mar-60,67/15833,0.002086205,0.018153347,0.0125739,Atf3/Fos/Btg2,3,
GO:0045665,negative regulation of neuron differentiation,May-60,241/15833,0.002166195,0.018773689,0.013003579,Apoe/H2-D1/H2-K1/Il1b/Id2,5,
GO:0043900,regulation of multi-organism process,Jun-60,355/15833,0.00220018,0.018962425,0.013134307,Apoe/Ccl4/Cd74/Zfp36/Tlr2/Il1b,6,
GO:0010038,response to metal ion,May-60,242/15833,0.002205546,0.018962425,0.013134307,Fos/Junb/Mt1/Id2/Hmox1,5,
GO:0014013,regulation of gliogenesis,Apr-60,146/15833,0.002267283,0.019206159,0.013303129,Tlr2/P2ry12/Il1b/Id2,4,
GO:2001236,regulation of extrinsic apoptotic signaling pathway,Apr-60,146/15833,0.002267283,0.019206159,0.013303129,Atf3/Cx3cr1/Il1b/Hmox1,4,
GO:0021885,forebrain cell migration,Mar-60,69/15833,0.002269495,0.019206159,0.013303129,Axl/Cx3cr1/P2ry12,3,
GO:0055072,iron ion homeostasis,Mar-60,69/15833,0.002269495,0.019206159,0.013303129,Fth1/Ftl1/Hmox1,3,
GO:0002428,antigen processing and presentation of peptide antigen via MHC class Ib,Feb-60,19/15833,0.002316771,0.019216741,0.013310459,H2-D1/H2-K1,2,
GO:0010743,regulation of macrophage derived foam cell differentiation,Feb-60,19/15833,0.002316771,0.019216741,0.013310459,Nfkbia/Lpl,2,
GO:0010874,regulation of cholesterol efflux,Feb-60,19/15833,0.002316771,0.019216741,0.013310459,Apoe/Nfkbia,2,
GO:0045076,regulation of interleukin-2 biosynthetic process,Feb-60,19/15833,0.002316771,0.019216741,0.013310459,Zfp36/Il1b,2,
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,Feb-60,19/15833,0.002316771,0.019216741,0.013310459,Cd74/Tlr2,2,
GO:0034612,response to tumor necrosis factor,Apr-60,147/15833,0.002324175,0.019216741,0.013310459,Ccl3/Ccl4/Nfkbia/Zfp36,4,
GO:0034103,regulation of tissue remodeling,Mar-60,70/15833,0.002364768,0.019477745,0.013491243,Spp1/Tmem119/Klf6,3,
GO:1903707,negative regulation of hemopoiesis,Apr-60,148/15833,0.002382045,0.019545449,0.013538139,Cd74/Nfkbia/Zfp36/Id2,4,
GO:0030168,platelet activation,Mar-60,71/15833,0.002462488,0.020128976,0.013942318,Apoe/Axl/P2ry12,3,
GO:0042176,regulation of protein catabolic process,Jun-60,366/15833,0.0025622,0.020833062,0.014430003,Apoe/Ier3/Rpl23/Cst3/Il1b/Hsp90aa1,6,
GO:1904469,positive regulation of tumor necrosis factor secretion,Feb-60,20/15833,0.002567931,0.020833062,0.014430003,Lpl/Tlr2,2,
GO:0030217,T cell differentiation,May-60,252/15833,0.002628345,0.021243327,0.014714172,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:0051090,regulation of DNA-binding transcription factor activity,Jun-60,370/15833,0.002704399,0.021776466,0.01508345,Nfkbia/Tlr2/Cx3cr1/Il1b/Id2/Hmox1,6,
GO:0002449,lymphocyte mediated immunity,May-60,254/15833,0.002719507,0.021816713,0.015111327,Cd74/H2-D1/H2-K1/Vsir/Il1b,5,
GO:0007611,learning or memory,May-60,256/15833,0.002812946,0.022381064,0.015502225,Apoe/Btg2/Tlr2/Cx3cr1/Il1b,5,
GO:0032897,negative regulation of viral transcription,Feb-60,21/15833,0.002831339,0.022381064,0.015502225,Ccl4/Zfp36,2,
GO:0042094,interleukin-2 biosynthetic process,Feb-60,21/15833,0.002831339,0.022381064,0.015502225,Zfp36/Il1b,2,
GO:1901623,regulation of lymphocyte chemotaxis,Feb-60,21/15833,0.002831339,0.022381064,0.015502225,Ccl4/Cxcl10,2,
GO:0002706,regulation of lymphocyte mediated immunity,Apr-60,156/15833,0.002881228,0.022692297,0.0157178,H2-D1/H2-K1/Vsir/Il1b,4,
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,Apr-60,158/15833,0.003016393,0.023443004,0.016237776,H2-D1/H2-K1/Vsir/Il1b,4,
GO:0042116,macrophage activation,Mar-60,77/15833,0.00310138,0.023443004,0.016237776,Cst7/Tlr2/Cx3cr1,3,
GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,Btg2/Zfp36,2,
GO:0001516,prostaglandin biosynthetic process,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,Cd74/Il1b,2,
GO:0002475,antigen processing and presentation via MHC class Ib,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,H2-D1/H2-K1,2,
GO:0032373,positive regulation of sterol transport,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,Apoe/Nfkbia,2,
GO:0032376,positive regulation of cholesterol transport,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,Apoe/Nfkbia,2,
GO:0032770,positive regulation of monooxygenase activity,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,Apoe/Il1b,2,
GO:0034405,response to fluid shear stress,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,Spp1/Klf2,2,
GO:0046457,prostanoid biosynthetic process,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,Cd74/Il1b,2,
GO:0051043,regulation of membrane protein ectodomain proteolysis,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,Apoe/Il1b,2,
GO:0090025,regulation of monocyte chemotaxis,Feb-60,22/15833,0.003106904,0.023443004,0.016237776,Dusp1/Cxcl10,2,
GO:0045807,positive regulation of endocytosis,Apr-60,160/15833,0.003155839,0.023729274,0.016436061,Apoe/Cd63/Axl/Il1b,4,
GO:0050792,regulation of viral process,Apr-60,161/15833,0.003227189,0.024181504,0.016749298,Apoe/Ccl4/Cd74/Zfp36,4,
GO:1903037,regulation of leukocyte cell-cell adhesion,May-60,265/15833,0.003262484,0.024361389,0.016873895,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:0043409,negative regulation of MAPK cascade,Apr-60,162/15833,0.003299633,0.02455382,0.017007182,Apoe/Atf3/Dusp1/Il1b,4,
GO:0002719,negative regulation of cytokine production involved in immune response,Feb-60,23/15833,0.003394532,0.025001364,0.017317173,Vsir/Hmox1,2,
GO:0010742,macrophage derived foam cell differentiation,Feb-60,23/15833,0.003394532,0.025001364,0.017317173,Nfkbia/Lpl,2,
GO:0050901,leukocyte tethering or rolling,Feb-60,23/15833,0.003394532,0.025001364,0.017317173,Cx3cr1/Selplg,2,
GO:2001233,regulation of apoptotic signaling pathway,Jun-60,388/15833,0.003419086,0.025096554,0.017383107,Atf3/Cd74/Ier3/Cx3cr1/Il1b/Hmox1,6,
GO:0046683,response to organophosphorus,Mar-60,80/15833,0.003455522,0.025278023,0.017508801,Junb/P2ry12/Il1b,3,
GO:0048771,tissue remodeling,Apr-60,165/15833,0.003523617,0.02568907,0.017793512,Spp1/Axl/Tmem119/Klf6,4,
GO:0030100,regulation of endocytosis,May-60,271/15833,0.003589646,0.025957776,0.017979631,Apoe/Cd63/Axl/Tlr2/Il1b,5,
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,May-60,272/15833,0.003646386,0.025957776,0.017979631,Cd74/H2-D1/H2-K1/Vsir/Il1b,5,
GO:0002478,antigen processing and presentation of exogenous peptide antigen,Feb-60,24/15833,0.00369413,0.025957776,0.017979631,Cd74/H2-K1,2,
GO:0002483,antigen processing and presentation of endogenous peptide antigen,Feb-60,24/15833,0.00369413,0.025957776,0.017979631,H2-D1/H2-K1,2,
GO:0007263,nitric oxide mediated signal transduction,Feb-60,24/15833,0.00369413,0.025957776,0.017979631,Apoe/Mt1,2,
GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,Feb-60,24/15833,0.00369413,0.025957776,0.017979631,H2-D1/H2-K1,2,
GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress,Feb-60,24/15833,0.00369413,0.025957776,0.017979631,Atf3/Klf2,2,
GO:0042533,tumor necrosis factor biosynthetic process,Feb-60,24/15833,0.00369413,0.025957776,0.017979631,Tlr2/Cx3cr1,2,
GO:0042534,regulation of tumor necrosis factor biosynthetic process,Feb-60,24/15833,0.00369413,0.025957776,0.017979631,Tlr2/Cx3cr1,2,
GO:0090077,foam cell differentiation,Feb-60,24/15833,0.00369413,0.025957776,0.017979631,Nfkbia/Lpl,2,
GO:1905809,negative regulation of synapse organization,Feb-60,24/15833,0.00369413,0.025957776,0.017979631,Apoe/Tlr2,2,
GO:0006641,triglyceride metabolic process,Mar-60,82/15833,0.003704817,0.025957776,0.017979631,Apoe/Lpl/Apoc1,3,
GO:0006869,lipid transport,May-60,276/15833,0.003879821,0.027095969,0.018768,Apoe/Spp1/Nfkbia/Apoc1/Il1b,5,
GO:0061351,neural precursor cell proliferation,Apr-60,170/15833,0.003919578,0.027268462,0.018887476,Btg2/Cx3cr1/Il1b/Id2,4,
GO:0043270,positive regulation of ion transport,May-60,277/15833,0.003939819,0.027268462,0.018887476,Apoe/Ccl4/P2ry12/Il1b/Cxcl10,5,
GO:0032755,positive regulation of interleukin-6 production,Mar-60,84/15833,0.00396484,0.027268462,0.018887476,Lpl/Tlr2/Il1b,3,
GO:0043405,regulation of MAP kinase activity,May-60,278/15833,0.004000481,0.027268462,0.018887476,Apoe/Cd74/Dusp1/Gadd45b/Il1b,5,
GO:0033198,response to ATP,Feb-60,25/15833,0.004005608,0.027268462,0.018887476,P2ry12/Il1b,2,
GO:0055094,response to lipoprotein particle,Feb-60,25/15833,0.004005608,0.027268462,0.018887476,Apoe/Lpl,2,
GO:0090023,positive regulation of neutrophil chemotaxis,Feb-60,25/15833,0.004005608,0.027268462,0.018887476,Cd74/Il1b,2,
GO:1900745,positive regulation of p38MAPK cascade,Feb-60,25/15833,0.004005608,0.027268462,0.018887476,Gadd45b/Il1b,2,
GO:0045765,regulation of angiogenesis,May-60,279/15833,0.004061811,0.027564112,0.019092258,Cx3cr1/Il1b/Cxcl10/Klf2/Hmox1,5,
GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,Mar-60,85/15833,0.004098919,0.027642082,0.019146264,Apoe/Ccl4/Tlr2,3,
GO:0070555,response to interleukin-1,Mar-60,85/15833,0.004098919,0.027642082,0.019146264,Ccl3/Ccl4/Il1b,3,
GO:0050863,regulation of T cell activation,May-60,280/15833,0.004123813,0.027723325,0.019202537,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:0072676,lymphocyte migration,Mar-60,86/15833,0.004235731,0.028387288,0.019662431,Ccl3/Ccl4/Cxcl10,3,
GO:0010035,response to inorganic substance,Jun-60,406/15833,0.004266506,0.028505015,0.019743974,Fos/Junb/Mt1/Axl/Id2/Hmox1,6,
GO:0019883,antigen processing and presentation of endogenous antigen,Feb-60,26/15833,0.004328874,0.028743721,0.019909313,H2-D1/H2-K1,2,
GO:0033687,osteoblast proliferation,Feb-60,26/15833,0.004328874,0.028743721,0.019909313,Junb/Tmem119,2,
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,Mar-60,87/15833,0.004375293,0.028962831,0.02006108,Cx3cr1/Il1b/Hmox1,3,
GO:0035690,cellular response to drug,May-60,285/15833,0.004444045,0.029238566,0.020252068,Ccl4/Axl/P2ry12/Il1b/Hmox1,5,
GO:0050890,cognition,May-60,285/15833,0.004444045,0.029238566,0.020252068,Apoe/Btg2/Tlr2/Cx3cr1/Il1b,5,
GO:0051651,maintenance of location in cell,Mar-60,88/15833,0.004517623,0.029632309,0.020524793,Apoe/Fth1/Ftl1,3,
GO:0046461,neutral lipid catabolic process,Feb-60,27/15833,0.004663836,0.030223899,0.020934557,Apoe/Lpl,2,
GO:0046464,acylglycerol catabolic process,Feb-60,27/15833,0.004663836,0.030223899,0.020934557,Apoe/Lpl,2,
GO:0071402,cellular response to lipoprotein particle stimulus,Feb-60,27/15833,0.004663836,0.030223899,0.020934557,Apoe/Lpl,2,
GO:0071624,positive regulation of granulocyte chemotaxis,Feb-60,27/15833,0.004663836,0.030223899,0.020934557,Cd74/Il1b,2,
GO:0019058,viral life cycle,Apr-60,179/15833,0.004706509,0.030409118,0.02106285,Apoe/Cd74/Ctsb/Axl,4,
GO:0002702,positive regulation of production of molecular mediator of immune response,Mar-60,90/15833,0.004810645,0.03080526,0.021337237,Cd74/Tlr2/Il1b,3,
GO:0019882,antigen processing and presentation,Mar-60,90/15833,0.004810645,0.03080526,0.021337237,Cd74/H2-D1/H2-K1,3,
GO:0045685,regulation of glial cell differentiation,Mar-60,90/15833,0.004810645,0.03080526,0.021337237,Tlr2/Il1b/Id2,3,
GO:0001779,natural killer cell differentiation,Feb-60,28/15833,0.005010405,0.031340448,0.021707935,Axl/Id2,2,
GO:0001893,maternal placenta development,Feb-60,28/15833,0.005010405,0.031340448,0.021707935,Junb/Ctsb,2,
GO:0032689,negative regulation of interferon-gamma production,Feb-60,28/15833,0.005010405,0.031340448,0.021707935,Axl/Vsir,2,
GO:0050999,regulation of nitric-oxide synthase activity,Feb-60,28/15833,0.005010405,0.031340448,0.021707935,Apoe/Il1b,2,
GO:0051953,negative regulation of amine transport,Feb-60,28/15833,0.005010405,0.031340448,0.021707935,P2ry12/Il1b,2,
GO:0055090,acylglycerol homeostasis,Feb-60,28/15833,0.005010405,0.031340448,0.021707935,Apoe/Lpl,2,
GO:0070328,triglyceride homeostasis,Feb-60,28/15833,0.005010405,0.031340448,0.021707935,Apoe/Lpl,2,
GO:0071827,plasma lipoprotein particle organization,Feb-60,28/15833,0.005010405,0.031340448,0.021707935,Apoe/Lpl,2,
GO:0043254,regulation of protein complex assembly,Jun-60,420/15833,0.005026447,0.031349918,0.021714494,Apoe/H3f3b/Tlr2/Pmepa1/P2ry12/Hsp90aa1,6,
GO:0019722,calcium-mediated signaling,Apr-60,184/15833,0.005186635,0.032255786,0.022341943,Ccl4/Ccrl2/Cx3cr1/P2ry12,4,
GO:0006469,negative regulation of protein kinase activity,Apr-60,185/15833,0.005286455,0.032726567,0.022668029,Apoe/Dusp1/Gadd45b/Il1b,4,
GO:0002724,regulation of T cell cytokine production,Feb-60,29/15833,0.005368492,0.032726567,0.022668029,Vsir/Il1b,2,
GO:0019884,antigen processing and presentation of exogenous antigen,Feb-60,29/15833,0.005368492,0.032726567,0.022668029,Cd74/H2-K1,2,
GO:0030574,collagen catabolic process,Feb-60,29/15833,0.005368492,0.032726567,0.022668029,Ctsb/Vsir,2,
GO:0032660,regulation of interleukin-17 production,Feb-60,29/15833,0.005368492,0.032726567,0.022668029,Tlr2/Vsir,2,
GO:1901099,negative regulation of signal transduction in absence of ligand,Feb-60,29/15833,0.005368492,0.032726567,0.022668029,Cx3cr1/Il1b,2,
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,Feb-60,29/15833,0.005368492,0.032726567,0.022668029,Cx3cr1/Il1b,2,
GO:0015850,organic hydroxy compound transport,Apr-60,186/15833,0.005387557,0.032750275,0.02268445,Apoe/Spp1/Nfkbia/P2ry12,4,
GO:0014074,response to purine-containing compound,Mar-60,95/15833,0.005592705,0.033901848,0.023482086,Junb/P2ry12/Il1b,3,
GO:0032733,positive regulation of interleukin-10 production,Feb-60,30/15833,0.005738005,0.034300875,0.023758472,Cd83/Tlr2,2,
GO:0032743,positive regulation of interleukin-2 production,Feb-60,30/15833,0.005738005,0.034300875,0.023758472,Cd83/Il1b,2,
GO:0045672,positive regulation of osteoclast differentiation,Feb-60,30/15833,0.005738005,0.034300875,0.023758472,Ccl3/Fos,2,
GO:1904467,regulation of tumor necrosis factor secretion,Feb-60,30/15833,0.005738005,0.034300875,0.023758472,Lpl/Tlr2,2,
GO:2000778,positive regulation of interleukin-6 secretion,Feb-60,30/15833,0.005738005,0.034300875,0.023758472,Lpl/Il1b,2,
GO:0032649,regulation of interferon-gamma production,Mar-60,96/15833,0.005757721,0.03432365,0.023774246,Axl/Vsir/Il1b,3,
GO:0002274,myeloid leukocyte activation,Apr-60,190/15833,0.005804935,0.034509779,0.023903169,Cst7/Tlr2/Cx3cr1/Hmox1,4,
GO:0006692,prostanoid metabolic process,Feb-60,31/15833,0.006118858,0.035979554,0.024921207,Cd74/Il1b,2,
GO:0006693,prostaglandin metabolic process,Feb-60,31/15833,0.006118858,0.035979554,0.024921207,Cd74/Il1b,2,
GO:0045940,positive regulation of steroid metabolic process,Feb-60,31/15833,0.006118858,0.035979554,0.024921207,Apoe/Il1b,2,
GO:0090022,regulation of neutrophil chemotaxis,Feb-60,31/15833,0.006118858,0.035979554,0.024921207,Cd74/Il1b,2,
GO:0050707,regulation of cytokine secretion,Apr-60,194/15833,0.006243413,0.036612186,0.025359399,Ccl3/Lpl/Tlr2/Il1b,4,
GO:0030316,osteoclast differentiation,Mar-60,99/15833,0.006270224,0.036669766,0.025399282,Ccl3/Fos/Junb,3,
GO:1901342,regulation of vasculature development,May-60,310/15833,0.006316545,0.036840821,0.025517763,Cx3cr1/Il1b/Cxcl10/Klf2/Hmox1,5,
GO:0042063,gliogenesis,May-60,311/15833,0.006401392,0.037134955,0.025721494,Ccl3/Tlr2/P2ry12/Il1b/Id2,5,
GO:0050768,negative regulation of neurogenesis,May-60,311/15833,0.006401392,0.037134955,0.025721494,Apoe/H2-D1/H2-K1/Il1b/Id2,5,
GO:0035821,modification of morphology or physiology of other organism,Mar-60,100/15833,0.006446922,0.037171046,0.025746493,Apoe/Ccl4/Tlr2,3,
GO:0032371,regulation of sterol transport,Feb-60,32/15833,0.006510962,0.037171046,0.025746493,Apoe/Nfkbia,2,
GO:0032374,regulation of cholesterol transport,Feb-60,32/15833,0.006510962,0.037171046,0.025746493,Apoe/Nfkbia,2,
GO:0033344,cholesterol efflux,Feb-60,32/15833,0.006510962,0.037171046,0.025746493,Apoe/Nfkbia,2,
GO:0071825,protein-lipid complex subunit organization,Feb-60,32/15833,0.006510962,0.037171046,0.025746493,Apoe/Lpl,2,
GO:1990774,tumor necrosis factor secretion,Feb-60,32/15833,0.006510962,0.037171046,0.025746493,Lpl/Tlr2,2,
GO:1901361,organic cyclic compound catabolic process,Jun-60,444/15833,0.006555392,0.037325951,0.025853788,Apoe/Spp1/Btg2/Ier3/Zfp36/Hmox1,6,
GO:0046394,carboxylic acid biosynthetic process,May-60,313/15833,0.006573492,0.037330515,0.025856949,Cd74/Lpl/Ier3/Ltc4s/Il1b,5,
GO:0016053,organic acid biosynthetic process,May-60,314/15833,0.006660753,0.037726786,0.026131426,Cd74/Lpl/Ier3/Ltc4s/Il1b,5,
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,Mar-60,102/15833,0.006809187,0.038466562,0.026643831,Cd74/Cx3cr1/Il1b,3,
GO:0001916,positive regulation of T cell mediated cytotoxicity,Feb-60,33/15833,0.006914228,0.038655192,0.026774485,H2-D1/H2-K1,2,
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,Feb-60,33/15833,0.006914228,0.038655192,0.026774485,H2-D1/H2-K1,2,
GO:0061756,leukocyte adhesion to vascular endothelial cell,Feb-60,33/15833,0.006914228,0.038655192,0.026774485,Cx3cr1/Selplg,2,
GO:1902624,positive regulation of neutrophil migration,Feb-60,33/15833,0.006914228,0.038655192,0.026774485,Cd74/Il1b,2,
GO:0006986,response to unfolded protein,Mar-60,104/15833,0.007183363,0.039861863,0.027610285,Atf3/Ppp1r15a/Hsp90aa1,3,
GO:0016525,negative regulation of angiogenesis,Mar-60,104/15833,0.007183363,0.039861863,0.027610285,Cx3cr1/Cxcl10/Klf2,3,
GO:0033673,negative regulation of kinase activity,Apr-60,202/15833,0.00718548,0.039861863,0.027610285,Apoe/Dusp1/Gadd45b/Il1b,4,
GO:0045732,positive regulation of protein catabolic process,Apr-60,203/15833,0.007309477,0.04018973,0.027837382,Apoe/Ier3/Il1b/Hsp90aa1,4,
GO:0002701,negative regulation of production of molecular mediator of immune response,Feb-60,34/15833,0.00732857,0.04018973,0.027837382,Vsir/Hmox1,2,
GO:0006636,unsaturated fatty acid biosynthetic process,Feb-60,34/15833,0.00732857,0.04018973,0.027837382,Cd74/Il1b,2,
GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,Feb-60,34/15833,0.00732857,0.04018973,0.027837382,Cxcl2/Cxcl10,2,
GO:0006639,acylglycerol metabolic process,Mar-60,105/15833,0.007374946,0.04018973,0.027837382,Apoe/Lpl/Apoc1,3,
GO:0071346,cellular response to interferon-gamma,Mar-60,105/15833,0.007374946,0.04018973,0.027837382,Ccl3/Ccl4/Tlr2,3,
GO:0071901,negative regulation of protein serine/threonine kinase activity,Mar-60,105/15833,0.007374946,0.04018973,0.027837382,Apoe/Dusp1/Il1b,3,
GO:1903531,negative regulation of secretion by cell,Apr-60,204/15833,0.007434883,0.040414304,0.027992933,Apoe/P2ry12/Il1b/Hmox1,4,
GO:0021782,glial cell development,Mar-60,106/15833,0.007569541,0.041042889,0.028428322,Tlr2/Il1b/Id2,3,
GO:0002791,regulation of peptide secretion,Jun-60,460/15833,0.007747607,0.041488938,0.028737277,Apoe/Ccl3/Cd74/Lpl/Tlr2/Il1b,6,
GO:0032620,interleukin-17 production,Feb-60,35/15833,0.0077539,0.041488938,0.028737277,Tlr2/Vsir,2,
GO:2000403,positive regulation of lymphocyte migration,Feb-60,35/15833,0.0077539,0.041488938,0.028737277,Ccl4/Cxcl10,2,
GO:0006638,neutral lipid metabolic process,Mar-60,107/15833,0.00776716,0.041488938,0.028737277,Apoe/Lpl/Apoc1,3,
GO:0007565,female pregnancy,Mar-60,107/15833,0.00776716,0.041488938,0.028737277,Junb/H3f3b/Ctsb,3,
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,Mar-60,107/15833,0.00776716,0.041488938,0.028737277,Cd74/Ier3/Hmox1,3,
GO:0032609,interferon-gamma production,Mar-60,108/15833,0.007967813,0.042247027,0.029262367,Axl/Vsir/Il1b,3,
GO:0060759,regulation of response to cytokine stimulus,Mar-60,108/15833,0.007967813,0.042247027,0.029262367,Cd74/Axl/Tlr2,3,
GO:2000181,negative regulation of blood vessel morphogenesis,Mar-60,108/15833,0.007967813,0.042247027,0.029262367,Cx3cr1/Cxcl10/Klf2,3,
GO:0014003,oligodendrocyte development,Feb-60,36/15833,0.008190133,0.043108064,0.029858763,Tlr2/Id2,2,
GO:0034105,positive regulation of tissue remodeling,Feb-60,36/15833,0.008190133,0.043108064,0.029858763,Spp1/Klf6,2,
GO:0071158,positive regulation of cell cycle arrest,Feb-60,36/15833,0.008190133,0.043108064,0.029858763,Rpl23/Id2,2,
GO:0001505,regulation of neurotransmitter levels,May-60,331/15833,0.008271703,0.043431475,0.030082773,Tlr2/Cx3cr1/Il1b/Klf2/Hsp90aa1,5,
GO:0097191,extrinsic apoptotic signaling pathway,Apr-60,212/15833,0.00848965,0.044467635,0.030800469,Atf3/Cx3cr1/Il1b/Hmox1,4,
GO:0002708,positive regulation of lymphocyte mediated immunity,Mar-60,111/15833,0.008588082,0.044697932,0.030959984,H2-D1/H2-K1/Il1b,3,
GO:0001914,regulation of T cell mediated cytotoxicity,Feb-60,37/15833,0.008637182,0.044697932,0.030959984,H2-D1/H2-K1,2,
GO:0010883,regulation of lipid storage,Feb-60,37/15833,0.008637182,0.044697932,0.030959984,Nfkbia/Lpl,2,
GO:0031670,cellular response to nutrient,Feb-60,37/15833,0.008637182,0.044697932,0.030959984,Lpl/P2ry12,2,
GO:0051154,negative regulation of striated muscle cell differentiation,Feb-60,37/15833,0.008637182,0.044697932,0.030959984,Tmem119/Cxcl10,2,
GO:0030900,forebrain development,May-60,335/15833,0.008686933,0.044847849,0.031063824,Btg2/Axl/Cx3cr1/P2ry12/Id2,5,
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,Mar-60,113/15833,0.009016954,0.046440543,0.032167002,H2-D1/H2-K1/Il1b,3,
GO:0032768,regulation of monooxygenase activity,Feb-60,38/15833,0.009094961,0.046619184,0.032290738,Apoe/Il1b,2,
GO:0048246,macrophage chemotaxis,Feb-60,38/15833,0.009094961,0.046619184,0.032290738,Ccl3/Cx3cr1,2,
GO:0001503,ossification,May-60,339/15833,0.009116448,0.046619184,0.032290738,Spp1/Junb/H3f3b/Tmem119/Id2,5,
GO:0021537,telencephalon development,Apr-60,217/15833,0.00919636,0.046916657,0.032496782,Btg2/Cx3cr1/P2ry12/Id2,4,
GO:0006633,fatty acid biosynthetic process,Mar-60,115/15833,0.009458203,0.048138686,0.033343219,Cd74/Lpl/Il1b,3,
GO:0002369,T cell cytokine production,Feb-60,39/15833,0.009563387,0.048445516,0.033555745,Vsir/Il1b,2,
GO:0030225,macrophage differentiation,Feb-60,39/15833,0.009563387,0.048445516,0.033555745,Tlr2/Id2,2,
GO:1901216,positive regulation of neuron death,Mar-60,116/15833,0.009683492,0.048939052,0.033897593,Ccl3/Fos/Il1b,3,
GO:0032757,positive regulation of interleukin-8 production,Feb-60,40/15833,0.010042375,0.050398709,0.034908622,Tlr2/Il1b,2,
GO:0046782,regulation of viral transcription,Feb-60,40/15833,0.010042375,0.050398709,0.034908622,Ccl4/Zfp36,2,
GO:0048710,regulation of astrocyte differentiation,Feb-60,40/15833,0.010042375,0.050398709,0.034908622,Il1b/Id2,2,
GO:0050663,cytokine secretion,Apr-60,223/15833,0.01009392,0.05053986,0.035006391,Ccl3/Lpl/Tlr2/Il1b,4,
GO:0072330,monocarboxylic acid biosynthetic process,Apr-60,224/15833,0.010248848,0.051196792,0.035461414,Cd74/Lpl/Ier3/Il1b,4,
GO:1901343,negative regulation of vasculature development,Mar-60,119/15833,0.010378117,0.051722812,0.035825761,Cx3cr1/Cxcl10/Klf2,3,
GO:0006509,membrane protein ectodomain proteolysis,Feb-60,41/15833,0.01053184,0.051771549,0.035859519,Apoe/Il1b,2,
GO:0045124,regulation of bone resorption,Feb-60,41/15833,0.01053184,0.051771549,0.035859519,Spp1/Tmem119,2,
GO:0060135,maternal process involved in female pregnancy,Feb-60,41/15833,0.01053184,0.051771549,0.035859519,Junb/Ctsb,2,
GO:1900077,negative regulation of cellular response to insulin stimulus,Feb-60,41/15833,0.01053184,0.051771549,0.035859519,Lpl/Il1b,2,
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,Feb-60,41/15833,0.01053184,0.051771549,0.035859519,Atf3/Hmox1,2,
GO:1902622,regulation of neutrophil migration,Feb-60,41/15833,0.01053184,0.051771549,0.035859519,Cd74/Il1b,2,
GO:0010721,negative regulation of cell development,May-60,353/15833,0.01073565,0.052653482,0.036470389,Apoe/H2-D1/H2-K1/Il1b/Id2,5,
GO:0001961,positive regulation of cytokine-mediated signaling pathway,Feb-60,42/15833,0.011031699,0.05398278,0.037391126,Cd74/Axl,2,
GO:0030218,erythrocyte differentiation,Mar-60,122/15833,0.011101054,0.054199262,0.037541072,Zfp36/Id2/Klf2,3,
GO:0045598,regulation of fat cell differentiation,Mar-60,123/15833,0.011348359,0.055281625,0.03829077,Lpl/Zfp36/Id2,3,
GO:0019083,viral transcription,Feb-60,43/15833,0.011541869,0.055721146,0.038595204,Ccl4/Zfp36,2,
GO:0046503,glycerolipid catabolic process,Feb-60,43/15833,0.011541869,0.055721146,0.038595204,Apoe/Lpl,2,
GO:1902930,regulation of alcohol biosynthetic process,Feb-60,43/15833,0.011541869,0.055721146,0.038595204,Apoe/Il1b,2,
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,Feb-60,43/15833,0.011541869,0.055721146,0.038595204,Cx3cr1/Il1b,2,
GO:0071407,cellular response to organic cyclic compound,May-60,360/15833,0.011615053,0.055949294,0.038753231,Spp1/Nfkbia/Zfp36/P2ry12/Il1b,5,
GO:0034341,response to interferon-gamma,Mar-60,125/15833,0.011852505,0.056839344,0.039369723,Ccl3/Ccl4/Tlr2,3,
GO:0051092,positive regulation of NF-kappaB transcription factor activity,Mar-60,125/15833,0.011852505,0.056839344,0.039369723,Tlr2/Cx3cr1/Il1b,3,
GO:0008202,steroid metabolic process,Apr-60,235/15833,0.012055914,0.057686613,0.039956583,Apoe/Spp1/Apoc1/Il1b,4,
GO:0035966,response to topologically incorrect protein,Mar-60,126/15833,0.012109358,0.057814146,0.040044918,Atf3/Ppp1r15a/Hsp90aa1,3,
GO:0022407,regulation of cell-cell adhesion,May-60,364/15833,0.012139103,0.057828222,0.040054668,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:0051353,positive regulation of oxidoreductase activity,Feb-60,45/15833,0.012592811,0.059594927,0.041278375,Apoe/Il1b,2,
GO:0071675,regulation of mononuclear cell migration,Feb-60,45/15833,0.012592811,0.059594927,0.041278375,Dusp1/Cxcl10,2,
GO:0072604,interleukin-6 secretion,Feb-60,45/15833,0.012592811,0.059594927,0.041278375,Lpl/Il1b,2,
GO:0044706,multi-multicellular organism process,Mar-60,128/15833,0.012632657,0.059652677,0.041318376,Junb/H3f3b/Ctsb,3,
GO:0002250,adaptive immune response,May-60,369/15833,0.012816598,0.060389122,0.041828474,Cd74/H2-D1/H2-K1/Vsir/Il1b,5,
GO:0009612,response to mechanical stimulus,Mar-60,129/15833,0.012899115,0.060645514,0.042006063,Nfkbia/Fos/Junb,3,
GO:0030336,negative regulation of cell migration,Apr-60,240/15833,0.012940884,0.060709624,0.042050468,Apoe/Dusp1/Cd63/Cx3cr1,4,
GO:0006979,response to oxidative stress,May-60,371/15833,0.01309466,0.060819572,0.042126624,Apoe/Fos/Axl/Cst3/Hmox1,5,
GO:0051403,stress-activated MAPK cascade,Apr-60,241/15833,0.013122735,0.060819572,0.042126624,Dusp1/Gadd45b/Zfp36/Il1b,4,
GO:0000288,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,Feb-60,46/15833,0.01313342,0.060819572,0.042126624,Btg2/Zfp36,2
GO:0048713,regulation of oligodendrocyte differentiation,Feb-60,46/15833,0.01313342,0.060819572,0.042126624,Tlr2/Id2,2,
GO:0061014,positive regulation of mRNA catabolic process,Feb-60,46/15833,0.01313342,0.060819572,0.042126624,Btg2/Zfp36,2,
GO:0070542,response to fatty acid,Feb-60,46/15833,0.01313342,0.060819572,0.042126624,Lpl/Tlr2,2,
GO:0006959,humoral immune response,Mar-60,130/15833,0.013168788,0.060852771,0.042149619,Cxcl2/Il1b/Cxcl10,3,
GO:0016042,lipid catabolic process,Apr-60,243/15833,0.013491335,0.062210045,0.043089734,Apoe/Spp1/Lpl/Il1b,4,
GO:0019730,antimicrobial humoral response,Feb-60,47/15833,0.013684012,0.062563768,0.04333474,Cxcl2/Cxcl10,2,
GO:0035176,social behavior,Feb-60,47/15833,0.013684012,0.062563768,0.04333474,Cx3cr1/Il1b,2,
GO:0045646,regulation of erythrocyte differentiation,Feb-60,47/15833,0.013684012,0.062563768,0.04333474,Zfp36/Id2,2,
GO:0051703,intraspecies interaction between organisms,Feb-60,47/15833,0.013684012,0.062563768,0.04333474,Cx3cr1/Il1b,2,
GO:0007596,blood coagulation,Mar-60,132/15833,0.013717796,0.062585633,0.043349885,Apoe/Axl/P2ry12,3,
GO:0007613,memory,Mar-60,133/15833,0.013997143,0.06372539,0.044139336,Apoe/Cx3cr1/Il1b,3,
GO:0031663,lipopolysaccharide-mediated signaling pathway,Feb-60,48/15833,0.014244507,0.06446788,0.044653622,Nfkbia/Il1b,2,
GO:0071622,regulation of granulocyte chemotaxis,Feb-60,48/15833,0.014244507,0.06446788,0.044653622,Cd74/Il1b,2,
GO:0007599,hemostasis,Mar-60,134/15833,0.014279725,0.06446788,0.044653622,Apoe/Axl/P2ry12,3,
GO:0050817,coagulation,Mar-60,134/15833,0.014279725,0.06446788,0.044653622,Apoe/Axl/P2ry12,3,
GO:0033619,membrane protein proteolysis,Feb-60,49/15833,0.014814824,0.066466506,0.046037968,Apoe/Il1b,2,
GO:0043392,negative regulation of DNA binding,Feb-60,49/15833,0.014814824,0.066466506,0.046037968,Id2/Hmox1,2,
GO:0046850,regulation of bone remodeling,Feb-60,49/15833,0.014814824,0.066466506,0.046037968,Spp1/Tmem119,2,
GO:2000146,negative regulation of cell motility,Apr-60,251/15833,0.015031746,0.067299807,0.046615153,Apoe/Dusp1/Cd63/Cx3cr1,4,
GO:0034249,negative regulation of cellular amide metabolic process,Mar-60,141/15833,0.016348765,0.073044794,0.050594414,Apoe/Btg2/Zfp36,3,
GO:0002704,negative regulation of leukocyte mediated immunity,Feb-60,52/15833,0.01658391,0.073486812,0.050900577,Vsir/Hmox1,2,
GO:0045620,negative regulation of lymphocyte differentiation,Feb-60,52/15833,0.01658391,0.073486812,0.050900577,Cd74/Id2,2,
GO:0097006,regulation of plasma lipoprotein particle levels,Feb-60,52/15833,0.01658391,0.073486812,0.050900577,Apoe/Lpl,2,
GO:1900271,regulation of long-term synaptic potentiation,Feb-60,52/15833,0.01658391,0.073486812,0.050900577,Apoe/Cx3cr1,2,
GO:0021543,pallium development,Mar-60,142/15833,0.016657386,0.073661147,0.05102133,Btg2/Cx3cr1/P2ry12,3,
GO:0098542,defense response to other organism,May-60,395/15833,0.016756644,0.073948543,0.051220394,Lyz2/H2-K1/Tlr2/Il1b/Cxcl10,5,
GO:0002705,positive regulation of leukocyte mediated immunity,Mar-60,143/15833,0.016969279,0.074581883,0.051659077,H2-D1/H2-K1/Il1b,3,
GO:0002792,negative regulation of peptide secretion,Mar-60,143/15833,0.016969279,0.074581883,0.051659077,Apoe/Cd74/Il1b,3,
GO:0001913,T cell mediated cytotoxicity,Feb-60,53/15833,0.017192721,0.074953316,0.05191635,H2-D1/H2-K1,2,
GO:0021795,cerebral cortex cell migration,Feb-60,53/15833,0.017192721,0.074953316,0.05191635,Cx3cr1/P2ry12,2,
GO:0051148,negative regulation of muscle cell differentiation,Feb-60,53/15833,0.017192721,0.074953316,0.05191635,Tmem119/Cxcl10,2,
GO:2000107,negative regulation of leukocyte apoptotic process,Feb-60,53/15833,0.017192721,0.074953316,0.05191635,Cd74/Axl,2,
GO:0021700,developmental maturation,Apr-60,264/15833,0.017764932,0.076998608,0.053333019,Cd63/Cx3cr1/Id2/Klf2,4,
GO:0045088,regulation of innate immune response,Apr-60,264/15833,0.017764932,0.076998608,0.053333019,Apoe/Cd74/Nfkbia/Tlr2,4,
GO:0008015,blood circulation,May-60,401/15833,0.017768909,0.076998608,0.053333019,Apoe/Ccl4/Ier3/Id2/Hmox1,5,
GO:2000401,regulation of lymphocyte migration,Feb-60,54/15833,0.017810959,0.07702615,0.053352097,Ccl4/Cxcl10,2,
GO:0043433,negative regulation of DNA-binding transcription factor activity,Mar-60,146/15833,0.017924618,0.077362653,0.053585175,Nfkbia/Id2/Hmox1,3,
GO:0050714,positive regulation of protein secretion,Apr-60,265/15833,0.017987192,0.077477763,0.053664906,Ccl3/Lpl/Tlr2/Il1b,4,
GO:0071900,regulation of protein serine/threonine kinase activity,May-60,403/15833,0.018115184,0.07787364,0.05393911,Apoe/Cd74/Dusp1/Gadd45b/Il1b,5,
GO:0032677,regulation of interleukin-8 production,Feb-60,55/15833,0.018438546,0.079106129,0.054792792,Tlr2/Il1b,2,
GO:0019080,viral gene expression,Feb-60,56/15833,0.019075406,0.081676044,0.056572842,Ccl4/Zfp36,2,
GO:0003013,circulatory system process,May-60,410/15833,0.019362442,0.082740891,0.057310407,Apoe/Ccl4/Ier3/Id2/Hmox1,5,
GO:0010830,regulation of myotube differentiation,Feb-60,57/15833,0.019721461,0.083612796,0.057914332,Tmem119/Cxcl10,2,
GO:0032720,negative regulation of tumor necrosis factor production,Feb-60,57/15833,0.019721461,0.083612796,0.057914332,Axl/Vsir,2,
GO:0055081,anion homeostasis,Feb-60,57/15833,0.019721461,0.083612796,0.057914332,Apoe/Ckb,2,
GO:1903793,positive regulation of anion transport,Feb-60,57/15833,0.019721461,0.083612796,0.057914332,Apoe/Il1b,2,
GO:0031098,stress-activated protein kinase signaling cascade,Apr-60,273/15833,0.019828089,0.083900032,0.058113285,Dusp1/Gadd45b/Zfp36/Il1b,4,
GO:0008217,regulation of blood pressure,Mar-60,152/15833,0.019924,0.084140883,0.05828011,Ier3/Id2/Hmox1,3,
GO:0009611,response to wounding,May-60,414/15833,0.02010007,0.084718656,0.058680304,Apoe/Axl/Zfp36/P2ry12/Hmox1,5,
GO:0008347,glial cell migration,Feb-60,58/15833,0.020376636,0.085218565,0.059026566,Ccl3/P2ry12,2,
GO:0033559,unsaturated fatty acid metabolic process,Feb-60,58/15833,0.020376636,0.085218565,0.059026566,Cd74/Il1b,2,
GO:0071156,regulation of cell cycle arrest,Feb-60,58/15833,0.020376636,0.085218565,0.059026566,Rpl23/Id2,2,
GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,Feb-60,58/15833,0.020376636,0.085218565,0.059026566,Axl/Vsir,2,
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,Mar-60,154/15833,0.020616802,0.086056205,0.059606756,Cd74/Cx3cr1/Il1b,3,
GO:1903532,positive regulation of secretion by cell,May-60,418/15833,0.020856025,0.086886683,0.060181986,Spp1/Ccl3/Lpl/Tlr2/Il1b,5,
GO:0030968,endoplasmic reticulum unfolded protein response,Feb-60,59/15833,0.021040853,0.087487786,0.06059834,Atf3/Ppp1r15a,2,
GO:0032637,interleukin-8 production,Feb-60,60/15833,0.021714038,0.089767997,0.062177726,Tlr2/Il1b,2,
GO:0034605,cellular response to heat,Feb-60,60/15833,0.021714038,0.089767997,0.062177726,Hmox1/Hsp90aa1,2,
GO:0045123,cellular extravasation,Feb-60,60/15833,0.021714038,0.089767997,0.062177726,Cx3cr1/Selplg,2,
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,Feb-60,61/15833,0.022396116,0.091301974,0.063240234,H2-D1/H2-K1,2,
GO:0015918,sterol transport,Feb-60,61/15833,0.022396116,0.091301974,0.063240234,Apoe/Nfkbia,2,
GO:0030032,lamellipodium assembly,Feb-60,61/15833,0.022396116,0.091301974,0.063240234,P2ry12/Hsp90aa1,2,
GO:0030301,cholesterol transport,Feb-60,61/15833,0.022396116,0.091301974,0.063240234,Apoe/Nfkbia,2,
GO:2000514,regulation of CD4-positive, alpha-beta T cell activation,Feb-60,61/15833,0.022396116,0.091301974,0.063240234,Cd83/Vsir,2
GO:0043901,negative regulation of multi-organism process,Mar-60,159/15833,0.022406531,0.091301974,0.063240234,Ccl4/Zfp36/Tlr2,3,
GO:0043902,positive regulation of multi-organism process,Mar-60,159/15833,0.022406531,0.091301974,0.063240234,Apoe/Cd74/Tlr2,3,
GO:0071417,cellular response to organonitrogen compound,May-60,426/15833,0.022423562,0.091301974,0.063240234,Lpl/Rpl23/Tlr2/P2ry12/Il1b,5,
GO:0051271,negative regulation of cellular component movement,Apr-60,284/15833,0.022544119,0.091619978,0.063460499,Apoe/Dusp1/Cd63/Cx3cr1,4,
GO:0050708,regulation of protein secretion,May-60,427/15833,0.022624767,0.0917749,0.063567806,Apoe/Ccl3/Lpl/Tlr2/Il1b,5,
GO:0045453,bone resorption,Feb-60,62/15833,0.023087011,0.093299195,0.064623607,Spp1/Tmem119,2,
GO:0051705,multi-organism behavior,Feb-60,62/15833,0.023087011,0.093299195,0.064623607,Cx3cr1/Il1b,2,
GO:0002793,positive regulation of peptide secretion,Apr-60,290/15833,0.024117135,0.097279959,0.06738088,Ccl3/Lpl/Tlr2/Il1b,4,
GO:0007519,skeletal muscle tissue development,Mar-60,164/15833,0.024278785,0.097749286,0.067705959,Atf3/Fos/Btg2,3,
GO:0010633,negative regulation of epithelial cell migration,Feb-60,64/15833,0.024494959,0.098435982,0.068181598,Apoe/Cd63,2,
GO:0042110,T cell activation,May-60,438/15833,0.024916249,0.099942872,0.069225344,Cd74/Cd83/Vsir/Il1b/Hsp90aa1,5,
GO:0010977,negative regulation of neuron projection development,Mar-60,166/15833,0.025050795,0.100013243,0.069274087,Apoe/H2-D1/H2-K1,3,
GO:0045766,positive regulation of angiogenesis,Mar-60,166/15833,0.025050795,0.100013243,0.069274087,Cx3cr1/Il1b/Hmox1,3,
GO:0016239,positive regulation of macroautophagy,Feb-60,65/15833,0.025211865,0.100013243,0.069274087,Tlr2/Hmox1,2,
GO:0042108,positive regulation of cytokine biosynthetic process,Feb-60,65/15833,0.025211865,0.100013243,0.069274087,Tlr2/Il1b,2,
GO:0050810,regulation of steroid biosynthetic process,Feb-60,65/15833,0.025211865,0.100013243,0.069274087,Apoe/Il1b,2,
GO:0051851,modification by host of symbiont morphology or physiology,Feb-60,65/15833,0.025211865,0.100013243,0.069274087,Apoe/Ccl4,2,
GO:0051047,positive regulation of secretion,May-60,441/15833,0.025566324,0.101233262,0.070119132,Spp1/Ccl3/Lpl/Tlr2/Il1b,5,
GO:0022029,telencephalon cell migration,Feb-60,66/15833,0.025937294,0.102326653,0.070876468,Cx3cr1/P2ry12,2,
GO:1903670,regulation of sprouting angiogenesis,Feb-60,66/15833,0.025937294,0.102326653,0.070876468,Klf2/Hmox1,2,
GO:0009636,response to toxic substance,Apr-60,297/15833,0.02603502,0.102524767,0.071013692,Ccl4/Mt1/Axl/Hmox1,4,
GO:0040013,negative regulation of locomotion,Apr-60,298/15833,0.02631632,0.103443751,0.071650225,Apoe/Dusp1/Cd63/Cx3cr1,4,
GO:0060538,skeletal muscle organ development,Mar-60,170/15833,0.026634408,0.104458061,0.072352786,Atf3/Fos/Btg2,3,
GO:0045670,regulation of osteoclast differentiation,Feb-60,67/15833,0.026671173,0.104458061,0.072352786,Ccl3/Fos,2,
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,Feb-60,68/15833,0.027413432,0.106399614,0.073697601,Atf3/Hmox1,2,
GO:0015908,fatty acid transport,Feb-60,68/15833,0.027413432,0.106399614,0.073697601,Apoe/Il1b,2,
GO:0042632,cholesterol homeostasis,Feb-60,68/15833,0.027413432,0.106399614,0.073697601,Apoe/Lpl,2,
GO:0050830,defense response to Gram-positive bacterium,Feb-60,68/15833,0.027413432,0.106399614,0.073697601,Lyz2/Tlr2,2,
GO:1901796,regulation of signal transduction by p53 class mediator,Feb-60,68/15833,0.027413432,0.106399614,0.073697601,Cd74/Rpl23,2,
GO:0030101,natural killer cell activation,Feb-60,69/15833,0.028163997,0.108920977,0.075444021,Axl/Id2,2,
GO:0055092,sterol homeostasis,Feb-60,69/15833,0.028163997,0.108920977,0.075444021,Apoe/Lpl,2,
GO:0031669,cellular response to nutrient levels,Mar-60,174/15833,0.028270752,0.108963449,0.075473439,Atf3/Lpl/P2ry12,3,
GO:0032870,cellular response to hormone stimulus,May-60,453/15833,0.028275965,0.108963449,0.075473439,Spp1/Junb/Lpl/Zfp36/Il1b,5,
GO:0051702,interaction with symbiont,Feb-60,70/15833,0.028922798,0.110665598,0.076652431,Apoe/Ccl4,2,
GO:0070373,negative regulation of ERK1 and ERK2 cascade,Feb-60,70/15833,0.028922798,0.110665598,0.076652431,Atf3/Dusp1,2,
GO:0070613,regulation of protein processing,Feb-60,70/15833,0.028922798,0.110665598,0.076652431,Cst7/Il1b,2,
GO:0071347,cellular response to interleukin-1,Feb-60,70/15833,0.028922798,0.110665598,0.076652431,Ccl3/Ccl4,2,
GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,Feb-60,71/15833,0.029689763,0.112601949,0.077993643,Cx3cr1/P2ry12,2,
GO:0031343,positive regulation of cell killing,Feb-60,71/15833,0.029689763,0.112601949,0.077993643,H2-D1/H2-K1,2,
GO:0061515,myeloid cell development,Feb-60,71/15833,0.029689763,0.112601949,0.077993643,Tlr2/Klf2,2,
GO:0071277,cellular response to calcium ion,Feb-60,71/15833,0.029689763,0.112601949,0.077993643,Fos/Junb,2,
GO:1901224,positive regulation of NIK/NF-kappaB signaling,Feb-60,71/15833,0.029689763,0.112601949,0.077993643,Tlr2/Il1b,2,
GO:0042060,wound healing,Apr-60,310/15833,0.029835769,0.112957174,0.078239689,Apoe/Axl/P2ry12/Hmox1,4,
GO:1903317,regulation of protein maturation,Feb-60,72/15833,0.030464823,0.115136756,0.079749375,Cst7/Il1b,2,
GO:0038034,signal transduction in absence of ligand,Feb-60,74/15833,0.032038944,0.120663248,0.083577295,Cx3cr1/Il1b,2,
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,Feb-60,74/15833,0.032038944,0.120663248,0.083577295,Cx3cr1/Il1b,2,
GO:0001525,angiogenesis,May-60,470/15833,0.032419146,0.121882432,0.084421762,Cx3cr1/Il1b/Cxcl10/Klf2/Hmox1,5,
GO:1904018,positive regulation of vasculature development,Mar-60,184/15833,0.032591573,0.122317589,0.084723173,Cx3cr1/Il1b/Hmox1,3,
GO:0051345,positive regulation of hydrolase activity,May-60,471/15833,0.03267414,0.122414572,0.084790348,Ccl3/Ccl4/Ppp1r15a/Vsir/Rgs1,5,
GO:0051341,regulation of oxidoreductase activity,Feb-60,75/15833,0.032837867,0.12281476,0.085067538,Apoe/Il1b,2,
GO:0042742,defense response to bacterium,Mar-60,186/15833,0.033495003,0.125055738,0.086619749,Lyz2/H2-K1/Tlr2,3,
GO:0034620,cellular response to unfolded protein,Feb-60,76/15833,0.033644605,0.125397337,0.086856358,Atf3/Ppp1r15a,2,
GO:1901699,cellular response to nitrogen compound,May-60,477/15833,0.034230688,0.127361765,0.088217017,Lpl/Rpl23/Tlr2/P2ry12/Il1b,5,
GO:0043525,positive regulation of neuron apoptotic process,Feb-60,77/15833,0.034459091,0.127990911,0.088652794,Ccl3/Il1b,2,
GO:0097581,lamellipodium organization,Feb-60,78/15833,0.035281257,0.130816014,0.090609599,P2ry12/Hsp90aa1,2,
GO:0000302,response to reactive oxygen species,Mar-60,190/15833,0.035340934,0.130816014,0.090609599,Fos/Axl/Hmox1,3,
GO:0002275,myeloid cell activation involved in immune response,Feb-60,79/15833,0.036111033,0.131405989,0.091018245,Cx3cr1/Hmox1,2,
GO:0048524,positive regulation of viral process,Feb-60,79/15833,0.036111033,0.131405989,0.091018245,Apoe/Cd74,2,
GO:0071774,response to fibroblast growth factor,Feb-60,79/15833,0.036111033,0.131405989,0.091018245,Ier2/Zfp36,2,
GO:1900076,regulation of cellular response to insulin stimulus,Feb-60,79/15833,0.036111033,0.131405989,0.091018245,Lpl/Il1b,2,
GO:1903313,positive regulation of mRNA metabolic process,Feb-60,79/15833,0.036111033,0.131405989,0.091018245,Btg2/Zfp36,2,
GO:0001910,regulation of leukocyte mediated cytotoxicity,Feb-60,80/15833,0.036948354,0.131405989,0.091018245,H2-D1/H2-K1,2,
GO:0003149,membranous septum morphogenesis,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Id2,1,
GO:0031392,regulation of prostaglandin biosynthetic process,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Il1b,1,
GO:0031620,regulation of fever generation,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Il1b,1,
GO:0032725,positive regulation of granulocyte macrophage colony-stimulating factor production,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Il1b,1,
GO:0032799,low-density lipoprotein receptor particle metabolic process,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Apoe,1,
GO:0033080,immature T cell proliferation in thymus,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Il1b,1,
GO:0035646,endosome to melanosome transport,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Cd63,1,
GO:0035744,T-helper 1 cell cytokine production,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Il1b,1,
GO:0043031,negative regulation of macrophage activation,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Cst7,1,
GO:0043301,negative regulation of leukocyte degranulation,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Hmox1,1,
GO:0043485,endosome to pigment granule transport,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Cd63,1,
GO:0043922,negative regulation by host of viral transcription,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Ccl4,1,
GO:0048757,pigment granule maturation,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Cd63,1,
GO:0070391,response to lipoteichoic acid,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Tlr2,1,
GO:0071223,cellular response to lipoteichoic acid,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Tlr2,1,
GO:0071294,cellular response to zinc ion,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Mt1,1,
GO:0071318,cellular response to ATP,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,P2ry12,1,
GO:0071639,positive regulation of monocyte chemotactic protein-1 production,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Il1b,1,
GO:0090209,negative regulation of triglyceride metabolic process,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Apoe,1,
GO:0097090,presynaptic membrane organization,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Apoe,1,
GO:0097113,AMPA glutamate receptor clustering,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Apoe,1,
GO:0097709,connective tissue replacement,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Klf6,1,
GO:0150079,negative regulation of neuroinflammatory response,Jan-60,10/15833,0.037266203,0.131405989,0.091018245,Cst7,1,
GO:0045833,negative regulation of lipid metabolic process,Feb-60,81/15833,0.037793152,0.132830003,0.092004587,Apoe/Il1b,2,
GO:0048708,astrocyte differentiation,Feb-60,81/15833,0.037793152,0.132830003,0.092004587,Il1b/Id2,2,
GO:0031345,negative regulation of cell projection organization,Mar-60,196/15833,0.038207063,0.134066409,0.092860983,Apoe/H2-D1/H2-K1,3,
GO:1904035,regulation of epithelial cell apoptotic process,Feb-60,82/15833,0.03864536,0.134806931,0.093373905,Zfp36/Hmox1,2,
GO:0017038,protein import,Mar-60,197/15833,0.038696042,0.134806931,0.093373905,Apoe/Nfkbia/Hsp90aa1,3,
GO:0030855,epithelial cell differentiation,May-60,496/15833,0.039463259,0.134806931,0.093373905,Cd63/Zfp36/Il1b/Id2/Klf2,5,
GO:0033077,T cell differentiation in thymus,Feb-60,83/15833,0.039504913,0.134806931,0.093373905,Cd74/Il1b,2,
GO:1901652,response to peptide,Apr-60,341/15833,0.040172743,0.134806931,0.093373905,Nfkbia/Lpl/Rpl23/Il1b,4,
GO:0002468,dendritic cell antigen processing and presentation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Cd74,1,
GO:0002579,positive regulation of antigen processing and presentation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Cd74,1,
GO:0010744,positive regulation of macrophage derived foam cell differentiation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Lpl,1,
GO:0019370,leukotriene biosynthetic process,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Ltc4s,1,
GO:0031055,chromatin remodeling at centromere,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,H3f3b,1,
GO:0031507,heterochromatin assembly,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,H3f3b,1,
GO:0032308,positive regulation of prostaglandin secretion,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Il1b,1,
GO:0032490,detection of molecule of bacterial origin,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Tlr2,1,
GO:0032825,positive regulation of natural killer cell differentiation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Axl,1,
GO:0033083,regulation of immature T cell proliferation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Il1b,1,
GO:0034116,positive regulation of heterotypic cell-cell adhesion,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Il1b,1,
GO:0035457,cellular response to interferon-alpha,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Axl,1,
GO:0035739,CD4-positive, alpha-beta T cell proliferation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Vsir,1
GO:0036005,response to macrophage colony-stimulating factor,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Tlr2,1,
GO:0036006,cellular response to macrophage colony-stimulating factor stimulus,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Tlr2,1,
GO:0042368,vitamin D biosynthetic process,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Il1b,1,
GO:0043117,positive regulation of vascular permeability,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Ccl4,1,
GO:0043476,pigment accumulation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Cd63,1,
GO:0043482,cellular pigment accumulation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Cd63,1,
GO:0043619,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Hmox1,1,
GO:0045080,positive regulation of chemokine biosynthetic process,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Il1b,1,
GO:0048548,regulation of pinocytosis,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Axl,1,
GO:0060068,vagina development,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Axl,1,
GO:0060394,negative regulation of pathway-restricted SMAD protein phosphorylation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Pmepa1,1,
GO:0070423,nucleotide-binding oligomerization domain containing signaling pathway,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Nfkbia,1,
GO:0070431,nucleotide-binding oligomerization domain containing 2 signaling pathway,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Nfkbia,1,
GO:0071281,cellular response to iron ion,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Hmox1,1,
GO:0097011,cellular response to granulocyte macrophage colony-stimulating factor stimulus,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Zfp36,1,
GO:0097421,liver regeneration,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Hmox1,1,
GO:0097688,glutamate receptor clustering,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Apoe,1,
GO:0098792,xenophagy,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Tlr2,1,
GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Cd74,1,
GO:1903977,positive regulation of glial cell migration,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,P2ry12,1,
GO:1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Atf3,1,
GO:2000561,regulation of CD4-positive, alpha-beta T cell proliferation,Jan-60,11/15833,0.04091684,0.134806931,0.093373905,Vsir,1
GO:0006909,phagocytosis,Mar-60,202/15833,0.04118906,0.135271141,0.093695439,Axl/Tlr2/Il1b,3,
GO:0046889,positive regulation of lipid biosynthetic process,Feb-60,85/15833,0.041245788,0.135271141,0.093695439,Apoe/Il1b,2,
GO:0048525,negative regulation of viral process,Feb-60,85/15833,0.041245788,0.135271141,0.093695439,Ccl4/Zfp36,2,
GO:0021954,central nervous system neuron development,Feb-60,86/15833,0.04212698,0.137157257,0.095001856,Btg2/Hsp90aa1,2,
GO:0046849,bone remodeling,Feb-60,86/15833,0.04212698,0.137157257,0.095001856,Spp1/Tmem119,2,
GO:0016485,protein processing,Mar-60,204/15833,0.042208633,0.137157257,0.095001856,Cst7/Vsir/Il1b,3,
GO:0043547,positive regulation of GTPase activity,Mar-60,204/15833,0.042208633,0.137157257,0.095001856,Ccl3/Ccl4/Rgs1,3,
GO:0043535,regulation of blood vessel endothelial cell migration,Feb-60,87/15833,0.043015255,0.137157257,0.095001856,Apoe/Hmox1,2,
GO:0034248,regulation of cellular amide metabolic process,Apr-60,350/15833,0.043513309,0.137157257,0.095001856,Apoe/Btg2/Ppp1r15a/Zfp36,4,
GO:0050670,regulation of lymphocyte proliferation,Mar-60,207/15833,0.043761825,0.137157257,0.095001856,Cd74/Vsir/Il1b,3,
GO:0006898,receptor-mediated endocytosis,Mar-60,208/15833,0.04428589,0.137157257,0.095001856,Apoe/Cd63/Siglech,3,
GO:0043406,positive regulation of MAP kinase activity,Mar-60,208/15833,0.04428589,0.137157257,0.095001856,Cd74/Gadd45b/Il1b,3,
GO:0001660,fever generation,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Il1b,1,
GO:0001973,adenosine receptor signaling pathway,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,P2ry12,1,
GO:0002730,regulation of dendritic cell cytokine production,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Tlr2,1,
GO:0002903,negative regulation of B cell apoptotic process,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Cd74,1,
GO:0003161,cardiac conduction system development,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Id2,1,
GO:0007183,SMAD protein complex assembly,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Pmepa1,1,
GO:0010889,regulation of sequestering of triglyceride,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Lpl,1,
GO:0010998,regulation of translational initiation by eIF2 alpha phosphorylation,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Ppp1r15a,1,
GO:0031652,positive regulation of heat generation,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Il1b,1,
GO:0032488,Cdc42 protein signal transduction,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Apoe,1,
GO:0032494,response to peptidoglycan,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Tlr2,1,
GO:0032604,granulocyte macrophage colony-stimulating factor production,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Il1b,1,
GO:0032645,regulation of granulocyte macrophage colony-stimulating factor production,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Il1b,1,
GO:0033004,negative regulation of mast cell activation,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Hmox1,1,
GO:0033079,immature T cell proliferation,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Il1b,1,
GO:0033280,response to vitamin D,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Spp1,1,
GO:0034433,steroid esterification,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Apoe,1,
GO:0034434,sterol esterification,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Apoe,1,
GO:0034435,cholesterol esterification,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Apoe,1,
GO:0035588,G protein-coupled purinergic receptor signaling pathway,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,P2ry12,1,
GO:0035872,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Nfkbia,1
GO:0045060,negative thymic T cell selection,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Cd74,1,
GO:0045086,positive regulation of interleukin-2 biosynthetic process,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Il1b,1,
GO:0045779,negative regulation of bone resorption,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Tmem119,1,
GO:0071285,cellular response to lithium ion,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Id2,1,
GO:0097012,response to granulocyte macrophage colony-stimulating factor,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Zfp36,1,
GO:0097201,negative regulation of transcription from RNA polymerase II promoter in response to stress,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Ppp1r15a,1,
GO:1900221,regulation of amyloid-beta clearance,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Apoe,1,
GO:1901550,regulation of endothelial cell development,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Il1b,1,
GO:1902950,regulation of dendritic spine maintenance,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Apoe,1,
GO:1903140,regulation of establishment of endothelial barrier,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Il1b,1,
GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Hmox1,1,
GO:2000484,positive regulation of interleukin-8 secretion,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Tlr2,1,
GO:2001279,regulation of unsaturated fatty acid biosynthetic process,Jan-60,12/15833,0.044553863,0.137157257,0.095001856,Il1b,1,
GO:0032944,regulation of mononuclear cell proliferation,Mar-60,209/15833,0.044813112,0.137758826,0.095418532,Cd74/Vsir/Il1b,3,
GO:0019218,regulation of steroid metabolic process,Feb-60,90/15833,0.045721937,0.140153324,0.097077079,Apoe/Il1b,2,
GO:0062014,negative regulation of small molecule metabolic process,Feb-60,90/15833,0.045721937,0.140153324,0.097077079,Apoe/Ier3,2,
GO:0010632,regulation of epithelial cell migration,Mar-60,211/15833,0.045877007,0.140429193,0.097268159,Apoe/Cd63/Hmox1,3,
GO:0045638,negative regulation of myeloid cell differentiation,Feb-60,91/15833,0.046637905,0.141837196,0.098243412,Nfkbia/Zfp36,2,
GO:2000106,regulation of leukocyte apoptotic process,Feb-60,91/15833,0.046637905,0.141837196,0.098243412,Cd74/Axl,2,
GO:0045089,positive regulation of innate immune response,Mar-60,215/15833,0.04804243,0.141837196,0.098243412,Cd74/Nfkbia/Tlr2,3,
GO:0002281,macrophage activation involved in immune response,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Cx3cr1,1,
GO:0002371,dendritic cell cytokine production,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Tlr2,1,
GO:0002689,negative regulation of leukocyte chemotaxis,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Dusp1,1,
GO:0008298,intracellular mRNA localization,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Zfp36,1,
GO:0010226,response to lithium ion,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Id2,1,
GO:0010885,regulation of cholesterol storage,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Lpl,1,
GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Cd74,1,
GO:0030213,hyaluronan biosynthetic process,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Il1b,1,
GO:0030656,regulation of vitamin metabolic process,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Il1b,1,
GO:0032306,regulation of prostaglandin secretion,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Il1b,1,
GO:0033089,positive regulation of T cell differentiation in thymus,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Il1b,1,
GO:0033690,positive regulation of osteoblast proliferation,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Tmem119,1,
GO:0035278,miRNA mediated inhibition of translation,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Zfp36,1,
GO:0042359,vitamin D metabolic process,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Il1b,1,
GO:0042994,cytoplasmic sequestering of transcription factor,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Nfkbia,1,
GO:0043249,erythrocyte maturation,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Klf2,1,
GO:0043383,negative T cell selection,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Cd74,1,
GO:0043558,regulation of translational initiation in response to stress,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Ppp1r15a,1,
GO:0045591,positive regulation of regulatory T cell differentiation,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Vsir,1,
GO:0045820,negative regulation of glycolytic process,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Ier3,1,
GO:0046642,negative regulation of alpha-beta T cell proliferation,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Vsir,1,
GO:0046851,negative regulation of bone remodeling,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Tmem119,1,
GO:0070486,leukocyte aggregation,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Il1b,1,
GO:0090594,inflammatory response to wounding,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Hmox1,1,
GO:1902931,negative regulation of alcohol biosynthetic process,Jan-60,13/15833,0.048177324,0.141837196,0.098243412,Apoe,1,
GO:0009408,response to heat,Feb-60,93/15833,0.048490073,0.142176057,0.098478124,Hmox1/Hsp90aa1,2,
GO:0033138,positive regulation of peptidyl-serine phosphorylation,Feb-60,93/15833,0.048490073,0.142176057,0.098478124,Ppp1r15a/Hsp90aa1,2,
GO:0050764,regulation of phagocytosis,Feb-60,93/15833,0.048490073,0.142176057,0.098478124,Tlr2/Il1b,2,
GO:0070663,regulation of leukocyte proliferation,Mar-60,217/15833,0.04914386,0.142911675,0.098987649,Cd74/Vsir/Il1b,3,
GO:0032872,regulation of stress-activated MAPK cascade,Mar-60,218/15833,0.049699232,0.142911675,0.098987649,Dusp1/Gadd45b/Il1b,3,
GO:0051952,regulation of amine transport,Feb-60,95/15833,0.050368804,0.142911675,0.098987649,P2ry12/Il1b,2,
GO:1902106,negative regulation of leukocyte differentiation,Feb-60,95/15833,0.050368804,0.142911675,0.098987649,Cd74/Id2,2,
GO:0070302,regulation of stress-activated protein kinase signaling cascade,Mar-60,220/15833,0.050819259,0.142911675,0.098987649,Dusp1/Gadd45b/Il1b,3,
GO:0032535,regulation of cellular component size,Apr-60,369/15833,0.05106881,0.142911675,0.098987649,Apoe/Ppp1r15a/Tlr2/Hsp90aa1,4,
GO:0007006,mitochondrial membrane organization,Feb-60,96/15833,0.051317976,0.142911675,0.098987649,Ier3/Hsp90aa1,2,
GO:0035710,CD4-positive, alpha-beta T cell activation,Feb-60,96/15833,0.051317976,0.142911675,0.098987649,Cd83/Vsir,2
GO:1901222,regulation of NIK/NF-kappaB signaling,Feb-60,96/15833,0.051317976,0.142911675,0.098987649,Tlr2/Il1b,2,
GO:0002544,chronic inflammatory response,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Cx3cr1,1,
GO:0002830,positive regulation of type 2 immune response,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Cd74,1,
GO:0002922,positive regulation of humoral immune response,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Il1b,1,
GO:0010888,negative regulation of lipid storage,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Nfkbia,1,
GO:0014061,regulation of norepinephrine secretion,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,P2ry12,1,
GO:0016045,detection of bacterium,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Tlr2,1,
GO:0030449,regulation of complement activation,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Il1b,1,
GO:0030812,negative regulation of nucleotide catabolic process,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Ier3,1,
GO:0031650,regulation of heat generation,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Il1b,1,
GO:0032305,positive regulation of icosanoid secretion,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Il1b,1,
GO:0033604,negative regulation of catecholamine secretion,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,P2ry12,1,
GO:0033623,regulation of integrin activation,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,P2ry12,1,
GO:0035641,locomotory exploration behavior,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Apoe,1,
GO:0035970,peptidyl-threonine dephosphorylation,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Dusp1,1,
GO:0040033,negative regulation of translation, ncRNA-mediated,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Zfp36,1
GO:0042033,chemokine biosynthetic process,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Il1b,1,
GO:0042362,fat-soluble vitamin biosynthetic process,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Il1b,1,
GO:0042447,hormone catabolic process,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Spp1,1,
GO:0045059,positive thymic T cell selection,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Cd74,1,
GO:0045073,regulation of chemokine biosynthetic process,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Il1b,1,
GO:0045410,positive regulation of interleukin-6 biosynthetic process,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Il1b,1,
GO:0045647,negative regulation of erythrocyte differentiation,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Zfp36,1,
GO:0045651,positive regulation of macrophage differentiation,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Id2,1,
GO:0045974,regulation of translation, ncRNA-mediated,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Zfp36,1
GO:0048243,norepinephrine secretion,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,P2ry12,1,
GO:0048537,mucosal-associated lymphoid tissue development,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Id2,1,
GO:0048541,Peyer's patch development,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Id2,1,
GO:0048755,branching morphogenesis of a nerve,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Il1b,1,
GO:0051198,negative regulation of coenzyme metabolic process,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Ier3,1,
GO:0071280,cellular response to copper ion,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Mt1,1,
GO:0090151,establishment of protein localization to mitochondrial membrane,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Hsp90aa1,1,
GO:0098543,detection of other organism,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Tlr2,1,
GO:1900029,positive regulation of ruffle assembly,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,P2ry12,1,
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Atf3,1,
GO:1902430,negative regulation of amyloid-beta formation,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Apoe,1,
GO:1903019,negative regulation of glycoprotein metabolic process,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Cst3,1,
GO:2001044,regulation of integrin-mediated signaling pathway,Jan-60,14/15833,0.051787271,0.142911675,0.098987649,Cd63,1,
GO:0046677,response to antibiotic,Mar-60,222/15833,0.051951618,0.143182109,0.099174964,Axl/Rpl23/Hmox1,3,
GO:0035967,cellular response to topologically incorrect protein,Feb-60,97/15833,0.052273604,0.143475715,0.099378331,Atf3/Ppp1r15a,2,
GO:0060291,long-term synaptic potentiation,Feb-60,97/15833,0.052273604,0.143475715,0.099378331,Apoe/Cx3cr1,2,
GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,Feb-60,97/15833,0.052273604,0.143475715,0.099378331,P2ry12/Hsp90aa1,2,
GO:0010959,regulation of metal ion transport,Apr-60,372/15833,0.052324091,0.143475715,0.099378331,Ccl4/Cd63/P2ry12/Cxcl10,4,
GO:0001101,response to acid chemical,Mar-60,223/15833,0.052522405,0.143836738,0.099628392,Lpl/Tlr2/Klf2,3,
GO:0045444,fat cell differentiation,Mar-60,224/15833,0.053096254,0.144870473,0.100344409,Lpl/Zfp36/Id2,3,
GO:0031341,regulation of cell killing,Feb-60,98/15833,0.053235628,0.144870473,0.100344409,H2-D1/H2-K1,2,
GO:0032963,collagen metabolic process,Feb-60,98/15833,0.053235628,0.144870473,0.100344409,Ctsb/Vsir,2,
GO:0048145,regulation of fibroblast proliferation,Feb-60,98/15833,0.053235628,0.144870473,0.100344409,Cd74/Fth1,2,
GO:0048709,oligodendrocyte differentiation,Feb-60,98/15833,0.053235628,0.144870473,0.100344409,Tlr2/Id2,2,
GO:0000956,nuclear-transcribed mRNA catabolic process,Feb-60,99/15833,0.054203987,0.144870473,0.100344409,Btg2/Zfp36,2,
GO:0001959,regulation of cytokine-mediated signaling pathway,Feb-60,99/15833,0.054203987,0.144870473,0.100344409,Cd74/Axl,2,
GO:0015837,amine transport,Feb-60,99/15833,0.054203987,0.144870473,0.100344409,P2ry12/Il1b,2,
GO:0046634,regulation of alpha-beta T cell activation,Feb-60,99/15833,0.054203987,0.144870473,0.100344409,Cd83/Vsir,2,
GO:0001667,ameboidal-type cell migration,Apr-60,378/15833,0.054885451,0.144870473,0.100344409,Apoe/Cd63/P2ry12/Hmox1,4,
GO:0002224,toll-like receptor signaling pathway,Feb-60,100/15833,0.055178621,0.144870473,0.100344409,Nfkbia/Tlr2,2,
GO:0048144,fibroblast proliferation,Feb-60,100/15833,0.055178621,0.144870473,0.100344409,Cd74/Fth1,2,
GO:0008209,androgen metabolic process,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Spp1,1,
GO:0010819,regulation of T cell chemotaxis,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Cxcl10,1,
GO:0010878,cholesterol storage,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Lpl,1,
GO:0030002,cellular anion homeostasis,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Ckb,1,
GO:0030320,cellular monovalent inorganic anion homeostasis,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Ckb,1,
GO:0032310,prostaglandin secretion,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Il1b,1,
GO:0032516,positive regulation of phosphoprotein phosphatase activity,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Ppp1r15a,1,
GO:0033574,response to testosterone,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Spp1,1,
GO:0035587,purinergic receptor signaling pathway,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,P2ry12,1,
GO:0042159,lipoprotein catabolic process,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Apoe,1,
GO:0045540,regulation of cholesterol biosynthetic process,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Apoe,1,
GO:0045655,regulation of monocyte differentiation,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Cd74,1,
GO:0048715,negative regulation of oligodendrocyte differentiation,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Id2,1,
GO:0051131,chaperone-mediated protein complex assembly,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Hsp90aa1,1,
GO:0051956,negative regulation of amino acid transport,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Il1b,1,
GO:0055089,fatty acid homeostasis,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Apoe,1,
GO:0060644,mammary gland epithelial cell differentiation,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Id2,1,
GO:0070935,3'-UTR-mediated mRNA stabilization,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Zfp36,1,
GO:0071243,cellular response to arsenic-containing substance,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Hmox1,1,
GO:0071404,cellular response to low-density lipoprotein particle stimulus,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Lpl,1,
GO:0090197,positive regulation of chemokine secretion,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Lpl,1,
GO:0106118,regulation of sterol biosynthetic process,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Apoe,1,
GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Cd74,1,
GO:1990000,amyloid fibril formation,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Apoe,1,
GO:2000257,regulation of protein activation cascade,Jan-60,15/15833,0.055383754,0.144870473,0.100344409,Il1b,1,
GO:0010001,glial cell differentiation,Mar-60,229/15833,0.056011188,0.146334313,0.101358336,Tlr2/Il1b/Id2,3,
GO:0032147,activation of protein kinase activity,Mar-60,230/15833,0.056603261,0.147523959,0.102182343,Cd74/Gadd45b/Il1b,3,
GO:1903362,regulation of cellular protein catabolic process,Mar-60,230/15833,0.056603261,0.147523959,0.102182343,Apoe/Rpl23/Hsp90aa1,3,
GO:0038061,NIK/NF-kappaB signaling,Feb-60,102/15833,0.057146476,0.148715701,0.103007802,Tlr2/Il1b,2,
GO:0090068,positive regulation of cell cycle process,Mar-60,231/15833,0.057198347,0.148715701,0.103007802,Rpl23/Il1b/Id2,3,
GO:0014706,striated muscle tissue development,Apr-60,384/15833,0.057514357,0.149179838,0.103329286,Atf3/Fos/Btg2/Id2,4,
GO:0016241,regulation of macroautophagy,Feb-60,103/15833,0.058139579,0.149179838,0.103329286,Tlr2/Hmox1,2,
GO:0048661,positive regulation of smooth muscle cell proliferation,Feb-60,103/15833,0.058139579,0.149179838,0.103329286,Id2/Hmox1,2,
GO:0051091,positive regulation of DNA-binding transcription factor activity,Mar-60,233/15833,0.058397522,0.149179838,0.103329286,Tlr2/Cx3cr1/Il1b,3,
GO:0003159,morphogenesis of an endothelium,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Cxcl10,1,
GO:0030540,female genitalia development,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Axl,1,
GO:0032823,regulation of natural killer cell differentiation,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Axl,1,
GO:0032986,protein-DNA complex disassembly,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Rpl23,1,
GO:0034134,toll-like receptor 2 signaling pathway,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Tlr2,1,
GO:0034377,plasma lipoprotein particle assembly,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Apoe,1,
GO:0043518,negative regulation of DNA damage response, signal transduction by p53 class mediator,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Cd74,1
GO:0044794,positive regulation by host of viral process,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Apoe,1,
GO:0045793,positive regulation of cell size,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Hsp90aa1,1,
GO:0050755,chemokine metabolic process,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Il1b,1,
GO:0051000,positive regulation of nitric-oxide synthase activity,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Apoe,1,
GO:0055064,chloride ion homeostasis,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Ckb,1,
GO:0061154,endothelial tube morphogenesis,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Cxcl10,1,
GO:0061158,3'-UTR-mediated mRNA destabilization,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Zfp36,1,
GO:0072578,neurotransmitter-gated ion channel clustering,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Apoe,1,
GO:0090196,regulation of chemokine secretion,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Lpl,1,
GO:1902992,negative regulation of amyloid precursor protein catabolic process,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Apoe,1,
GO:1904706,negative regulation of vascular smooth muscle cell proliferation,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Hmox1,1,
GO:2001185,regulation of CD8-positive, alpha-beta T cell activation,Jan-60,16/15833,0.058966822,0.149179838,0.103329286,Vsir,1
GO:0000187,activation of MAPK activity,Feb-60,104/15833,0.05913872,0.149264747,0.103388098,Cd74/Il1b,2,
GO:0044070,regulation of anion transport,Feb-60,104/15833,0.05913872,0.149264747,0.103388098,Apoe/Il1b,2,
GO:0021987,cerebral cortex development,Feb-60,105/15833,0.060143842,0.151624312,0.105022449,Cx3cr1/P2ry12,2,
GO:0048608,reproductive structure development,Apr-60,391/15833,0.060666429,0.15258526,0.105688049,Junb/H3f3b/Ctsb/Axl,4,
GO:0050673,epithelial cell proliferation,Apr-60,391/15833,0.060666429,0.15258526,0.105688049,Apoe/Zfp36/Id2/Hmox1,4,
GO:0051924,regulation of calcium ion transport,Mar-60,237/15833,0.060831678,0.152822773,0.105852562,Ccl4/P2ry12/Cxcl10,3,
GO:0051222,positive regulation of protein transport,Apr-60,392/15833,0.061124172,0.153277868,0.106167784,Ccl3/Lpl/Tlr2/Il1b,4,
GO:1904019,epithelial cell apoptotic process,Feb-60,106/15833,0.061154886,0.153277868,0.106167784,Zfp36/Hmox1,2,
GO:0061458,reproductive system development,Apr-60,394/15833,0.062045229,0.153356614,0.106222327,Junb/H3f3b/Ctsb/Axl,4,
GO:0000188,inactivation of MAPK activity,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Dusp1,1,
GO:0002710,negative regulation of T cell mediated immunity,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Vsir,1,
GO:0010623,programmed cell death involved in cell development,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Il1b,1,
GO:0015874,norepinephrine transport,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,P2ry12,1,
GO:0021542,dentate gyrus development,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Btg2,1,
GO:0032693,negative regulation of interleukin-10 production,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Vsir,1,
GO:0042535,positive regulation of tumor necrosis factor biosynthetic process,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Tlr2,1,
GO:0043555,regulation of translation in response to stress,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Ppp1r15a,1,
GO:0046886,positive regulation of hormone biosynthetic process,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Il1b,1,
GO:0048143,astrocyte activation,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Il1b,1,
GO:0051444,negative regulation of ubiquitin-protein transferase activity,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Rpl23,1,
GO:0071605,monocyte chemotactic protein-1 production,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Il1b,1,
GO:0071637,regulation of monocyte chemotactic protein-1 production,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Il1b,1,
GO:0090026,positive regulation of monocyte chemotaxis,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Cxcl10,1,
GO:0090195,chemokine secretion,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Lpl,1,
GO:0140131,positive regulation of lymphocyte chemotaxis,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Ccl4,1,
GO:1900746,regulation of vascular endothelial growth factor signaling pathway,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Cd63,1,
GO:2001170,negative regulation of ATP biosynthetic process,Jan-60,17/15833,0.062536525,0.153356614,0.106222327,Ier3,1,
GO:0001776,leukocyte homeostasis,Feb-60,108/15833,0.063194512,0.154618772,0.107096559,Cd74/Axl,2,
GO:0050868,negative regulation of T cell activation,Feb-60,108/15833,0.063194512,0.154618772,0.107096559,Cd74/Vsir,2,
GO:0008203,cholesterol metabolic process,Feb-60,109/15833,0.064222979,0.156779626,0.108593273,Apoe/Apoc1,2,
GO:0014902,myotube differentiation,Feb-60,109/15833,0.064222979,0.156779626,0.108593273,Tmem119/Cxcl10,2,
GO:0001909,leukocyte mediated cytotoxicity,Feb-60,110/15833,0.065257141,0.15704588,0.108777693,H2-D1/H2-K1,2,
GO:0043534,blood vessel endothelial cell migration,Feb-60,110/15833,0.065257141,0.15704588,0.108777693,Apoe/Hmox1,2,
GO:0061013,regulation of mRNA catabolic process,Feb-60,110/15833,0.065257141,0.15704588,0.108777693,Btg2/Zfp36,2,
GO:0071887,leukocyte apoptotic process,Feb-60,110/15833,0.065257141,0.15704588,0.108777693,Cd74/Axl,2,
GO:2000278,regulation of DNA biosynthetic process,Feb-60,110/15833,0.065257141,0.15704588,0.108777693,Dusp1/Hsp90aa1,2,
GO:0090287,regulation of cellular response to growth factor stimulus,Mar-60,245/15833,0.06584143,0.15704588,0.108777693,Cd63/Vsir/Pmepa1,3,
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Hmox1,1,
GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Cd74,1,
GO:0002726,positive regulation of T cell cytokine production,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Il1b,1,
GO:0010039,response to iron ion,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Hmox1,1,
GO:0010544,negative regulation of platelet activation,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Apoe,1,
GO:0015732,prostaglandin transport,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Il1b,1,
GO:0030809,negative regulation of nucleotide biosynthetic process,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Ier3,1,
GO:0032303,regulation of icosanoid secretion,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Il1b,1,
GO:0032495,response to muramyl dipeptide,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Nfkbia,1,
GO:0032695,negative regulation of interleukin-12 production,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Tlr2,1,
GO:0034104,negative regulation of tissue remodeling,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Tmem119,1,
GO:0044130,negative regulation of growth of symbiont in host,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Tlr2,1,
GO:0048557,embryonic digestive tract morphogenesis,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Id2,1,
GO:1900372,negative regulation of purine nucleotide biosynthetic process,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Ier3,1,
GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Cd63,1,
GO:1903975,regulation of glial cell migration,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,P2ry12,1,
GO:1903978,regulation of microglial cell activation,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Cst7,1,
GO:2000193,positive regulation of fatty acid transport,Jan-60,18/15833,0.066092911,0.15704588,0.108777693,Il1b,1,
GO:0051052,regulation of DNA metabolic process,Apr-60,403/15833,0.066281554,0.15704588,0.108777693,Dusp1/Ier3/Cst3/Hsp90aa1,4,
GO:0002040,sprouting angiogenesis,Feb-60,111/15833,0.06629694,0.15704588,0.108777693,Klf2/Hmox1,2,
GO:0051153,regulation of striated muscle cell differentiation,Feb-60,111/15833,0.06629694,0.15704588,0.108777693,Tmem119/Cxcl10,2,
GO:0060537,muscle tissue development,Apr-60,405/15833,0.067243221,0.159112797,0.110209342,Atf3/Fos/Btg2/Id2,4,
GO:0042157,lipoprotein metabolic process,Feb-60,113/15833,0.068393229,0.160136555,0.110918447,Apoe/Apoc1,2,
GO:0045860,positive regulation of protein kinase activity,Apr-60,409/15833,0.069188539,0.160136555,0.110918447,Cd74/Gadd45b/Il1b/Hsp90aa1,4,
GO:0003158,endothelium development,Feb-60,114/15833,0.069449607,0.160136555,0.110918447,Il1b/Cxcl10,2,
GO:0051592,response to calcium ion,Feb-60,114/15833,0.069449607,0.160136555,0.110918447,Fos/Junb,2,
GO:0051928,positive regulation of calcium ion transport,Feb-60,114/15833,0.069449607,0.160136555,0.110918447,Ccl4/Cxcl10,2,
GO:1902652,secondary alcohol metabolic process,Feb-60,114/15833,0.069449607,0.160136555,0.110918447,Apoe/Apoc1,2,
GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Cd74,1,
GO:0002577,regulation of antigen processing and presentation,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Cd74,1,
GO:0002755,MyD88-dependent toll-like receptor signaling pathway,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Tlr2,1,
GO:0002902,regulation of B cell apoptotic process,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Cd74,1,
GO:0010592,positive regulation of lamellipodium assembly,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Hsp90aa1,1,
GO:0010818,T cell chemotaxis,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Cxcl10,1,
GO:0031649,heat generation,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Il1b,1,
GO:0033630,positive regulation of cell adhesion mediated by integrin,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,P2ry12,1,
GO:0044126,regulation of growth of symbiont in host,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Tlr2,1,
GO:0044146,negative regulation of growth of symbiont involved in interaction with host,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Tlr2,1,
GO:0045475,locomotor rhythm,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Id2,1,
GO:0045649,regulation of macrophage differentiation,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Id2,1,
GO:0045723,positive regulation of fatty acid biosynthetic process,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Il1b,1,
GO:0048245,eosinophil chemotaxis,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Ccl4,1,
GO:0051195,negative regulation of cofactor metabolic process,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Ier3,1,
GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Tlr2,1,
GO:0071157,negative regulation of cell cycle arrest,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Rpl23,1,
GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Ier3,1,
GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Cd74,1,
GO:2000482,regulation of interleukin-8 secretion,Jan-60,19/15833,0.06963603,0.160136555,0.110918447,Tlr2,1,
GO:1904951,positive regulation of establishment of protein localization,Apr-60,410/15833,0.069679437,0.160136555,0.110918447,Ccl3/Lpl/Tlr2/Il1b,4,
GO:0044270,cellular nitrogen compound catabolic process,Apr-60,412/15833,0.070666698,0.162232696,0.112370338,Btg2/Ier3/Zfp36/Hmox1,4,
GO:0034599,cellular response to oxidative stress,Mar-60,253/15833,0.071036234,0.16290775,0.112837913,Fos/Axl/Hmox1,3,
GO:0010508,positive regulation of autophagy,Feb-60,116/15833,0.071578558,0.163977207,0.113578671,Tlr2/Hmox1,2,
GO:0016125,sterol metabolic process,Feb-60,117/15833,0.072651022,0.16481586,0.114159563,Apoe/Apoc1,2,
GO:0042542,response to hydrogen peroxide,Feb-60,117/15833,0.072651022,0.16481586,0.114159563,Axl/Hmox1,2,
GO:0006516,glycoprotein catabolic process,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Cst3,1,
GO:0009110,vitamin biosynthetic process,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Il1b,1,
GO:0010884,positive regulation of lipid storage,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Lpl,1,
GO:0032288,myelin assembly,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Tlr2,1,
GO:0044144,modulation of growth of symbiont involved in interaction with host,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Tlr2,1,
GO:0050765,negative regulation of phagocytosis,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Tlr2,1,
GO:0060252,positive regulation of glial cell proliferation,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Il1b,1,
GO:0065005,protein-lipid complex assembly,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Apoe,1,
GO:0070828,heterochromatin organization,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,H3f3b,1,
GO:0098581,detection of external biotic stimulus,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Tlr2,1,
GO:1903010,regulation of bone development,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Tmem119,1,
GO:1904666,regulation of ubiquitin protein ligase activity,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Rpl23,1,
GO:2000738,positive regulation of stem cell differentiation,Jan-60,20/15833,0.07316593,0.16481586,0.114159563,Vsir,1,
GO:0046700,heterocycle catabolic process,Apr-60,417/15833,0.073166633,0.16481586,0.114159563,Btg2/Ier3/Zfp36/Hmox1,4,
GO:0051101,regulation of DNA binding,Feb-60,118/15833,0.073728739,0.165908883,0.114916645,Id2/Hmox1,2,
GO:0015718,monocarboxylic acid transport,Feb-60,119/15833,0.074811655,0.167995372,0.11636185,Apoe/Il1b,2,
GO:1903038,negative regulation of leukocyte cell-cell adhesion,Feb-60,119/15833,0.074811655,0.167995372,0.11636185,Cd74/Vsir,2,
GO:0051604,protein maturation,Mar-60,260/15833,0.075729994,0.168686218,0.116840364,Cst7/Vsir/Il1b,3,
GO:0055088,lipid homeostasis,Feb-60,120/15833,0.075899718,0.168686218,0.116840364,Apoe/Lpl,2,
GO:0010631,epithelial cell migration,Mar-60,261/15833,0.076411639,0.168686218,0.116840364,Apoe/Cd63/Hmox1,3,
GO:0050878,regulation of body fluid levels,Mar-60,261/15833,0.076411639,0.168686218,0.116840364,Apoe/Axl/P2ry12,3,
GO:0003085,negative regulation of systemic arterial blood pressure,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Ier3,1,
GO:0006882,cellular zinc ion homeostasis,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Mt1,1,
GO:0006907,pinocytosis,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Axl,1,
GO:0007095,mitotic G2 DNA damage checkpoint,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Ier3,1,
GO:0014048,regulation of glutamate secretion,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Il1b,1,
GO:0022010,central nervous system myelination,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Tlr2,1,
GO:0031643,positive regulation of myelination,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Cst7,1,
GO:0032291,axon ensheathment in central nervous system,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Tlr2,1,
GO:0032691,negative regulation of interleukin-1 beta production,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Cx3cr1,1,
GO:0034114,regulation of heterotypic cell-cell adhesion,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Il1b,1,
GO:0043153,entrainment of circadian clock by photoperiod,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Id2,1,
GO:0044117,growth of symbiont in host,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Tlr2,1,
GO:0051220,cytoplasmic sequestering of protein,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Nfkbia,1,
GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Hmox1,1,
GO:0097062,dendritic spine maintenance,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Apoe,1,
GO:1901626,regulation of postsynaptic membrane organization,Jan-60,21/15833,0.07668266,0.168686218,0.116840364,Apoe,1,
GO:0032200,telomere organization,Feb-60,121/15833,0.076992875,0.169196155,0.117193571,H3f3b/Hsp90aa1,2,
GO:0090132,epithelium migration,Mar-60,262/15833,0.077096034,0.169250499,0.117231212,Apoe/Cd63/Hmox1,3,
GO:0019439,aromatic compound catabolic process,Apr-60,425/15833,0.077260344,0.169266825,0.11724252,Btg2/Ier3/Zfp36/Hmox1,4,
GO:0045786,negative regulation of cell cycle,Apr-60,425/15833,0.077260344,0.169266825,0.11724252,Btg2/Ier3/Rpl23/Id2,4,
GO:0090130,tissue migration,Mar-60,263/15833,0.077783168,0.169396416,0.117332281,Apoe/Cd63/Hmox1,3,
GO:1901653,cellular response to peptide,Mar-60,263/15833,0.077783168,0.169396416,0.117332281,Lpl/Rpl23/Il1b,3,
GO:0001936,regulation of endothelial cell proliferation,Feb-60,122/15833,0.078091072,0.169396416,0.117332281,Apoe/Hmox1,2,
GO:0017148,negative regulation of translation,Feb-60,122/15833,0.078091072,0.169396416,0.117332281,Btg2/Zfp36,2,
GO:0045667,regulation of osteoblast differentiation,Feb-60,122/15833,0.078091072,0.169396416,0.117332281,Tmem119/Id2,2,
GO:0046165,alcohol biosynthetic process,Feb-60,122/15833,0.078091072,0.169396416,0.117332281,Apoe/Il1b,2,
GO:0007162,negative regulation of cell adhesion,Mar-60,264/15833,0.078473032,0.169396416,0.117332281,Cd74/Dusp1/Vsir,3,
GO:0071902,positive regulation of protein serine/threonine kinase activity,Mar-60,264/15833,0.078473032,0.169396416,0.117332281,Cd74/Gadd45b/Il1b,3,
GO:0002698,negative regulation of immune effector process,Feb-60,123/15833,0.079194257,0.169396416,0.117332281,Vsir/Hmox1,2,
GO:0006694,steroid biosynthetic process,Feb-60,123/15833,0.079194257,0.169396416,0.117332281,Apoe/Il1b,2,
GO:0045861,negative regulation of proteolysis,Mar-60,266/15833,0.079860916,0.169396416,0.117332281,Cst7/Rpl23/Cst3,3,
GO:0046651,lymphocyte proliferation,Mar-60,266/15833,0.079860916,0.169396416,0.117332281,Cd74/Vsir/Il1b,3,
GO:0001780,neutrophil homeostasis,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Axl,1,
GO:0002374,cytokine secretion involved in immune response,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Tlr2,1,
GO:0002827,positive regulation of T-helper 1 type immune response,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Il1b,1,
GO:0009595,detection of biotic stimulus,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Tlr2,1,
GO:0009648,photoperiodism,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Id2,1,
GO:0009649,entrainment of circadian clock,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Id2,1,
GO:0010575,positive regulation of vascular endothelial growth factor production,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Il1b,1,
GO:0010954,positive regulation of protein processing,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Il1b,1,
GO:0019835,cytolysis,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Lyz2,1,
GO:0032352,positive regulation of hormone metabolic process,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Il1b,1,
GO:0032462,regulation of protein homooligomerization,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Apoe,1,
GO:0032515,negative regulation of phosphoprotein phosphatase activity,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Ppp1r15a,1,
GO:0042226,interleukin-6 biosynthetic process,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Il1b,1,
GO:0044110,growth involved in symbiotic interaction,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Tlr2,1,
GO:0044116,growth of symbiont involved in interaction with host,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Tlr2,1,
GO:0045408,regulation of interleukin-6 biosynthetic process,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Il1b,1,
GO:0050996,positive regulation of lipid catabolic process,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Il1b,1,
GO:0055069,zinc ion homeostasis,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Mt1,1,
GO:0060749,mammary gland alveolus development,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Id2,1,
GO:0061377,mammary gland lobule development,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Id2,1,
GO:0072606,interleukin-8 secretion,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Tlr2,1,
GO:0072677,eosinophil migration,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Ccl4,1,
GO:1901739,regulation of myoblast fusion,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Cxcl10,1,
GO:1902932,positive regulation of alcohol biosynthetic process,Jan-60,22/15833,0.080186267,0.169396416,0.117332281,Il1b,1,
GO:0042177,negative regulation of protein catabolic process,Feb-60,124/15833,0.080302379,0.169396416,0.117332281,Rpl23/Cst3,2,
GO:0050671,positive regulation of lymphocyte proliferation,Feb-60,124/15833,0.080302379,0.169396416,0.117332281,Cd74/Il1b,2,
GO:0006066,alcohol metabolic process,Mar-60,268/15833,0.081259609,0.171081205,0.11849925,Apoe/Apoc1/Il1b,3,
GO:0032943,mononuclear cell proliferation,Mar-60,268/15833,0.081259609,0.171081205,0.11849925,Cd74/Vsir/Il1b,3,
GO:0033135,regulation of peptidyl-serine phosphorylation,Feb-60,125/15833,0.081415385,0.171242106,0.118610697,Ppp1r15a/Hsp90aa1,2,
GO:0032946,positive regulation of mononuclear cell proliferation,Feb-60,126/15833,0.082533224,0.172633399,0.119574375,Cd74/Il1b,2,
GO:0048675,axon extension,Feb-60,126/15833,0.082533224,0.172633399,0.119574375,Apoe/Hsp90aa1,2,
GO:0000470,maturation of LSU-rRNA,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Rpl10a,1,
GO:0001829,trophectodermal cell differentiation,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Junb,1,
GO:0010829,negative regulation of glucose transmembrane transport,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Il1b,1,
GO:0010894,negative regulation of steroid biosynthetic process,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Apoe,1,
GO:0031100,animal organ regeneration,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Hmox1,1,
GO:0032703,negative regulation of interleukin-2 production,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Zfp36,1,
GO:0032891,negative regulation of organic acid transport,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Il1b,1,
GO:0033622,integrin activation,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,P2ry12,1,
GO:0033688,regulation of osteoblast proliferation,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Tmem119,1,
GO:0035455,response to interferon-alpha,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Axl,1,
GO:0035743,CD4-positive, alpha-beta T cell cytokine production,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Il1b,1
GO:0044788,modulation by host of viral process,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Apoe,1,
GO:0045939,negative regulation of steroid metabolic process,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Apoe,1,
GO:0045943,positive regulation of transcription by RNA polymerase I,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Ppp1r15a,1,
GO:0050995,negative regulation of lipid catabolic process,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Il1b,1,
GO:0060716,labyrinthine layer blood vessel development,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Junb,1,
GO:0071677,positive regulation of mononuclear cell migration,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Cxcl10,1,
GO:1903306,negative regulation of regulated secretory pathway,Jan-60,23/15833,0.083676801,0.172633399,0.119574375,Hmox1,1,
GO:0097193,intrinsic apoptotic signaling pathway,Mar-60,276/15833,0.086960927,0.175774763,0.121750238,Cd74/Ier3/Hmox1,3,
GO:0071236,cellular response to antibiotic,Feb-60,130/15833,0.087051893,0.175774763,0.121750238,Axl/Rpl23,2,
GO:1903364,positive regulation of cellular protein catabolic process,Feb-60,130/15833,0.087051893,0.175774763,0.121750238,Apoe/Hsp90aa1,2,
GO:0002052,positive regulation of neuroblast proliferation,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Cx3cr1,1,
GO:0019068,virion assembly,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Apoe,1,
GO:0021801,cerebral cortex radial glia guided migration,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,P2ry12,1,
GO:0022030,telencephalon glial cell migration,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,P2ry12,1,
GO:0030212,hyaluronan metabolic process,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Il1b,1,
GO:0032801,receptor catabolic process,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Apoe,1,
GO:0043921,modulation by host of viral transcription,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Ccl4,1,
GO:0045061,thymic T cell selection,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Cd74,1,
GO:0045780,positive regulation of bone resorption,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Spp1,1,
GO:0046685,response to arsenic-containing substance,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Hmox1,1,
GO:0046688,response to copper ion,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Mt1,1,
GO:0046852,positive regulation of bone remodeling,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Spp1,1,
GO:0051767,nitric-oxide synthase biosynthetic process,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Tlr2,1,
GO:0051769,regulation of nitric-oxide synthase biosynthetic process,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Tlr2,1,
GO:0052312,modulation of transcription in other organism involved in symbiotic interaction,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Ccl4,1,
GO:0052472,modulation by host of symbiont transcription,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Ccl4,1,
GO:1901798,positive regulation of signal transduction by p53 class mediator,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Rpl23,1,
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Hmox1,1,
GO:1903319,positive regulation of protein maturation,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Il1b,1,
GO:1905523,positive regulation of macrophage migration,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,P2ry12,1,
GO:2000637,positive regulation of gene silencing by miRNA,Jan-60,24/15833,0.087154308,0.175774763,0.121750238,Zfp36,1,
GO:0033674,positive regulation of kinase activity,Apr-60,444/15833,0.087438461,0.176183193,0.122033137,Cd74/Gadd45b/Il1b/Hsp90aa1,4,
GO:0070665,positive regulation of leukocyte proliferation,Feb-60,131/15833,0.088193137,0.17737259,0.122856972,Cd74/Il1b,2,
GO:0072331,signal transduction by p53 class mediator,Feb-60,131/15833,0.088193137,0.17737259,0.122856972,Cd74/Rpl23,2,
GO:0002221,pattern recognition receptor signaling pathway,Feb-60,132/15833,0.089338911,0.17940867,0.124267261,Nfkbia/Tlr2,2,
GO:0002831,regulation of response to biotic stimulus,Feb-60,133/15833,0.090489167,0.17940867,0.124267261,Tlr2/Il1b,2,
GO:0030856,regulation of epithelial cell differentiation,Feb-60,133/15833,0.090489167,0.17940867,0.124267261,Zfp36/Il1b,2,
GO:0031333,negative regulation of protein complex assembly,Feb-60,133/15833,0.090489167,0.17940867,0.124267261,Tlr2/Pmepa1,2,
GO:0001783,B cell apoptotic process,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Cd74,1,
GO:0002021,response to dietary excess,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Apoe,1,
GO:0002092,positive regulation of receptor internalization,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Cd63,1,
GO:0010893,positive regulation of steroid biosynthetic process,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Il1b,1,
GO:0034123,positive regulation of toll-like receptor signaling pathway,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Tlr2,1,
GO:0035640,exploration behavior,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Apoe,1,
GO:0036037,CD8-positive, alpha-beta T cell activation,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Vsir,1
GO:0045648,positive regulation of erythrocyte differentiation,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Id2,1,
GO:0048714,positive regulation of oligodendrocyte differentiation,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Tlr2,1,
GO:0060148,positive regulation of posttranscriptional gene silencing,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Zfp36,1,
GO:1902003,regulation of amyloid-beta formation,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Apoe,1,
GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Cd74,1,
GO:1903671,negative regulation of sprouting angiogenesis,Jan-60,25/15833,0.090618837,0.17940867,0.124267261,Klf2,1,
GO:0043087,regulation of GTPase activity,Mar-60,282/15833,0.091346596,0.180683735,0.125150433,Ccl3/Ccl4/Rgs1,3,
GO:0002758,innate immune response-activating signal transduction,Feb-60,134/15833,0.091643856,0.180940019,0.125327948,Nfkbia/Tlr2,2,
GO:0050864,regulation of B cell activation,Feb-60,134/15833,0.091643856,0.180940019,0.125327948,Cd74/Id2,2,
GO:0046330,positive regulation of JNK cascade,Feb-60,135/15833,0.092802928,0.183060986,0.126797034,Gadd45b/Il1b,2,
GO:0070661,leukocyte proliferation,Mar-60,285/15833,0.093573922,0.183714027,0.127249363,Cd74/Vsir/Il1b,3,
GO:0001906,cell killing,Feb-60,136/15833,0.093966336,0.183714027,0.127249363,H2-D1/H2-K1,2,
GO:0001935,endothelial cell proliferation,Feb-60,136/15833,0.093966336,0.183714027,0.127249363,Apoe/Hmox1,2,
GO:0007050,cell cycle arrest,Feb-60,136/15833,0.093966336,0.183714027,0.127249363,Rpl23/Id2,2,
GO:0048515,spermatid differentiation,Feb-60,136/15833,0.093966336,0.183714027,0.127249363,H3f3b/Tmem119,2,
GO:0010043,response to zinc ion,Jan-60,26/15833,0.094070436,0.183714027,0.127249363,Mt1,1,
GO:0045589,regulation of regulatory T cell differentiation,Jan-60,26/15833,0.094070436,0.183714027,0.127249363,Vsir,1,
GO:0090181,regulation of cholesterol metabolic process,Jan-60,26/15833,0.094070436,0.183714027,0.127249363,Apoe,1,
GO:0150077,regulation of neuroinflammatory response,Jan-60,26/15833,0.094070436,0.183714027,0.127249363,Cst7,1,
GO:1902745,positive regulation of lamellipodium organization,Jan-60,26/15833,0.094070436,0.183714027,0.127249363,Hsp90aa1,1,
GO:1903579,negative regulation of ATP metabolic process,Jan-60,26/15833,0.094070436,0.183714027,0.127249363,Ier3,1,
GO:0031214,biomineral tissue development,Feb-60,137/15833,0.095134031,0.185288121,0.128339658,Spp1/Tmem119,2,
GO:0050709,negative regulation of protein secretion,Feb-60,137/15833,0.095134031,0.185288121,0.128339658,Apoe/Il1b,2,
GO:1902904,negative regulation of supramolecular fiber organization,Feb-60,137/15833,0.095134031,0.185288121,0.128339658,Apoe/Tlr2,2,
GO:0032787,monocarboxylic acid metabolic process,Apr-60,459/15833,0.095916137,0.186642943,0.129278074,Cd74/Lpl/Ier3/Il1b,4,
GO:0006775,fat-soluble vitamin metabolic process,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Il1b,1,
GO:0006929,substrate-dependent cell migration,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,P2ry12,1,
GO:0010922,positive regulation of phosphatase activity,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Ppp1r15a,1,
GO:0030224,monocyte differentiation,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Cd74,1,
GO:0032673,regulation of interleukin-4 production,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Cd83,1,
GO:0032816,positive regulation of natural killer cell activation,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Axl,1,
GO:0033273,response to vitamin,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Spp1,1,
GO:0035094,response to nicotine,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Hmox1,1,
GO:0035335,peptidyl-tyrosine dephosphorylation,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Dusp1,1,
GO:0042168,heme metabolic process,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Hmox1,1,
GO:0044003,modification by symbiont of host morphology or physiology,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Tlr2,1,
GO:0055083,monovalent inorganic anion homeostasis,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Ckb,1,
GO:1900543,negative regulation of purine nucleotide metabolic process,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Ier3,1,
GO:1903131,mononuclear cell differentiation,Jan-60,27/15833,0.097509151,0.187377336,0.12978675,Cd74,1,
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,Mar-60,291/15833,0.098096186,0.188337695,0.130451942,Fos/Vsir/Pmepa1,3,
GO:0042552,myelination,Feb-60,140/15833,0.098662362,0.189256335,0.131088237,Cst7/Tlr2,2,
GO:0046486,glycerolipid metabolic process,Mar-60,293/15833,0.099623338,0.190589032,0.132011329,Apoe/Lpl/Apoc1,3,
GO:0045834,positive regulation of lipid metabolic process,Feb-60,141/15833,0.09984673,0.190589032,0.132011329,Apoe/Il1b,2,
GO:0007346,regulation of mitotic cell cycle,Apr-60,466/15833,0.1000025,0.190589032,0.132011329,Btg2/Ier3/Il1b/Id2,4,
GO:0002825,regulation of T-helper 1 type immune response,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Il1b,1,
GO:0010574,regulation of vascular endothelial growth factor production,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Il1b,1,
GO:0010591,regulation of lamellipodium assembly,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Hsp90aa1,1,
GO:0014047,glutamate secretion,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Il1b,1,
GO:0034508,centromere complex assembly,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,H3f3b,1,
GO:0042036,negative regulation of cytokine biosynthetic process,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Zfp36,1,
GO:0043372,positive regulation of CD4-positive, alpha-beta T cell differentiation,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Cd83,1
GO:0045616,regulation of keratinocyte differentiation,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Zfp36,1,
GO:0045980,negative regulation of nucleotide metabolic process,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Ier3,1,
GO:0097242,amyloid-beta clearance,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Apoe,1,
GO:0097345,mitochondrial outer membrane permeabilization,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Ier3,1,
GO:1900027,regulation of ruffle assembly,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,P2ry12,1,
GO:2000191,regulation of fatty acid transport,Jan-60,28/15833,0.100935031,0.190589032,0.132011329,Il1b,1,
GO:0007272,ensheathment of neurons,Feb-60,142/15833,0.101035149,0.190589032,0.132011329,Cst7/Tlr2,2,
GO:0008366,axon ensheathment,Feb-60,142/15833,0.101035149,0.190589032,0.132011329,Cst7/Tlr2,2,
GO:0050777,negative regulation of immune response,Feb-60,142/15833,0.101035149,0.190589032,0.132011329,Vsir/Hmox1,2,
GO:0034614,cellular response to reactive oxygen species,Feb-60,143/15833,0.102227573,0.192669959,0.133452681,Fos/Axl,2,
GO:0006457,protein folding,Feb-60,144/15833,0.103423955,0.193956284,0.134343653,Cd74/Hsp90aa1,2,
GO:0097237,cellular response to toxic substance,Feb-60,144/15833,0.103423955,0.193956284,0.134343653,Axl/Hmox1,2,
GO:0001958,endochondral ossification,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Tmem119,1,
GO:0002828,regulation of type 2 immune response,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Cd74,1,
GO:0032692,negative regulation of interleukin-1 production,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Cx3cr1,1,
GO:0033081,regulation of T cell differentiation in thymus,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Il1b,1,
GO:0034381,plasma lipoprotein particle clearance,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Apoe,1,
GO:0036075,replacement ossification,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Tmem119,1,
GO:0042026,protein refolding,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Hsp90aa1,1,
GO:0043537,negative regulation of blood vessel endothelial cell migration,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Apoe,1,
GO:0045066,regulatory T cell differentiation,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Vsir,1,
GO:0045662,negative regulation of myoblast differentiation,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Cxcl10,1,
GO:0046596,regulation of viral entry into host cell,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Cd74,1,
GO:0048535,lymph node development,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Id2,1,
GO:0061157,mRNA destabilization,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Zfp36,1,
GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,Jan-60,29/15833,0.104348121,0.193956284,0.134343653,Cd74,1,
GO:0006631,fatty acid metabolic process,Mar-60,300/15833,0.105044424,0.194914761,0.135007541,Cd74/Lpl/Il1b,3,
GO:0019216,regulation of lipid metabolic process,Mar-60,300/15833,0.105044424,0.194914761,0.135007541,Apoe/Il1b/Id2,3,
GO:0009266,response to temperature stimulus,Feb-60,146/15833,0.105828411,0.19603237,0.135781652,Hmox1/Hsp90aa1,2,
GO:0010594,regulation of endothelial cell migration,Feb-60,146/15833,0.105828411,0.19603237,0.135781652,Apoe/Hmox1,2,
GO:0002675,positive regulation of acute inflammatory response,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Il1b,1,
GO:0010573,vascular endothelial growth factor production,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Il1b,1,
GO:0010714,positive regulation of collagen metabolic process,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Vsir,1,
GO:0010837,regulation of keratinocyte proliferation,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Zfp36,1,
GO:0016242,negative regulation of macroautophagy,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Hmox1,1,
GO:0043114,regulation of vascular permeability,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Ccl4,1,
GO:0045577,regulation of B cell differentiation,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Id2,1,
GO:0045920,negative regulation of exocytosis,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Hmox1,1,
GO:0051085,chaperone cofactor-dependent protein refolding,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Cd74,1,
GO:1901797,negative regulation of signal transduction by p53 class mediator,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Cd74,1,
GO:1903792,negative regulation of anion transport,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Il1b,1,
GO:2000515,negative regulation of CD4-positive, alpha-beta T cell activation,Jan-60,30/15833,0.10774847,0.197491212,0.136792118,Vsir,1
GO:0008610,lipid biosynthetic process,Apr-60,479/15833,0.107805676,0.197491212,0.136792118,Apoe/Cd74/Lpl/Il1b,4,
GO:0051147,regulation of muscle cell differentiation,Feb-60,148/15833,0.108248154,0.198133602,0.137237069,Tmem119/Cxcl10,2,
GO:0006417,regulation of translation,Mar-60,305/15833,0.108987584,0.199317972,0.138057422,Btg2/Ppp1r15a/Zfp36,3,
GO:0007612,learning,Feb-60,149/15833,0.109463646,0.200019093,0.138543052,Btg2/Tlr2,2,
GO:0045862,positive regulation of proteolysis,Mar-60,307/15833,0.110581058,0.200193452,0.138663822,Apoe/Vsir/Il1b,3,
GO:0001890,placenta development,Feb-60,150/15833,0.110682825,0.200193452,0.138663822,Junb/Ctsb,2,
GO:0042594,response to starvation,Feb-60,150/15833,0.110682825,0.200193452,0.138663822,Atf3/Zfp36,2,
GO:0046631,alpha-beta T cell activation,Feb-60,150/15833,0.110682825,0.200193452,0.138663822,Cd83/Vsir,2,
GO:0002920,regulation of humoral immune response,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Il1b,1,
GO:0010543,regulation of platelet activation,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Apoe,1,
GO:0032735,positive regulation of interleukin-12 production,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Tlr2,1,
GO:0034205,amyloid-beta formation,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Apoe,1,
GO:0042311,vasodilation,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Apoe,1,
GO:0044818,mitotic G2/M transition checkpoint,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Ier3,1,
GO:0048566,embryonic digestive tract development,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Id2,1,
GO:0050779,RNA destabilization,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Zfp36,1,
GO:0060074,synapse maturation,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Cx3cr1,1,
GO:0071398,cellular response to fatty acid,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Lpl,1,
GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Ier3,1,
GO:1902991,regulation of amyloid precursor protein catabolic process,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Apoe,1,
GO:2000406,positive regulation of T cell migration,Jan-60,31/15833,0.111136124,0.200193452,0.138663822,Cxcl10,1,
GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,Feb-60,151/15833,0.111905648,0.2014115,0.139507502,P2ry12/Cxcl10,2,
GO:0046890,regulation of lipid biosynthetic process,Feb-60,152/15833,0.11313207,0.203110655,0.14068442,Apoe/Il1b,2,
GO:0048660,regulation of smooth muscle cell proliferation,Feb-60,152/15833,0.11313207,0.203110655,0.14068442,Id2/Hmox1,2,
GO:0071229,cellular response to acid chemical,Feb-60,152/15833,0.11313207,0.203110655,0.14068442,Lpl/Klf2,2,
GO:0051346,negative regulation of hydrolase activity,Mar-60,311/15833,0.113795323,0.203219586,0.140759871,Cst7/Ppp1r15a/Cst3,3,
GO:0071897,DNA biosynthetic process,Feb-60,153/15833,0.114362048,0.203219586,0.140759871,Dusp1/Hsp90aa1,2,
GO:0002931,response to ischemia,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Cx3cr1,1,
GO:0019934,cGMP-mediated signaling,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Apoe,1,
GO:0031572,G2 DNA damage checkpoint,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Ier3,1,
GO:0032309,icosanoid secretion,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Il1b,1,
GO:0032728,positive regulation of interferon-beta production,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Tlr2,1,
GO:0033598,mammary gland epithelial cell proliferation,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Id2,1,
GO:0035308,negative regulation of protein dephosphorylation,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Ppp1r15a,1,
GO:0046164,alcohol catabolic process,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Apoe,1,
GO:0048147,negative regulation of fibroblast proliferation,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Fth1,1,
GO:0060142,regulation of syncytium formation by plasma membrane fusion,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Cxcl10,1,
GO:0060487,lung epithelial cell differentiation,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Klf2,1,
GO:1905953,negative regulation of lipid localization,Jan-60,32/15833,0.114511129,0.203219586,0.140759871,Nfkbia,1,
GO:0071695,anatomical structure maturation,Feb-60,154/15833,0.115595538,0.204975489,0.141976096,Cx3cr1/Klf2,2,
GO:0062012,regulation of small molecule metabolic process,Mar-60,314/15833,0.116229584,0.205930577,0.142637637,Apoe/Ier3/Il1b,3,
GO:0007179,transforming growth factor beta receptor signaling pathway,Feb-60,155/15833,0.116832497,0.206135399,0.142779507,Fos/Pmepa1,2,
GO:0051100,negative regulation of binding,Feb-60,155/15833,0.116832497,0.206135399,0.142779507,Id2/Hmox1,2,
GO:0031589,cell-substrate adhesion,Mar-60,316/15833,0.117863484,0.206135399,0.142779507,Spp1/Cd63/Axl,3,
GO:0000186,activation of MAPKK activity,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Gadd45b,1,
GO:0006356,regulation of transcription by RNA polymerase I,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Ppp1r15a,1,
GO:0006953,acute-phase response,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Il1b,1,
GO:0010955,negative regulation of protein processing,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Cst7,1,
GO:0019432,triglyceride biosynthetic process,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Lpl,1,
GO:0032633,interleukin-4 production,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Cd83,1,
GO:0034142,toll-like receptor 4 signaling pathway,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Nfkbia,1,
GO:0043330,response to exogenous dsRNA,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Nfkbia,1,
GO:0060479,lung cell differentiation,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Klf2,1,
GO:0060674,placenta blood vessel development,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Junb,1,
GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Ier3,1,
GO:1903318,negative regulation of protein maturation,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Cst7,1,
GO:1905898,positive regulation of response to endoplasmic reticulum stress,Jan-60,33/15833,0.117873532,0.206135399,0.142779507,Ppp1r15a,1,
GO:0042129,regulation of T cell proliferation,Feb-60,156/15833,0.118072883,0.206149904,0.142789553,Vsir/Il1b,2,
GO:0048659,smooth muscle cell proliferation,Feb-60,156/15833,0.118072883,0.206149904,0.142789553,Id2/Hmox1,2,
GO:0002218,activation of innate immune response,Feb-60,157/15833,0.119316652,0.208153061,0.144177038,Nfkbia/Tlr2,2,
GO:0001562,response to protozoan,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Ier3,1,
GO:0006778,porphyrin-containing compound metabolic process,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Hmox1,1,
GO:0030513,positive regulation of BMP signaling pathway,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Vsir,1,
GO:0042304,regulation of fatty acid biosynthetic process,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Il1b,1,
GO:0043304,regulation of mast cell degranulation,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Hmox1,1,
GO:0043516,regulation of DNA damage response, signal transduction by p53 class mediator,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Cd74,1
GO:0045686,negative regulation of glial cell differentiation,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Id2,1,
GO:0046885,regulation of hormone biosynthetic process,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Il1b,1,
GO:0050869,negative regulation of B cell activation,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Id2,1,
GO:0051973,positive regulation of telomerase activity,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Hsp90aa1,1,
GO:0071385,cellular response to glucocorticoid stimulus,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Zfp36,1,
GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Fos,1,
GO:2000516,positive regulation of CD4-positive, alpha-beta T cell activation,Jan-60,34/15833,0.12122338,0.209280042,0.144957641,Cd83,1
GO:0032874,positive regulation of stress-activated MAPK cascade,Feb-60,159/15833,0.121814174,0.210131885,0.145547669,Gadd45b/Il1b,2,
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,Feb-60,160/15833,0.123067843,0.211488613,0.146487406,Gadd45b/Il1b,2,
GO:0007187,G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,Feb-60,161/15833,0.124324727,0.211488613,0.146487406,P2ry12/Cxcl10,2
GO:0042445,hormone metabolic process,Feb-60,161/15833,0.124324727,0.211488613,0.146487406,Spp1/Il1b,2,
GO:0002686,negative regulation of leukocyte migration,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Dusp1,1,
GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Nfkbia,1,
GO:0006826,iron ion transport,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Fth1,1,
GO:0009620,response to fungus,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Tlr2,1,
GO:0014002,astrocyte development,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Il1b,1,
GO:0021772,olfactory bulb development,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Id2,1,
GO:0033006,regulation of mast cell activation involved in immune response,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Hmox1,1,
GO:0038084,vascular endothelial growth factor signaling pathway,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Cd63,1,
GO:0042092,type 2 immune response,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Cd74,1,
GO:0045601,regulation of endothelial cell differentiation,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Il1b,1,
GO:0045923,positive regulation of fatty acid metabolic process,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Il1b,1,
GO:0046640,regulation of alpha-beta T cell proliferation,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Vsir,1,
GO:0048821,erythrocyte development,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Klf2,1,
GO:0051084,'de novo' posttranslational protein folding,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Cd74,1,
GO:0070229,negative regulation of lymphocyte apoptotic process,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Cd74,1,
GO:0071384,cellular response to corticosteroid stimulus,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Zfp36,1,
GO:1902692,regulation of neuroblast proliferation,Jan-60,35/15833,0.124560717,0.211488613,0.146487406,Cx3cr1,1,
GO:0045787,positive regulation of cell cycle,Mar-60,325/15833,0.125322996,0.212448567,0.147152317,Rpl23/Il1b/Id2,3,
GO:0052547,regulation of peptidase activity,Mar-60,325/15833,0.125322996,0.212448567,0.147152317,Cst7/Vsir/Cst3,3,
GO:0050821,protein stabilization,Feb-60,162/15833,0.125584786,0.21272525,0.147343961,Rpl23/Hsp90aa1,2,
GO:0006458,'de novo' protein folding,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Cd74,1,
GO:0021799,cerebral cortex radially oriented cell migration,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,P2ry12,1,
GO:0030195,negative regulation of blood coagulation,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Apoe,1,
GO:0035794,positive regulation of mitochondrial membrane permeability,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Ier3,1,
GO:0043368,positive T cell selection,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Cd74,1,
GO:0045746,negative regulation of Notch signaling pathway,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Nfkbia,1,
GO:0046460,neutral lipid biosynthetic process,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Lpl,1,
GO:0046463,acylglycerol biosynthetic process,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Lpl,1,
GO:0048255,mRNA stabilization,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Zfp36,1,
GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Cxcl10,1,
GO:0071715,icosanoid transport,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Il1b,1,
GO:0090207,regulation of triglyceride metabolic process,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Apoe,1,
GO:1901571,fatty acid derivative transport,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Il1b,1,
GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Cd74,1,
GO:2000279,negative regulation of DNA biosynthetic process,Jan-60,36/15833,0.127885591,0.214101711,0.148297366,Dusp1,1,
GO:0019935,cyclic-nucleotide-mediated signaling,Feb-60,165/15833,0.129383605,0.215939535,0.149570333,Apoe/Cxcl10,2,
GO:0048469,cell maturation,Feb-60,165/15833,0.129383605,0.215939535,0.149570333,Id2/Klf2,2,
GO:0071804,cellular potassium ion transport,Feb-60,165/15833,0.129383605,0.215939535,0.149570333,Cd63/P2ry12,2,
GO:0071805,potassium ion transmembrane transport,Feb-60,165/15833,0.129383605,0.215939535,0.149570333,Cd63/P2ry12,2,
GO:0050678,regulation of epithelial cell proliferation,Mar-60,331/15833,0.130390457,0.216788197,0.150158158,Apoe/Zfp36/Hmox1,3,
GO:0001764,neuron migration,Feb-60,166/15833,0.130655956,0.216788197,0.150158158,Axl/Hsp90aa1,2,
GO:0010466,negative regulation of peptidase activity,Feb-60,166/15833,0.130655956,0.216788197,0.150158158,Cst7/Cst3,2,
GO:0001782,B cell homeostasis,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,Cd74,1,
GO:0007616,long-term memory,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,Apoe,1,
GO:0021988,olfactory lobe development,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,Id2,1,
GO:0030261,chromosome condensation,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,H3f3b,1,
GO:0032814,regulation of natural killer cell activation,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,Axl,1,
GO:0035307,positive regulation of protein dephosphorylation,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,Ppp1r15a,1,
GO:0043616,keratinocyte proliferation,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,Zfp36,1,
GO:0046627,negative regulation of insulin receptor signaling pathway,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,Il1b,1,
GO:0050819,negative regulation of coagulation,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,Apoe,1,
GO:1900047,negative regulation of hemostasis,Jan-60,37/15833,0.131198047,0.216788197,0.150158158,Apoe,1,
GO:0120032,regulation of plasma membrane bounded cell projection assembly,Feb-60,167/15833,0.13193128,0.217832978,0.150881825,P2ry12/Hsp90aa1,2,
GO:0060491,regulation of cell projection assembly,Feb-60,168/15833,0.133209536,0.219054313,0.151727781,P2ry12/Hsp90aa1,2,
GO:0022408,negative regulation of cell-cell adhesion,Feb-60,169/15833,0.134490686,0.219054313,0.151727781,Cd74/Vsir,2,
GO:0001937,negative regulation of endothelial cell proliferation,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Apoe,1,
GO:0006024,glycosaminoglycan biosynthetic process,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Il1b,1,
GO:0006110,regulation of glycolytic process,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Ier3,1,
GO:0030811,regulation of nucleotide catabolic process,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Ier3,1,
GO:0032459,regulation of protein oligomerization,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Apoe,1,
GO:0033059,cellular pigmentation,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Cd63,1,
GO:0042398,cellular modified amino acid biosynthetic process,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Ckb,1,
GO:0046633,alpha-beta T cell proliferation,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Vsir,1,
GO:0050931,pigment cell differentiation,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Cd63,1,
GO:0060251,regulation of glial cell proliferation,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Il1b,1,
GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Ier3,1,
GO:1902743,regulation of lamellipodium organization,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Hsp90aa1,1,
GO:1903573,negative regulation of response to endoplasmic reticulum stress,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Ppp1r15a,1,
GO:1903672,positive regulation of sprouting angiogenesis,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Hmox1,1,
GO:1905521,regulation of macrophage migration,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,P2ry12,1,
GO:1905710,positive regulation of membrane permeability,Jan-60,38/15833,0.13449813,0.219054313,0.151727781,Ier3,1,
GO:0003018,vascular process in circulatory system,Feb-60,170/15833,0.135774689,0.220966651,0.15305236,Apoe/Ccl4,2,
GO:0006839,mitochondrial transport,Feb-60,171/15833,0.137061507,0.222228657,0.153926488,Ier3/Hsp90aa1,2,
GO:0044242,cellular lipid catabolic process,Feb-60,171/15833,0.137061507,0.222228657,0.153926488,Apoe/Lpl,2,
GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,Vsir,1,
GO:0009593,detection of chemical stimulus,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,Tlr2,1,
GO:0030501,positive regulation of bone mineralization,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,Tmem119,1,
GO:0033628,regulation of cell adhesion mediated by integrin,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,P2ry12,1,
GO:0043331,response to dsRNA,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,Nfkbia,1,
GO:0045740,positive regulation of DNA replication,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,Cst3,1,
GO:0045777,positive regulation of blood pressure,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,Id2,1,
GO:0050691,regulation of defense response to virus by host,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,Il1b,1,
GO:0060964,regulation of gene silencing by miRNA,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,Zfp36,1,
GO:0090049,regulation of cell migration involved in sprouting angiogenesis,Jan-60,39/15833,0.137785887,0.222228657,0.153926488,Hmox1,1,
GO:0006695,cholesterol biosynthetic process,Jan-60,40/15833,0.141061361,0.2261593,0.156649044,Apoe,1,
GO:0007520,myoblast fusion,Jan-60,40/15833,0.141061361,0.2261593,0.156649044,Cxcl10,1,
GO:0021955,central nervous system neuron axonogenesis,Jan-60,40/15833,0.141061361,0.2261593,0.156649044,Hsp90aa1,1,
GO:0043277,apoptotic cell clearance,Jan-60,40/15833,0.141061361,0.2261593,0.156649044,Axl,1,
GO:0046636,negative regulation of alpha-beta T cell activation,Jan-60,40/15833,0.141061361,0.2261593,0.156649044,Vsir,1,
GO:0048806,genitalia development,Jan-60,40/15833,0.141061361,0.2261593,0.156649044,Axl,1,
GO:0070527,platelet aggregation,Jan-60,40/15833,0.141061361,0.2261593,0.156649044,P2ry12,1,
GO:0097178,ruffle assembly,Jan-60,40/15833,0.141061361,0.2261593,0.156649044,P2ry12,1,
GO:0032869,cellular response to insulin stimulus,Feb-60,175/15833,0.142236157,0.227873516,0.157836395,Lpl/Il1b,2,
GO:0001941,postsynaptic membrane organization,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Apoe,1,
GO:0010677,negative regulation of cellular carbohydrate metabolic process,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Ier3,1,
GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Ier3,1,
GO:0030890,positive regulation of B cell proliferation,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Cd74,1,
GO:0033013,tetrapyrrole metabolic process,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Hmox1,1,
GO:0034198,cellular response to amino acid starvation,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Atf3,1,
GO:0042987,amyloid precursor protein catabolic process,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Apoe,1,
GO:0043489,RNA stabilization,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Zfp36,1,
GO:0071364,cellular response to epidermal growth factor stimulus,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Zfp36,1,
GO:0098754,detoxification,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Mt1,1,
GO:1902653,secondary alcohol biosynthetic process,Jan-60,41/15833,0.144324599,0.229346455,0.158856624,Apoe,1,
GO:0007568,aging,Feb-60,177/15833,0.144839375,0.229995122,0.159305923,Apoe/Id2,2,
GO:0060249,anatomical structure homeostasis,Mar-60,349/15833,0.146020058,0.231699474,0.160486441,Spp1/Tmem119/Hsp90aa1,3,
GO:1990138,neuron projection extension,Feb-60,178/15833,0.146144825,0.231727063,0.160505551,Apoe/Hsp90aa1,2,
GO:0046328,regulation of JNK cascade,Feb-60,179/15833,0.147452787,0.232458572,0.16101223,Gadd45b/Il1b,2,
GO:0002707,negative regulation of lymphocyte mediated immunity,Jan-60,42/15833,0.147575646,0.232458572,0.16101223,Vsir,1,
GO:0032892,positive regulation of organic acid transport,Jan-60,42/15833,0.147575646,0.232458572,0.16101223,Il1b,1,
GO:0045776,negative regulation of blood pressure,Jan-60,42/15833,0.147575646,0.232458572,0.16101223,Ier3,1,
GO:0060147,regulation of posttranscriptional gene silencing,Jan-60,42/15833,0.147575646,0.232458572,0.16101223,Zfp36,1,
GO:0060966,regulation of gene silencing by RNA,Jan-60,42/15833,0.147575646,0.232458572,0.16101223,Zfp36,1,
GO:0061028,establishment of endothelial barrier,Jan-60,42/15833,0.147575646,0.232458572,0.16101223,Il1b,1,
GO:1901616,organic hydroxy compound catabolic process,Jan-60,42/15833,0.147575646,0.232458572,0.16101223,Apoe,1,
GO:2000404,regulation of T cell migration,Jan-60,42/15833,0.147575646,0.232458572,0.16101223,Cxcl10,1,
GO:0042692,muscle cell differentiation,Mar-60,352/15833,0.148684159,0.234033855,0.162103348,H3f3b/Tmem119/Cxcl10,3,
GO:0032873,negative regulation of stress-activated MAPK cascade,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Dusp1,1,
GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Cd74,1,
GO:0050435,amyloid-beta metabolic process,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Apoe,1,
GO:0051955,regulation of amino acid transport,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Il1b,1,
GO:0060412,ventricular septum morphogenesis,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Id2,1,
GO:0060612,adipose tissue development,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Id2,1,
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Dusp1,1,
GO:1902373,negative regulation of mRNA catabolic process,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Zfp36,1,
GO:1903018,regulation of glycoprotein metabolic process,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Cst3,1,
GO:1904036,negative regulation of epithelial cell apoptotic process,Jan-60,43/15833,0.150814545,0.235668203,0.163235378,Hmox1,1,
GO:0021953,central nervous system neuron differentiation,Feb-60,182/15833,0.151391376,0.2363984,0.163741148,Btg2/Hsp90aa1,2,
GO:0048545,response to steroid hormone,Feb-60,183/15833,0.152709018,0.238283486,0.165046851,Spp1/Zfp36,2,
GO:0051224,negative regulation of protein transport,Feb-60,184/15833,0.15402899,0.238495202,0.165193496,Apoe/Il1b,2,
GO:0002820,negative regulation of adaptive immune response,Jan-60,44/15833,0.154041342,0.238495202,0.165193496,Vsir,1,
GO:0015909,long-chain fatty acid transport,Jan-60,44/15833,0.154041342,0.238495202,0.165193496,Apoe,1,
GO:0031638,zymogen activation,Jan-60,44/15833,0.154041342,0.238495202,0.165193496,Vsir,1,
GO:0044060,regulation of endocrine process,Jan-60,44/15833,0.154041342,0.238495202,0.165193496,Il1b,1,
GO:0050850,positive regulation of calcium-mediated signaling,Jan-60,44/15833,0.154041342,0.238495202,0.165193496,Ccl4,1,
GO:0051055,negative regulation of lipid biosynthetic process,Jan-60,44/15833,0.154041342,0.238495202,0.165193496,Apoe,1,
GO:0070169,positive regulation of biomineral tissue development,Jan-60,44/15833,0.154041342,0.238495202,0.165193496,Tmem119,1,
GO:0070849,response to epidermal growth factor,Jan-60,44/15833,0.154041342,0.238495202,0.165193496,Zfp36,1,
GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II,Jan-60,44/15833,0.154041342,0.238495202,0.165193496,Fos,1,
GO:0007517,muscle organ development,Mar-60,358/15833,0.154060385,0.238495202,0.165193496,Atf3/Fos/Btg2,3,
GO:0043112,receptor metabolic process,Feb-60,185/15833,0.155351256,0.240149004,0.166339001,Apoe/Cd63,2,
GO:0043542,endothelial cell migration,Feb-60,185/15833,0.155351256,0.240149004,0.166339001,Apoe/Hmox1,2,
GO:0002253,activation of immune response,Mar-60,360/15833,0.155866365,0.24077281,0.16677108,Nfkbia/Tlr2/Il1b,3,
GO:0001662,behavioral fear response,Jan-60,45/15833,0.157256082,0.241880701,0.16753846,Apoe,1,
GO:0010596,negative regulation of endothelial cell migration,Jan-60,45/15833,0.157256082,0.241880701,0.16753846,Apoe,1,
GO:0010718,positive regulation of epithelial to mesenchymal transition,Jan-60,45/15833,0.157256082,0.241880701,0.16753846,Il1b,1,
GO:0045581,negative regulation of T cell differentiation,Jan-60,45/15833,0.157256082,0.241880701,0.16753846,Cd74,1,
GO:0045668,negative regulation of osteoblast differentiation,Jan-60,45/15833,0.157256082,0.241880701,0.16753846,Id2,1,
GO:1990928,response to amino acid starvation,Jan-60,45/15833,0.157256082,0.241880701,0.16753846,Atf3,1,
GO:0006402,mRNA catabolic process,Feb-60,187/15833,0.158002528,0.242855738,0.168213818,Btg2/Zfp36,2,
GO:0016236,macroautophagy,Feb-60,188/15833,0.159331464,0.244724057,0.169507907,Tlr2/Hmox1,2,
GO:0002209,behavioral defense response,Jan-60,46/15833,0.160458807,0.244851548,0.169596214,Apoe,1,
GO:0016126,sterol biosynthetic process,Jan-60,46/15833,0.160458807,0.244851548,0.169596214,Apoe,1,
GO:0032715,negative regulation of interleukin-6 production,Jan-60,46/15833,0.160458807,0.244851548,0.169596214,Klf2,1,
GO:0042088,T-helper 1 type immune response,Jan-60,46/15833,0.160458807,0.244851548,0.169596214,Il1b,1,
GO:0043303,mast cell degranulation,Jan-60,46/15833,0.160458807,0.244851548,0.169596214,Hmox1,1,
GO:0045912,negative regulation of carbohydrate metabolic process,Jan-60,46/15833,0.160458807,0.244851548,0.169596214,Ier3,1,
GO:0046638,positive regulation of alpha-beta T cell differentiation,Jan-60,46/15833,0.160458807,0.244851548,0.169596214,Cd83,1,
GO:0051187,cofactor catabolic process,Jan-60,46/15833,0.160458807,0.244851548,0.169596214,Hmox1,1,
GO:0050806,positive regulation of synaptic transmission,Feb-60,189/15833,0.160662554,0.244851548,0.169596214,Apoe/Cx3cr1,2,
GO:0071560,cellular response to transforming growth factor beta stimulus,Feb-60,189/15833,0.160662554,0.244851548,0.169596214,Fos/Pmepa1,2,
GO:1904950,negative regulation of establishment of protein localization,Feb-60,189/15833,0.160662554,0.244851548,0.169596214,Apoe/Il1b,2,
GO:0007254,JNK cascade,Feb-60,191/15833,0.163331056,0.247134891,0.171177769,Gadd45b/Il1b,2,
GO:0042098,T cell proliferation,Feb-60,191/15833,0.163331056,0.247134891,0.171177769,Vsir/Il1b,2,
GO:0001974,blood vessel remodeling,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Axl,1,
GO:0002279,mast cell activation involved in immune response,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Hmox1,1,
GO:0002448,mast cell mediated immunity,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Hmox1,1,
GO:0007566,embryo implantation,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,H3f3b,1,
GO:0043370,regulation of CD4-positive, alpha-beta T cell differentiation,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Cd83,1
GO:0043470,regulation of carbohydrate catabolic process,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Ier3,1,
GO:0043627,response to estrogen,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Hmox1,1,
GO:0051196,regulation of coenzyme metabolic process,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Ier3,1,
GO:0051438,regulation of ubiquitin-protein transferase activity,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Rpl23,1,
GO:0051972,regulation of telomerase activity,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Hsp90aa1,1,
GO:0061912,selective autophagy,Jan-60,47/15833,0.163649564,0.247134891,0.171177769,Tlr2,1,
GO:0035264,multicellular organism growth,Feb-60,192/15833,0.1646684,0.248499586,0.172123024,H3f3b/Klf2,2,
GO:0071559,response to transforming growth factor beta,Feb-60,193/15833,0.166007761,0.249166196,0.172584751,Fos/Pmepa1,2,
GO:1901617,organic hydroxy compound biosynthetic process,Feb-60,193/15833,0.166007761,0.249166196,0.172584751,Apoe/Il1b,2,
GO:0006023,aminoglycan biosynthetic process,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Il1b,1,
GO:0006360,transcription by RNA polymerase I,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Ppp1r15a,1,
GO:0010712,regulation of collagen metabolic process,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Vsir,1,
GO:0032350,regulation of hormone metabolic process,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Il1b,1,
GO:0033003,regulation of mast cell activation,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Hmox1,1,
GO:0042596,fear response,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Apoe,1,
GO:0042698,ovulation cycle,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Axl,1,
GO:0043300,regulation of leukocyte degranulation,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Hmox1,1,
GO:0048662,negative regulation of smooth muscle cell proliferation,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Hmox1,1,
GO:0051290,protein heterotetramerization,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Cd74,1,
GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Rpl23,1,
GO:2000648,positive regulation of stem cell proliferation,Jan-60,48/15833,0.166828395,0.249166196,0.172584751,Cx3cr1,1,
GO:0010639,negative regulation of organelle organization,Mar-60,372/15833,0.166842054,0.249166196,0.172584751,H3f3b/Ier3/Tlr2,3,
GO:0031396,regulation of protein ubiquitination,Feb-60,194/15833,0.167349104,0.2497506,0.172989538,Rpl23/Hsp90aa1,2,
GO:0006816,calcium ion transport,Mar-60,373/15833,0.167767155,0.250201465,0.173301829,Ccl4/P2ry12/Cxcl10,3,
GO:0071824,protein-DNA complex subunit organization,Feb-60,195/15833,0.168692398,0.250814188,0.173726231,H3f3b/Rpl23,2,
GO:0016055,Wnt signaling pathway,Mar-60,375/15833,0.169622019,0.250814188,0.173726231,Apoe/Axl/Tlr2,3,
GO:0002833,positive regulation of response to biotic stimulus,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Tlr2,1,
GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,P2ry12,1,
GO:0014014,negative regulation of gliogenesis,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Id2,1,
GO:0032481,positive regulation of type I interferon production,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Tlr2,1,
GO:0032655,regulation of interleukin-12 production,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Tlr2,1,
GO:0034113,heterotypic cell-cell adhesion,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Il1b,1,
GO:0043666,regulation of phosphoprotein phosphatase activity,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Ppp1r15a,1,
GO:0045058,T cell selection,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Cd74,1,
GO:0045604,regulation of epidermal cell differentiation,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Zfp36,1,
GO:0048546,digestive tract morphogenesis,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Id2,1,
GO:0050922,negative regulation of chemotaxis,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Dusp1,1,
GO:0060428,lung epithelium development,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Klf2,1,
GO:0060986,endocrine hormone secretion,Jan-60,49/15833,0.169995344,0.250814188,0.173726231,Il1b,1,
GO:0008361,regulation of cell size,Feb-60,196/15833,0.170037607,0.250814188,0.173726231,Apoe/Hsp90aa1,2,
GO:0051098,regulation of binding,Mar-60,376/15833,0.170551761,0.251400751,0.174132514,Apoe/Id2/Hmox1,3,
GO:0198738,cell-cell signaling by wnt,Mar-60,377/15833,0.171483027,0.252600937,0.174963822,Apoe/Axl/Tlr2,3,
GO:0001894,tissue homeostasis,Feb-60,198/15833,0.172733644,0.252984891,0.175229767,Spp1/Tmem119,2,
GO:0010823,negative regulation of mitochondrion organization,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Ier3,1,
GO:0031529,ruffle organization,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,P2ry12,1,
GO:0032648,regulation of interferon-beta production,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Tlr2,1,
GO:0035306,positive regulation of dephosphorylation,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Ppp1r15a,1,
GO:0043030,regulation of macrophage activation,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Cst7,1,
GO:0048066,developmental pigmentation,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Cd63,1,
GO:0048512,circadian behavior,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Id2,1,
GO:0050829,defense response to Gram-negative bacterium,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Lyz2,1,
GO:0050994,regulation of lipid catabolic process,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Il1b,1,
GO:1902369,negative regulation of RNA catabolic process,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Zfp36,1,
GO:2001169,regulation of ATP biosynthetic process,Jan-60,50/15833,0.173150456,0.252984891,0.175229767,Ier3,1,
GO:0034655,nucleobase-containing compound catabolic process,Mar-60,379/15833,0.173350092,0.253105208,0.175313105,Btg2/Ier3/Zfp36,3,
GO:0032271,regulation of protein polymerization,Feb-60,199/15833,0.174084405,0.253833883,0.175817821,Tlr2/Hsp90aa1,2,
GO:0051607,defense response to virus,Feb-60,199/15833,0.174084405,0.253833883,0.175817821,Il1b/Cxcl10,2,
GO:0007622,rhythmic behavior,Jan-60,51/15833,0.176293773,0.255673361,0.177091934,Id2,1,
GO:0032615,interleukin-12 production,Jan-60,51/15833,0.176293773,0.255673361,0.177091934,Tlr2,1,
GO:0045773,positive regulation of axon extension,Jan-60,51/15833,0.176293773,0.255673361,0.177091934,Apoe,1,
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,Jan-60,51/15833,0.176293773,0.255673361,0.177091934,Pmepa1,1,
GO:0061077,chaperone-mediated protein folding,Jan-60,51/15833,0.176293773,0.255673361,0.177091934,Cd74,1,
GO:0061614,pri-miRNA transcription by RNA polymerase II,Jan-60,51/15833,0.176293773,0.255673361,0.177091934,Fos,1,
GO:1904705,regulation of vascular smooth muscle cell proliferation,Jan-60,51/15833,0.176293773,0.255673361,0.177091934,Hmox1,1,
GO:1990874,vascular smooth muscle cell proliferation,Jan-60,51/15833,0.176293773,0.255673361,0.177091934,Hmox1,1,
GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,Feb-60,201/15833,0.176791253,0.256050687,0.177353288,Apoe/Rpl23,2,
GO:2001020,regulation of response to DNA damage stimulus,Feb-60,201/15833,0.176791253,0.256050687,0.177353288,Cd74/Ier3,2,
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,Feb-60,202/15833,0.178147275,0.257389874,0.178280875,Vsir/Pmepa1,2,
GO:0003229,ventricular cardiac muscle tissue development,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Id2,1,
GO:0006956,complement activation,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Il1b,1,
GO:0010524,positive regulation of calcium ion transport into cytosol,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Cxcl10,1,
GO:0010656,negative regulation of muscle cell apoptotic process,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Hmox1,1,
GO:0014009,glial cell proliferation,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Il1b,1,
GO:0031641,regulation of myelination,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Cst7,1,
GO:0032608,interferon-beta production,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Tlr2,1,
GO:0035924,cellular response to vascular endothelial growth factor stimulus,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Cd63,1,
GO:0045840,positive regulation of mitotic nuclear division,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Il1b,1,
GO:0046902,regulation of mitochondrial membrane permeability,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Ier3,1,
GO:0072678,T cell migration,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Cxcl10,1,
GO:1902750,negative regulation of cell cycle G2/M phase transition,Jan-60,52/15833,0.179425339,0.257389874,0.178280875,Ier3,1,
GO:0006813,potassium ion transport,Feb-60,203/15833,0.179504986,0.257389874,0.178280875,Cd63/P2ry12,2,
GO:0048167,regulation of synaptic plasticity,Feb-60,203/15833,0.179504986,0.257389874,0.178280875,Apoe/Cx3cr1,2,
GO:0040029,regulation of gene expression, epigenetic,Feb-60,204/15833,0.180864356,0.259166853,0.179511698,Zfp36/Klf2,2
GO:0030278,regulation of ossification,Feb-60,205/15833,0.182225353,0.260365191,0.180341726,Tmem119/Id2,2,
GO:0032868,response to insulin,Feb-60,205/15833,0.182225353,0.260365191,0.180341726,Lpl/Il1b,2,
GO:0048260,positive regulation of receptor-mediated endocytosis,Jan-60,53/15833,0.182545197,0.260365191,0.180341726,Cd63,1,
GO:0051591,response to cAMP,Jan-60,53/15833,0.182545197,0.260365191,0.180341726,Junb,1,
GO:0060711,labyrinthine layer development,Jan-60,53/15833,0.182545197,0.260365191,0.180341726,Junb,1,
GO:1903510,mucopolysaccharide metabolic process,Jan-60,53/15833,0.182545197,0.260365191,0.180341726,Il1b,1,
GO:2000736,regulation of stem cell differentiation,Jan-60,53/15833,0.182545197,0.260365191,0.180341726,Vsir,1,
GO:0007283,spermatogenesis,Mar-60,391/15833,0.184674766,0.26322863,0.182325084,H3f3b/Axl/Tmem119,3,
GO:0002042,cell migration involved in sprouting angiogenesis,Jan-60,54/15833,0.18565339,0.263926229,0.182808275,Hmox1,1,
GO:0015914,phospholipid transport,Jan-60,54/15833,0.18565339,0.263926229,0.182808275,Apoe,1,
GO:0045806,negative regulation of endocytosis,Jan-60,54/15833,0.18565339,0.263926229,0.182808275,Tlr2,1,
GO:0060389,pathway-restricted SMAD protein phosphorylation,Jan-60,54/15833,0.18565339,0.263926229,0.182808275,Pmepa1,1,
GO:0001825,blastocyst formation,Jan-60,55/15833,0.188749961,0.26779909,0.185490809,Junb,1,
GO:0043536,positive regulation of blood vessel endothelial cell migration,Jan-60,55/15833,0.188749961,0.26779909,0.185490809,Hmox1,1,
GO:0044773,mitotic DNA damage checkpoint,Jan-60,55/15833,0.188749961,0.26779909,0.185490809,Ier3,1,
GO:1901615,organic hydroxy compound metabolic process,Mar-60,397/15833,0.190411809,0.269819103,0.186889969,Apoe/Apoc1/Il1b,3,
GO:0033002,muscle cell proliferation,Feb-60,211/15833,0.190423769,0.269819103,0.186889969,Id2/Hmox1,2,
GO:0010948,negative regulation of cell cycle process,Feb-60,212/15833,0.191795294,0.27004555,0.187046818,Ier3/Rpl23,2,
GO:0002673,regulation of acute inflammatory response,Jan-60,56/15833,0.191834953,0.27004555,0.187046818,Il1b,1,
GO:0015800,acidic amino acid transport,Jan-60,56/15833,0.191834953,0.27004555,0.187046818,Il1b,1,
GO:0030837,negative regulation of actin filament polymerization,Jan-60,56/15833,0.191834953,0.27004555,0.187046818,Tlr2,1,
GO:0042446,hormone biosynthetic process,Jan-60,56/15833,0.191834953,0.27004555,0.187046818,Il1b,1,
GO:0042982,amyloid precursor protein metabolic process,Jan-60,56/15833,0.191834953,0.27004555,0.187046818,Apoe,1,
GO:0043954,cellular component maintenance,Jan-60,56/15833,0.191834953,0.27004555,0.187046818,Apoe,1,
GO:0050433,regulation of catecholamine secretion,Jan-60,56/15833,0.191834953,0.27004555,0.187046818,P2ry12,1,
GO:1903902,positive regulation of viral life cycle,Jan-60,56/15833,0.191834953,0.27004555,0.187046818,Cd74,1,
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,Jan-60,56/15833,0.191834953,0.27004555,0.187046818,Atf3,1,
GO:0000768,syncytium formation by plasma membrane fusion,Jan-60,57/15833,0.194908408,0.273480068,0.189425734,Cxcl10,1,
GO:0033209,tumor necrosis factor-mediated signaling pathway,Jan-60,57/15833,0.194908408,0.273480068,0.189425734,Nfkbia,1,
GO:0061045,negative regulation of wound healing,Jan-60,57/15833,0.194908408,0.273480068,0.189425734,Apoe,1,
GO:0070206,protein trimerization,Jan-60,57/15833,0.194908408,0.273480068,0.189425734,Cd74,1,
GO:0140253,cell-cell fusion,Jan-60,57/15833,0.194908408,0.273480068,0.189425734,Cxcl10,1,
GO:0006401,RNA catabolic process,Feb-60,215/15833,0.195918052,0.2747181,0.190283255,Btg2/Zfp36,2,
GO:0042440,pigment metabolic process,Jan-60,58/15833,0.197970369,0.277235598,0.192026998,Hmox1,1,
GO:0045661,regulation of myoblast differentiation,Jan-60,58/15833,0.197970369,0.277235598,0.192026998,Cxcl10,1,
GO:0006278,RNA-dependent DNA biosynthetic process,Jan-60,59/15833,0.201020878,0.279872938,0.19385375,Hsp90aa1,1,
GO:0006446,regulation of translational initiation,Jan-60,59/15833,0.201020878,0.279872938,0.19385375,Ppp1r15a,1,
GO:0006766,vitamin metabolic process,Jan-60,59/15833,0.201020878,0.279872938,0.19385375,Il1b,1,
GO:0006949,syncytium formation,Jan-60,59/15833,0.201020878,0.279872938,0.19385375,Cxcl10,1,
GO:0007004,telomere maintenance via telomerase,Jan-60,59/15833,0.201020878,0.279872938,0.19385375,Hsp90aa1,1,
GO:0050432,catecholamine secretion,Jan-60,59/15833,0.201020878,0.279872938,0.19385375,P2ry12,1,
GO:0070972,protein localization to endoplasmic reticulum,Jan-60,59/15833,0.201020878,0.279872938,0.19385375,Ppp1r15a,1,
GO:0072376,protein activation cascade,Jan-60,59/15833,0.201020878,0.279872938,0.19385375,Il1b,1,
GO:0097755,positive regulation of blood vessel diameter,Jan-60,59/15833,0.201020878,0.279872938,0.19385375,Apoe,1,
GO:0007626,locomotory behavior,Feb-60,219/15833,0.201433068,0.280085413,0.194000921,Apoe/Id2,2,
GO:0045930,negative regulation of mitotic cell cycle,Feb-60,219/15833,0.201433068,0.280085413,0.194000921,Btg2/Ier3,2,
GO:0010608,posttranscriptional regulation of gene expression,Mar-60,409/15833,0.202023683,0.280545114,0.194319332,Btg2/Ppp1r15a/Zfp36,3,
GO:0048232,male gamete generation,Mar-60,409/15833,0.202023683,0.280545114,0.194319332,H3f3b/Axl/Tmem119,3,
GO:0002886,regulation of myeloid leukocyte mediated immunity,Jan-60,60/15833,0.204059977,0.283008631,0.196025685,Hmox1,1,
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,Jan-60,60/15833,0.204059977,0.283008631,0.196025685,Pmepa1,1,
GO:0071375,cellular response to peptide hormone stimulus,Feb-60,221/15833,0.204197778,0.283017857,0.196032075,Lpl/Il1b,2,
GO:1903320,regulation of protein modification by small protein conjugation or removal,Feb-60,223/15833,0.206966987,0.285738666,0.197916641,Rpl23/Hsp90aa1,2,
GO:0030330,DNA damage response, signal transduction by p53 class mediator,Jan-60,61/15833,0.207087708,0.285738666,0.197916641,Cd74,1
GO:0032387,negative regulation of intracellular transport,Jan-60,61/15833,0.207087708,0.285738666,0.197916641,Hmox1,1,
GO:0034121,regulation of toll-like receptor signaling pathway,Jan-60,61/15833,0.207087708,0.285738666,0.197916641,Tlr2,1,
GO:0060688,regulation of morphogenesis of a branching structure,Jan-60,61/15833,0.207087708,0.285738666,0.197916641,Il1b,1,
GO:0070228,regulation of lymphocyte apoptotic process,Jan-60,61/15833,0.207087708,0.285738666,0.197916641,Cd74,1,
GO:2000179,positive regulation of neural precursor cell proliferation,Jan-60,61/15833,0.207087708,0.285738666,0.197916641,Cx3cr1,1,
GO:0034976,response to endoplasmic reticulum stress,Feb-60,224/15833,0.20835321,0.287301103,0.198998862,Atf3/Ppp1r15a,2,
GO:0006470,protein dephosphorylation,Feb-60,225/15833,0.209740475,0.287328692,0.199017971,Dusp1/Ppp1r15a,2,
GO:0048871,multicellular organismal homeostasis,Mar-60,417/15833,0.209859629,0.287328692,0.199017971,Spp1/Tmem119/Il1b,3,
GO:0050808,synapse organization,Mar-60,417/15833,0.209859629,0.287328692,0.199017971,Apoe/Tlr2/Cx3cr1,3,
GO:0001885,endothelial cell development,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,Il1b,1,
GO:0002090,regulation of receptor internalization,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,Cd63,1,
GO:0030193,regulation of blood coagulation,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,Apoe,1,
GO:0030808,regulation of nucleotide biosynthetic process,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,Ier3,1,
GO:0033627,cell adhesion mediated by integrin,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,P2ry12,1,
GO:0042130,negative regulation of T cell proliferation,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,Vsir,1,
GO:0060999,positive regulation of dendritic spine development,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,Apoe,1,
GO:0090398,cellular senescence,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,Id2,1,
GO:1900371,regulation of purine nucleotide biosynthetic process,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,Ier3,1,
GO:1903845,negative regulation of cellular response to transforming growth factor beta stimulus,Jan-60,62/15833,0.210104113,0.287328692,0.199017971,Pmepa1,1,
GO:0070838,divalent metal ion transport,Mar-60,419/15833,0.211829682,0.289238821,0.20034102,Ccl4/P2ry12/Cxcl10,3,
GO:0007548,sex differentiation,Feb-60,227/15833,0.212518023,0.289238821,0.20034102,H3f3b/Axl,2,
GO:0006094,gluconeogenesis,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,Atf3,1,
GO:0021766,hippocampus development,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,Btg2,1,
GO:0034109,homotypic cell-cell adhesion,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,P2ry12,1,
GO:0044774,mitotic DNA integrity checkpoint,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,Ier3,1,
GO:0048146,positive regulation of fibroblast proliferation,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,Cd74,1,
GO:0048678,response to axon injury,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,P2ry12,1,
GO:0051193,regulation of cofactor metabolic process,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,Ier3,1,
GO:0090559,regulation of membrane permeability,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,Ier3,1,
GO:0097327,response to antineoplastic agent,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,Hmox1,1,
GO:1900046,regulation of hemostasis,Jan-60,63/15833,0.213109233,0.289238821,0.20034102,Apoe,1,
GO:0072511,divalent inorganic cation transport,Mar-60,421/15833,0.213803994,0.289999383,0.200867823,Ccl4/P2ry12/Cxcl10,3,
GO:0031334,positive regulation of protein complex assembly,Feb-60,229/15833,0.215299415,0.291661104,0.202018812,P2ry12/Hsp90aa1,2,
GO:0051054,positive regulation of DNA metabolic process,Feb-60,229/15833,0.215299415,0.291661104,0.202018812,Cst3/Hsp90aa1,2,
GO:0007405,neuroblast proliferation,Jan-60,64/15833,0.216103111,0.292016601,0.202265048,Cx3cr1,1,
GO:0046637,regulation of alpha-beta T cell differentiation,Jan-60,64/15833,0.216103111,0.292016601,0.202265048,Cd83,1,
GO:0051384,response to glucocorticoid,Jan-60,64/15833,0.216103111,0.292016601,0.202265048,Zfp36,1,
GO:2001021,negative regulation of response to DNA damage stimulus,Jan-60,64/15833,0.216103111,0.292016601,0.202265048,Cd74,1,
GO:0002366,leukocyte activation involved in immune response,Feb-60,230/15833,0.216691487,0.292445421,0.202562069,Cx3cr1/Hmox1,2,
GO:1903311,regulation of mRNA metabolic process,Feb-60,230/15833,0.216691487,0.292445421,0.202562069,Btg2/Zfp36,2,
GO:0030888,regulation of B cell proliferation,Jan-60,65/15833,0.219085786,0.294204808,0.203780707,Cd74,1,
GO:0032922,circadian regulation of gene expression,Jan-60,65/15833,0.219085786,0.294204808,0.203780707,Id2,1,
GO:0043113,receptor clustering,Jan-60,65/15833,0.219085786,0.294204808,0.203780707,Apoe,1,
GO:0045576,mast cell activation,Jan-60,65/15833,0.219085786,0.294204808,0.203780707,Hmox1,1,
GO:0046626,regulation of insulin receptor signaling pathway,Jan-60,65/15833,0.219085786,0.294204808,0.203780707,Il1b,1,
GO:0046635,positive regulation of alpha-beta T cell activation,Jan-60,65/15833,0.219085786,0.294204808,0.203780707,Cd83,1,
GO:0050818,regulation of coagulation,Jan-60,65/15833,0.219085786,0.294204808,0.203780707,Apoe,1,
GO:0060395,SMAD protein signal transduction,Jan-60,65/15833,0.219085786,0.294204808,0.203780707,Fos,1,
GO:0002088,lens development in camera-type eye,Jan-60,66/15833,0.222057302,0.297270259,0.205903989,Crybb1,1,
GO:0019319,hexose biosynthetic process,Jan-60,66/15833,0.222057302,0.297270259,0.205903989,Atf3,1,
GO:0031960,response to corticosteroid,Jan-60,66/15833,0.222057302,0.297270259,0.205903989,Zfp36,1,
GO:0035195,gene silencing by miRNA,Jan-60,66/15833,0.222057302,0.297270259,0.205903989,Zfp36,1,
GO:0045669,positive regulation of osteoblast differentiation,Jan-60,66/15833,0.222057302,0.297270259,0.205903989,Tmem119,1,
GO:0002263,cell activation involved in immune response,Feb-60,234/15833,0.222268329,0.297368292,0.205971891,Cx3cr1/Hmox1,2,
GO:0032729,positive regulation of interferon-gamma production,Jan-60,67/15833,0.225017697,0.299745797,0.207618668,Il1b,1,
GO:0043299,leukocyte degranulation,Jan-60,67/15833,0.225017697,0.299745797,0.207618668,Hmox1,1,
GO:0048663,neuron fate commitment,Jan-60,67/15833,0.225017697,0.299745797,0.207618668,Id2,1,
GO:0048844,artery morphogenesis,Jan-60,67/15833,0.225017697,0.299745797,0.207618668,Apoe,1,
GO:0050766,positive regulation of phagocytosis,Jan-60,67/15833,0.225017697,0.299745797,0.207618668,Il1b,1,
GO:0051781,positive regulation of cell division,Jan-60,67/15833,0.225017697,0.299745797,0.207618668,Il1b,1,
GO:1901655,cellular response to ketone,Jan-60,67/15833,0.225017697,0.299745797,0.207618668,Spp1,1,
GO:0010506,regulation of autophagy,Feb-60,237/15833,0.226459224,0.301479953,0.20881983,Tlr2/Hmox1,2,
GO:0051785,positive regulation of nuclear division,Jan-60,68/15833,0.227967015,0.303113258,0.209951137,Il1b,1,
GO:1903051,negative regulation of proteolysis involved in cellular protein catabolic process,Jan-60,68/15833,0.227967015,0.303113258,0.209951137,Rpl23,1,
GO:0031346,positive regulation of cell projection organization,Mar-60,437/15833,0.229741954,0.305285183,0.211455519,Apoe/P2ry12/Hsp90aa1,3,
GO:0009615,response to virus,Feb-60,240/15833,0.230656442,0.306123371,0.212036089,Il1b/Cxcl10,2,
GO:0048588,developmental cell growth,Feb-60,240/15833,0.230656442,0.306123371,0.212036089,Apoe/Hsp90aa1,2,
GO:0051937,catecholamine transport,Jan-60,69/15833,0.230905295,0.306265289,0.212134389,P2ry12,1,
GO:0042113,B cell activation,Feb-60,241/15833,0.232056804,0.307603552,0.213061336,Cd74/Id2,2,
GO:0006626,protein targeting to mitochondrion,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Hsp90aa1,1,
GO:0006835,dicarboxylic acid transport,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Il1b,1,
GO:0032272,negative regulation of protein polymerization,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Tlr2,1,
GO:0032418,lysosome localization,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Hmox1,1,
GO:0032890,regulation of organic acid transport,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Il1b,1,
GO:0034754,cellular hormone metabolic process,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Spp1,1,
GO:0045682,regulation of epidermis development,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Zfp36,1,
GO:0046364,monosaccharide biosynthetic process,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Atf3,1,
GO:0060350,endochondral bone morphogenesis,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Tmem119,1,
GO:0060411,cardiac septum morphogenesis,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Id2,1,
GO:1904427,positive regulation of calcium ion transmembrane transport,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Cxcl10,1,
GO:2000573,positive regulation of DNA biosynthetic process,Jan-60,70/15833,0.233832577,0.307689452,0.213120834,Hsp90aa1,1,
GO:0046883,regulation of hormone secretion,Feb-60,243/15833,0.234859316,0.308852166,0.213926187,Spp1/Il1b,2,
GO:1901990,regulation of mitotic cell cycle phase transition,Feb-60,244/15833,0.236261418,0.309826642,0.214601157,Ier3/Id2,2,
GO:0003281,ventricular septum development,Jan-60,71/15833,0.236748903,0.309826642,0.214601157,Id2,1,
GO:0010507,negative regulation of autophagy,Jan-60,71/15833,0.236748903,0.309826642,0.214601157,Hmox1,1,
GO:0031397,negative regulation of protein ubiquitination,Jan-60,71/15833,0.236748903,0.309826642,0.214601157,Rpl23,1,
GO:0031646,positive regulation of neurological system process,Jan-60,71/15833,0.236748903,0.309826642,0.214601157,Cst7,1,
GO:0035194,posttranscriptional gene silencing by RNA,Jan-60,71/15833,0.236748903,0.309826642,0.214601157,Zfp36,1,
GO:0042273,ribosomal large subunit biogenesis,Jan-60,71/15833,0.236748903,0.309826642,0.214601157,Rpl10a,1,
GO:0050688,regulation of defense response to virus,Jan-60,71/15833,0.236748903,0.309826642,0.214601157,Il1b,1,
GO:0010833,telomere maintenance via telomere lengthening,Jan-60,72/15833,0.239654313,0.312303144,0.216316504,Hsp90aa1,1,
GO:0015748,organophosphate ester transport,Jan-60,72/15833,0.239654313,0.312303144,0.216316504,Apoe,1,
GO:0016441,posttranscriptional gene silencing,Jan-60,72/15833,0.239654313,0.312303144,0.216316504,Zfp36,1,
GO:0030500,regulation of bone mineralization,Jan-60,72/15833,0.239654313,0.312303144,0.216316504,Tmem119,1,
GO:0050805,negative regulation of synaptic transmission,Jan-60,72/15833,0.239654313,0.312303144,0.216316504,Il1b,1,
GO:0051279,regulation of release of sequestered calcium ion into cytosol,Jan-60,72/15833,0.239654313,0.312303144,0.216316504,Cxcl10,1,
GO:1905897,regulation of response to endoplasmic reticulum stress,Jan-60,72/15833,0.239654313,0.312303144,0.216316504,Ppp1r15a,1,
GO:0050807,regulation of synapse organization,Feb-60,248/15833,0.241874908,0.314934061,0.218138806,Apoe/Tlr2,2,
GO:0010923,negative regulation of phosphatase activity,Jan-60,73/15833,0.242548846,0.314934061,0.218138806,Ppp1r15a,1,
GO:0030203,glycosaminoglycan metabolic process,Jan-60,73/15833,0.242548846,0.314934061,0.218138806,Il1b,1,
GO:0032088,negative regulation of NF-kappaB transcription factor activity,Jan-60,73/15833,0.242548846,0.314934061,0.218138806,Nfkbia,1,
GO:0061180,mammary gland epithelium development,Jan-60,73/15833,0.242548846,0.314934061,0.218138806,Id2,1,
GO:1903312,negative regulation of mRNA metabolic process,Jan-60,73/15833,0.242548846,0.314934061,0.218138806,Zfp36,1,
GO:0046942,carboxylic acid transport,Feb-60,250/15833,0.244684374,0.317515863,0.219927089,Apoe/Il1b,2,
GO:0030279,negative regulation of ossification,Jan-60,74/15833,0.245432543,0.317913222,0.22020232,Id2,1,
GO:0050795,regulation of behavior,Jan-60,74/15833,0.245432543,0.317913222,0.22020232,Apoe,1,
GO:1903035,negative regulation of response to wounding,Jan-60,74/15833,0.245432543,0.317913222,0.22020232,Apoe,1,
GO:0015849,organic acid transport,Feb-60,251/15833,0.246089707,0.318382247,0.220527189,Apoe/Il1b,2,
GO:0070588,calcium ion transmembrane transport,Feb-60,251/15833,0.246089707,0.318382247,0.220527189,P2ry12/Cxcl10,2,
GO:0051258,protein polymerization,Feb-60,252/15833,0.24749541,0.320009044,0.221653989,Tlr2/Hsp90aa1,2,
GO:0006096,glycolytic process,Jan-60,75/15833,0.248305444,0.320288792,0.221847756,Ier3,1,
GO:0032479,regulation of type I interferon production,Jan-60,75/15833,0.248305444,0.320288792,0.221847756,Tlr2,1,
GO:0046888,negative regulation of hormone secretion,Jan-60,75/15833,0.248305444,0.320288792,0.221847756,Il1b,1,
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,Jan-60,75/15833,0.248305444,0.320288792,0.221847756,Cd74,1,
GO:0060560,developmental growth involved in morphogenesis,Feb-60,253/15833,0.248901459,0.320865799,0.22224742,Apoe/Hsp90aa1,2,
GO:0006757,ATP generation from ADP,Jan-60,76/15833,0.251167589,0.32243882,0.223336971,Ier3,1,
GO:0010389,regulation of G2/M transition of mitotic cell cycle,Jan-60,76/15833,0.251167589,0.32243882,0.223336971,Ier3,1,
GO:0019217,regulation of fatty acid metabolic process,Jan-60,76/15833,0.251167589,0.32243882,0.223336971,Il1b,1,
GO:0032945,negative regulation of mononuclear cell proliferation,Jan-60,76/15833,0.251167589,0.32243882,0.223336971,Vsir,1,
GO:0043507,positive regulation of JUN kinase activity,Jan-60,76/15833,0.251167589,0.32243882,0.223336971,Il1b,1,
GO:0050672,negative regulation of lymphocyte proliferation,Jan-60,76/15833,0.251167589,0.32243882,0.223336971,Vsir,1,
GO:1903578,regulation of ATP metabolic process,Jan-60,76/15833,0.251167589,0.32243882,0.223336971,Ier3,1,
GO:0002260,lymphocyte homeostasis,Jan-60,77/15833,0.254019016,0.325183988,0.225238409,Cd74,1,
GO:0010827,regulation of glucose transmembrane transport,Jan-60,77/15833,0.254019016,0.325183988,0.225238409,Il1b,1,
GO:0043367,CD4-positive, alpha-beta T cell differentiation,Jan-60,77/15833,0.254019016,0.325183988,0.225238409,Cd83,1
GO:0044344,cellular response to fibroblast growth factor stimulus,Jan-60,77/15833,0.254019016,0.325183988,0.225238409,Zfp36,1,
GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,Mar-60,461/15833,0.254059409,0.325183988,0.225238409,Apoe/Axl/Tlr2,3,
GO:0048511,rhythmic process,Feb-60,257/15833,0.254528679,0.325398631,0.225387081,Axl/Id2,2,
GO:0050803,regulation of synapse structure or activity,Feb-60,257/15833,0.254528679,0.325398631,0.225387081,Apoe/Tlr2,2,
GO:0042866,pyruvate biosynthetic process,Jan-60,78/15833,0.256859767,0.327602468,0.226913568,Ier3,1,
GO:0048477,oogenesis,Jan-60,78/15833,0.256859767,0.327602468,0.226913568,H3f3b,1,
GO:0070227,lymphocyte apoptotic process,Jan-60,78/15833,0.256859767,0.327602468,0.226913568,Cd74,1,
GO:1901379,regulation of potassium ion transmembrane transport,Jan-60,78/15833,0.256859767,0.327602468,0.226913568,Cd63,1,
GO:0050804,modulation of chemical synaptic transmission,Mar-60,464/15833,0.257128017,0.327750892,0.227016373,Apoe/Cx3cr1/Il1b,3,
GO:0099177,regulation of trans-synaptic signaling,Mar-60,465/15833,0.258152135,0.328862047,0.227786014,Apoe/Cx3cr1/Il1b,3,
GO:0008593,regulation of Notch signaling pathway,Jan-60,79/15833,0.259689879,0.329847415,0.228468528,Nfkbia,1,
GO:0032606,type I interferon production,Jan-60,79/15833,0.259689879,0.329847415,0.228468528,Tlr2,1,
GO:0070664,negative regulation of leukocyte proliferation,Jan-60,79/15833,0.259689879,0.329847415,0.228468528,Vsir,1,
GO:0072091,regulation of stem cell proliferation,Jan-60,79/15833,0.259689879,0.329847415,0.228468528,Cx3cr1,1,
GO:1903363,negative regulation of cellular protein catabolic process,Jan-60,79/15833,0.259689879,0.329847415,0.228468528,Rpl23,1,
GO:0000041,transition metal ion transport,Jan-60,80/15833,0.262509391,0.332645488,0.230406611,Fth1,1,
GO:0001656,metanephros development,Jan-60,80/15833,0.262509391,0.332645488,0.230406611,Id2,1,
GO:0035304,regulation of protein dephosphorylation,Jan-60,80/15833,0.262509391,0.332645488,0.230406611,Ppp1r15a,1,
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,Jan-60,80/15833,0.262509391,0.332645488,0.230406611,Rpl23,1,
GO:0031647,regulation of protein stability,Feb-60,263/15833,0.262976179,0.333041428,0.230680858,Rpl23/Hsp90aa1,2,
GO:0030510,regulation of BMP signaling pathway,Jan-60,81/15833,0.265318344,0.335220719,0.232190342,Vsir,1,
GO:0050886,endocrine process,Jan-60,81/15833,0.265318344,0.335220719,0.232190342,Il1b,1,
GO:0060968,regulation of gene silencing,Jan-60,81/15833,0.265318344,0.335220719,0.232190342,Zfp36,1,
GO:2000117,negative regulation of cysteine-type endopeptidase activity,Jan-60,81/15833,0.265318344,0.335220719,0.232190342,Cst7,1,
GO:0010717,regulation of epithelial to mesenchymal transition,Jan-60,82/15833,0.268116776,0.33816248,0.234227951,Il1b,1,
GO:0033555,multicellular organismal response to stress,Jan-60,82/15833,0.268116776,0.33816248,0.234227951,Apoe,1,
GO:0045445,myoblast differentiation,Jan-60,82/15833,0.268116776,0.33816248,0.234227951,Cxcl10,1,
GO:0030111,regulation of Wnt signaling pathway,Feb-60,267/15833,0.268610311,0.338587062,0.234522037,Apoe/Tlr2,2,
GO:0001570,vasculogenesis,Jan-60,83/15833,0.270904726,0.340881865,0.23611153,Junb,1,
GO:0002181,cytoplasmic translation,Jan-60,83/15833,0.270904726,0.340881865,0.23611153,Rpl10a,1,
GO:0046031,ADP metabolic process,Jan-60,83/15833,0.270904726,0.340881865,0.23611153,Ier3,1,
GO:0018105,peptidyl-serine phosphorylation,Feb-60,269/15833,0.271427622,0.341340797,0.236429409,Ppp1r15a/Hsp90aa1,2,
GO:0003073,regulation of systemic arterial blood pressure,Jan-60,84/15833,0.273682232,0.343575483,0.237977263,Ier3,1,
GO:0021761,limbic system development,Jan-60,84/15833,0.273682232,0.343575483,0.237977263,Btg2,1,
GO:0042100,B cell proliferation,Jan-60,84/15833,0.273682232,0.343575483,0.237977263,Cd74,1,
GO:0015844,monoamine transport,Jan-60,85/15833,0.276449332,0.346645938,0.24010401,P2ry12,1,
GO:0030216,keratinocyte differentiation,Jan-60,85/15833,0.276449332,0.346645938,0.24010401,Zfp36,1,
GO:0006913,nucleocytoplasmic transport,Feb-60,273/15833,0.277061932,0.346809541,0.24021733,Nfkbia/Ier3,2,
GO:0051169,nuclear transport,Feb-60,273/15833,0.277061932,0.346809541,0.24021733,Nfkbia/Ier3,2,
GO:1901987,regulation of cell cycle phase transition,Feb-60,273/15833,0.277061932,0.346809541,0.24021733,Ier3/Id2,2,
GO:0007229,integrin-mediated signaling pathway,Jan-60,86/15833,0.279206066,0.348684427,0.241515968,Cd63,1,
GO:0035305,negative regulation of dephosphorylation,Jan-60,86/15833,0.279206066,0.348684427,0.241515968,Ppp1r15a,1,
GO:0042770,signal transduction in response to DNA damage,Jan-60,86/15833,0.279206066,0.348684427,0.241515968,Cd74,1,
GO:0070167,regulation of biomineral tissue development,Jan-60,86/15833,0.279206066,0.348684427,0.241515968,Tmem119,1,
GO:0001938,positive regulation of endothelial cell proliferation,Jan-60,87/15833,0.281952471,0.351504004,0.243468946,Hmox1,1,
GO:0046717,acid secretion,Jan-60,87/15833,0.281952471,0.351504004,0.243468946,Il1b,1,
GO:0072655,establishment of protein localization to mitochondrion,Jan-60,87/15833,0.281952471,0.351504004,0.243468946,Hsp90aa1,1,
GO:0051146,striated muscle cell differentiation,Feb-60,278/15833,0.284102629,0.353079291,0.244560067,Tmem119/Cxcl10,2,
GO:0052548,regulation of endopeptidase activity,Feb-60,278/15833,0.284102629,0.353079291,0.244560067,Cst7/Vsir,2,
GO:0006165,nucleoside diphosphate phosphorylation,Jan-60,88/15833,0.284688585,0.353079291,0.244560067,Ier3,1,
GO:0009135,purine nucleoside diphosphate metabolic process,Jan-60,88/15833,0.284688585,0.353079291,0.244560067,Ier3,1,
GO:0009179,purine ribonucleoside diphosphate metabolic process,Jan-60,88/15833,0.284688585,0.353079291,0.244560067,Ier3,1,
GO:0019359,nicotinamide nucleotide biosynthetic process,Jan-60,88/15833,0.284688585,0.353079291,0.244560067,Ier3,1,
GO:0050871,positive regulation of B cell activation,Jan-60,88/15833,0.284688585,0.353079291,0.244560067,Cd74,1,
GO:0070301,cellular response to hydrogen peroxide,Jan-60,88/15833,0.284688585,0.353079291,0.244560067,Axl,1,
GO:1900542,regulation of purine nucleotide metabolic process,Jan-60,88/15833,0.284688585,0.353079291,0.244560067,Ier3,1,
GO:0034762,regulation of transmembrane transport,Mar-60,491/15833,0.284965927,0.353220259,0.244657708,Cd63/Il1b/Cxcl10,3,
GO:0043062,extracellular structure organization,Feb-60,280/15833,0.286917738,0.355435407,0.246192028,Apoe/Lpl,2,
GO:0006022,aminoglycan metabolic process,Jan-60,89/15833,0.287414446,0.35543861,0.246194247,Il1b,1,
GO:0008306,associative learning,Jan-60,89/15833,0.287414446,0.35543861,0.246194247,Btg2,1,
GO:0043488,regulation of mRNA stability,Jan-60,89/15833,0.287414446,0.35543861,0.246194247,Zfp36,1,
GO:0042102,positive regulation of T cell proliferation,Jan-60,90/15833,0.290130092,0.357771851,0.247810364,Il1b,1,
GO:0043506,regulation of JUN kinase activity,Jan-60,90/15833,0.290130092,0.357771851,0.247810364,Il1b,1,
GO:0046939,nucleotide phosphorylation,Jan-60,90/15833,0.290130092,0.357771851,0.247810364,Ier3,1,
GO:0070585,protein localization to mitochondrion,Jan-60,90/15833,0.290130092,0.357771851,0.247810364,Hsp90aa1,1,
GO:0097061,dendritic spine organization,Jan-60,90/15833,0.290130092,0.357771851,0.247810364,Apoe,1,
GO:0043434,response to peptide hormone,Feb-60,284/15833,0.292545137,0.359874226,0.249266573,Lpl/Il1b,2,
GO:0002444,myeloid leukocyte mediated immunity,Jan-60,91/15833,0.292835561,0.359874226,0.249266573,Hmox1,1,
GO:0010660,regulation of muscle cell apoptotic process,Jan-60,91/15833,0.292835561,0.359874226,0.249266573,Hmox1,1,
GO:0019363,pyridine nucleotide biosynthetic process,Jan-60,91/15833,0.292835561,0.359874226,0.249266573,Ier3,1,
GO:0043473,pigmentation,Jan-60,91/15833,0.292835561,0.359874226,0.249266573,Cd63,1,
GO:0060998,regulation of dendritic spine development,Jan-60,91/15833,0.292835561,0.359874226,0.249266573,Apoe,1,
GO:0006140,regulation of nucleotide metabolic process,Jan-60,92/15833,0.29553089,0.361949864,0.250704261,Ier3,1,
GO:0009185,ribonucleoside diphosphate metabolic process,Jan-60,92/15833,0.29553089,0.361949864,0.250704261,Ier3,1,
GO:0010522,regulation of calcium ion transport into cytosol,Jan-60,92/15833,0.29553089,0.361949864,0.250704261,Cxcl10,1,
GO:0042158,lipoprotein biosynthetic process,Jan-60,92/15833,0.29553089,0.361949864,0.250704261,Apoe,1,
GO:0050848,regulation of calcium-mediated signaling,Jan-60,92/15833,0.29553089,0.361949864,0.250704261,Ccl4,1,
GO:1902749,regulation of cell cycle G2/M phase transition,Jan-60,92/15833,0.29553089,0.361949864,0.250704261,Ier3,1,
GO:0008344,adult locomotory behavior,Jan-60,93/15833,0.298216116,0.364824477,0.25269536,Id2,1,
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,Jan-60,93/15833,0.298216116,0.364824477,0.25269536,Cd74,1,
GO:0008645,hexose transmembrane transport,Jan-60,94/15833,0.300891277,0.367472199,0.254529302,Il1b,1,
GO:0010595,positive regulation of endothelial cell migration,Jan-60,94/15833,0.300891277,0.367472199,0.254529302,Hmox1,1,
GO:1904659,glucose transmembrane transport,Jan-60,94/15833,0.300891277,0.367472199,0.254529302,Il1b,1,
GO:0018209,peptidyl-serine modification,Feb-60,291/15833,0.302381058,0.369082763,0.255644858,Ppp1r15a/Hsp90aa1,2,
GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,Jan-60,95/15833,0.303556409,0.369472494,0.255914805,Cxcl10,1,
GO:0010657,muscle cell apoptotic process,Jan-60,95/15833,0.303556409,0.369472494,0.255914805,Hmox1,1,
GO:0043266,regulation of potassium ion transport,Jan-60,95/15833,0.303556409,0.369472494,0.255914805,Cd63,1,
GO:0060840,artery development,Jan-60,95/15833,0.303556409,0.369472494,0.255914805,Apoe,1,
GO:0072525,pyridine-containing compound biosynthetic process,Jan-60,95/15833,0.303556409,0.369472494,0.255914805,Ier3,1,
GO:0015749,monosaccharide transmembrane transport,Jan-60,96/15833,0.306211551,0.371865237,0.257572137,Il1b,1,
GO:0031047,gene silencing by RNA,Jan-60,96/15833,0.306211551,0.371865237,0.257572137,Zfp36,1,
GO:0043487,regulation of RNA stability,Jan-60,96/15833,0.306211551,0.371865237,0.257572137,Zfp36,1,
GO:0045778,positive regulation of ossification,Jan-60,96/15833,0.306211551,0.371865237,0.257572137,Tmem119,1,
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,Jan-60,97/15833,0.308856738,0.374025163,0.259068207,Pmepa1,1,
GO:0034219,carbohydrate transmembrane transport,Jan-60,97/15833,0.308856738,0.374025163,0.259068207,Il1b,1,
GO:0050772,positive regulation of axonogenesis,Jan-60,97/15833,0.308856738,0.374025163,0.259068207,Apoe,1,
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,Jan-60,97/15833,0.308856738,0.374025163,0.259068207,Vsir,1,
GO:1901654,response to ketone,Jan-60,97/15833,0.308856738,0.374025163,0.259068207,Spp1,1,
GO:0007569,cell aging,Jan-60,98/15833,0.311492007,0.376793582,0.260985751,Id2,1,
GO:0106027,neuron projection organization,Jan-60,98/15833,0.311492007,0.376793582,0.260985751,Apoe,1,
GO:0046879,hormone secretion,Feb-60,299/15833,0.31359684,0.37869572,0.262303264,Spp1/Il1b,2,
GO:0000077,DNA damage checkpoint,Jan-60,99/15833,0.314117395,0.37869572,0.262303264,Ier3,1,
GO:0006275,regulation of DNA replication,Jan-60,99/15833,0.314117395,0.37869572,0.262303264,Cst3,1,
GO:0034446,substrate adhesion-dependent cell spreading,Jan-60,99/15833,0.314117395,0.37869572,0.262303264,Axl,1,
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,Jan-60,99/15833,0.314117395,0.37869572,0.262303264,Pmepa1,1,
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,Jan-60,99/15833,0.314117395,0.37869572,0.262303264,Pmepa1,1,
GO:0006090,pyruvate metabolic process,Jan-60,100/15833,0.316732938,0.381635779,0.264339694,Ier3,1,
GO:0002757,immune response-activating signal transduction,Feb-60,302/15833,0.317794179,0.382700802,0.265077381,Nfkbia/Tlr2,2,
GO:0002526,acute inflammatory response,Jan-60,101/15833,0.319338673,0.383704263,0.265772427,Il1b,1,
GO:0006413,translational initiation,Jan-60,101/15833,0.319338673,0.383704263,0.265772427,Ppp1r15a,1,
GO:0045446,endothelial cell differentiation,Jan-60,101/15833,0.319338673,0.383704263,0.265772427,Il1b,1,
GO:0048259,regulation of receptor-mediated endocytosis,Jan-60,101/15833,0.319338673,0.383704263,0.265772427,Cd63,1,
GO:0001892,embryonic placenta development,Jan-60,102/15833,0.321934635,0.385811306,0.267231869,Junb,1,
GO:0045185,maintenance of protein location,Jan-60,102/15833,0.321934635,0.385811306,0.267231869,Nfkbia,1,
GO:0051028,mRNA transport,Jan-60,102/15833,0.321934635,0.385811306,0.267231869,Zfp36,1,
GO:0009914,hormone transport,Feb-60,305/15833,0.321986173,0.385811306,0.267231869,Spp1/Il1b,2,
GO:1904062,regulation of cation transmembrane transport,Feb-60,305/15833,0.321986173,0.385811306,0.267231869,Cd63/Cxcl10,2,
GO:0008584,male gonad development,Jan-60,103/15833,0.324520861,0.388417093,0.269036765,H3f3b,1,
GO:1905330,regulation of morphogenesis of an epithelium,Jan-60,103/15833,0.324520861,0.388417093,0.269036765,Cxcl10,1,
GO:0022412,cellular process involved in reproduction in multicellular organism,Feb-60,308/15833,0.326172411,0.390177419,0.270256053,H3f3b/Tmem119,2,
GO:0007338,single fertilization,Jan-60,104/15833,0.327097387,0.390202411,0.270273364,H3f3b,1,
GO:0010927,cellular component assembly involved in morphogenesis,Jan-60,104/15833,0.327097387,0.390202411,0.270273364,Tlr2,1,
GO:0030282,bone mineralization,Jan-60,104/15833,0.327097387,0.390202411,0.270273364,Tmem119,1,
GO:0046546,development of primary male sexual characteristics,Jan-60,104/15833,0.327097387,0.390202411,0.270273364,H3f3b,1,
GO:0060349,bone morphogenesis,Jan-60,104/15833,0.327097387,0.390202411,0.270273364,Tmem119,1,
GO:0009132,nucleoside diphosphate metabolic process,Jan-60,105/15833,0.329664248,0.392180511,0.271643493,Ier3,1,
GO:0030516,regulation of axon extension,Jan-60,105/15833,0.329664248,0.392180511,0.271643493,Apoe,1,
GO:0051963,regulation of synapse assembly,Jan-60,105/15833,0.329664248,0.392180511,0.271643493,Tlr2,1,
GO:0090305,nucleic acid phosphodiester bond hydrolysis,Jan-60,105/15833,0.329664248,0.392180511,0.271643493,Zfp36,1,
GO:1900006,positive regulation of dendrite development,Jan-60,105/15833,0.329664248,0.392180511,0.271643493,Apoe,1,
GO:0032092,positive regulation of protein binding,Jan-60,106/15833,0.33222148,0.395004933,0.273599827,Apoe,1,
GO:0002764,immune response-regulating signaling pathway,Feb-60,314/15833,0.334526015,0.396722547,0.27478953,Nfkbia/Tlr2,2,
GO:0001889,liver development,Jan-60,107/15833,0.334769118,0.396722547,0.27478953,Hmox1,1,
GO:0046632,alpha-beta T cell differentiation,Jan-60,107/15833,0.334769118,0.396722547,0.27478953,Cd83,1,
GO:0046822,regulation of nucleocytoplasmic transport,Jan-60,107/15833,0.334769118,0.396722547,0.27478953,Ier3,1,
GO:0051209,release of sequestered calcium ion into cytosol,Jan-60,107/15833,0.334769118,0.396722547,0.27478953,Cxcl10,1,
GO:0090090,negative regulation of canonical Wnt signaling pathway,Jan-60,107/15833,0.334769118,0.396722547,0.27478953,Apoe,1,
GO:0000086,G2/M transition of mitotic cell cycle,Jan-60,108/15833,0.337307199,0.39863578,0.27611473,Ier3,1,
GO:0003279,cardiac septum development,Jan-60,108/15833,0.337307199,0.39863578,0.27611473,Id2,1,
GO:0006997,nucleus organization,Jan-60,108/15833,0.337307199,0.39863578,0.27611473,H3f3b,1,
GO:0031497,chromatin assembly,Jan-60,108/15833,0.337307199,0.39863578,0.27611473,H3f3b,1,
GO:0048565,digestive tract development,Jan-60,108/15833,0.337307199,0.39863578,0.27611473,Id2,1,
GO:0008637,apoptotic mitochondrial changes,Jan-60,109/15833,0.339835756,0.400527342,0.277424918,Ier3,1,
GO:0031570,DNA integrity checkpoint,Jan-60,109/15833,0.339835756,0.400527342,0.277424918,Ier3,1,
GO:0042752,regulation of circadian rhythm,Jan-60,109/15833,0.339835756,0.400527342,0.277424918,Id2,1,
GO:0051283,negative regulation of sequestering of calcium ion,Jan-60,109/15833,0.339835756,0.400527342,0.277424918,Cxcl10,1,
GO:2000045,regulation of G1/S transition of mitotic cell cycle,Jan-60,109/15833,0.339835756,0.400527342,0.277424918,Id2,1,
GO:0006282,regulation of DNA repair,Jan-60,110/15833,0.342354826,0.402397448,0.278720246,Ier3,1,
GO:0008286,insulin receptor signaling pathway,Jan-60,110/15833,0.342354826,0.402397448,0.278720246,Il1b,1,
GO:0051282,regulation of sequestering of calcium ion,Jan-60,110/15833,0.342354826,0.402397448,0.278720246,Cxcl10,1,
GO:0061008,hepaticobiliary system development,Jan-60,110/15833,0.342354826,0.402397448,0.278720246,Hmox1,1,
GO:1901136,carbohydrate derivative catabolic process,Jan-60,110/15833,0.342354826,0.402397448,0.278720246,Cst3,1,
GO:0007601,visual perception,Jan-60,111/15833,0.344864443,0.404466016,0.280153038,Crybb1,1,
GO:0010565,regulation of cellular ketone metabolic process,Jan-60,111/15833,0.344864443,0.404466016,0.280153038,Il1b,1,
GO:0043467,regulation of generation of precursor metabolites and energy,Jan-60,111/15833,0.344864443,0.404466016,0.280153038,Ier3,1,
GO:0051208,sequestering of calcium ion,Jan-60,111/15833,0.344864443,0.404466016,0.280153038,Cxcl10,1,
GO:0006754,ATP biosynthetic process,Jan-60,112/15833,0.347364643,0.40673516,0.281724758,Ier3,1,
GO:0034763,negative regulation of transmembrane transport,Jan-60,112/15833,0.347364643,0.40673516,0.281724758,Il1b,1,
GO:0046660,female sex differentiation,Jan-60,112/15833,0.347364643,0.40673516,0.281724758,Axl,1,
GO:1902903,regulation of supramolecular fiber organization,Feb-60,324/15833,0.348385577,0.407709368,0.282399543,Apoe/Tlr2,2,
GO:0010921,regulation of phosphatase activity,Jan-60,114/15833,0.352336927,0.41188683,0.285293058,Ppp1r15a,1,
GO:0031623,receptor internalization,Jan-60,114/15833,0.352336927,0.41188683,0.285293058,Cd63,1,
GO:0050953,sensory perception of light stimulus,Jan-60,115/15833,0.35480908,0.414552244,0.287139255,Crybb1,1,
GO:0150063,visual system development,Feb-60,329/15833,0.355282225,0.414880434,0.287366575,Crybb1/P2ry12,2,
GO:0048880,sensory system development,Feb-60,330/15833,0.356658697,0.416262558,0.288323902,Crybb1/P2ry12,2,
GO:0008277,regulation of G protein-coupled receptor signaling pathway,Jan-60,116/15833,0.357271954,0.416527757,0.288507592,Rgs1,1,
GO:0030183,B cell differentiation,Jan-60,116/15833,0.357271954,0.416527757,0.288507592,Id2,1,
GO:0009166,nucleotide catabolic process,Jan-60,118/15833,0.362170001,0.42178244,0.292147244,Ier3,1,
GO:0061041,regulation of wound healing,Jan-60,118/15833,0.362170001,0.42178244,0.292147244,Apoe,1,
GO:0000723,telomere maintenance,Jan-60,119/15833,0.364605241,0.423703883,0.293478129,Hsp90aa1,1,
GO:0016064,immunoglobulin mediated immune response,Jan-60,119/15833,0.364605241,0.423703883,0.293478129,Cd74,1,
GO:0032273,positive regulation of protein polymerization,Jan-60,119/15833,0.364605241,0.423703883,0.293478129,Hsp90aa1,1,
GO:0055123,digestive system development,Jan-60,119/15833,0.364605241,0.423703883,0.293478129,Id2,1,
GO:0061387,regulation of extent of cell growth,Jan-60,120/15833,0.367031338,0.426293664,0.295271939,Apoe,1,
GO:0003231,cardiac ventricle development,Jan-60,121/15833,0.369448325,0.427490341,0.296100816,Id2,1,
GO:0007292,female gamete generation,Jan-60,121/15833,0.369448325,0.427490341,0.296100816,H3f3b,1,
GO:0010811,positive regulation of cell-substrate adhesion,Jan-60,121/15833,0.369448325,0.427490341,0.296100816,Spp1,1,
GO:0060996,dendritic spine development,Jan-60,121/15833,0.369448325,0.427490341,0.296100816,Apoe,1,
GO:0099175,regulation of postsynapse organization,Jan-60,121/15833,0.369448325,0.427490341,0.296100816,Apoe,1,
GO:1990823,response to leukemia inhibitory factor,Jan-60,121/15833,0.369448325,0.427490341,0.296100816,Spp1,1,
GO:1990830,cellular response to leukemia inhibitory factor,Jan-60,121/15833,0.369448325,0.427490341,0.296100816,Spp1,1,
GO:0015711,organic anion transport,Feb-60,341/15833,0.371732468,0.429126074,0.297233805,Apoe/Il1b,2,
GO:0044772,mitotic cell cycle phase transition,Feb-60,341/15833,0.371732468,0.429126074,0.297233805,Ier3/Id2,2,
GO:0051260,protein homooligomerization,Feb-60,341/15833,0.371732468,0.429126074,0.297233805,Apoe/Hmox1,2,
GO:0009206,purine ribonucleoside triphosphate biosynthetic process,Jan-60,122/15833,0.371856236,0.429126074,0.297233805,Ier3,1,
GO:0019724,B cell mediated immunity,Jan-60,122/15833,0.371856236,0.429126074,0.297233805,Cd74,1,
GO:0016311,dephosphorylation,Feb-60,342/15833,0.373096375,0.430327086,0.298065686,Dusp1/Ppp1r15a,2,
GO:0003206,cardiac chamber morphogenesis,Jan-60,123/15833,0.374255105,0.430742675,0.298353543,Id2,1,
GO:0009145,purine nucleoside triphosphate biosynthetic process,Jan-60,123/15833,0.374255105,0.430742675,0.298353543,Ier3,1,
GO:0097553,calcium ion transmembrane import into cytosol,Jan-60,123/15833,0.374255105,0.430742675,0.298353543,Cxcl10,1,
GO:1902806,regulation of cell cycle G1/S phase transition,Jan-60,123/15833,0.374255105,0.430742675,0.298353543,Id2,1,
GO:0007093,mitotic cell cycle checkpoint,Jan-60,124/15833,0.376644964,0.432800763,0.299779076,Ier3,1,
GO:0016052,carbohydrate catabolic process,Jan-60,124/15833,0.376644964,0.432800763,0.299779076,Ier3,1,
GO:0046661,male sex differentiation,Jan-60,124/15833,0.376644964,0.432800763,0.299779076,H3f3b,1,
GO:0009201,ribonucleoside triphosphate biosynthetic process,Jan-60,125/15833,0.379025848,0.434841988,0.301192929,Ier3,1,
GO:0030177,positive regulation of Wnt signaling pathway,Jan-60,125/15833,0.379025848,0.434841988,0.301192929,Tlr2,1,
GO:0044839,cell cycle G2/M phase transition,Jan-60,125/15833,0.379025848,0.434841988,0.301192929,Ier3,1,
GO:0001837,epithelial to mesenchymal transition,Jan-60,126/15833,0.381397789,0.437330727,0.302916752,Il1b,1,
GO:0030509,BMP signaling pathway,Jan-60,127/15833,0.38376082,0.439573169,0.304469977,Vsir,1,
GO:1903900,regulation of viral life cycle,Jan-60,127/15833,0.38376082,0.439573169,0.304469977,Cd74,1,
GO:0007286,spermatid development,Jan-60,128/15833,0.386114975,0.441566569,0.305850704,H3f3b,1,
GO:0030879,mammary gland development,Jan-60,128/15833,0.386114975,0.441566569,0.305850704,Id2,1,
GO:1901292,nucleoside phosphate catabolic process,Jan-60,128/15833,0.386114975,0.441566569,0.305850704,Ier3,1,
GO:0006338,chromatin remodeling,Jan-60,129/15833,0.388460285,0.443308988,0.307057589,H3f3b,1,
GO:0010951,negative regulation of endopeptidase activity,Jan-60,129/15833,0.388460285,0.443308988,0.307057589,Cst7,1,
GO:0072089,stem cell proliferation,Jan-60,129/15833,0.388460285,0.443308988,0.307057589,Cx3cr1,1,
GO:0090288,negative regulation of cellular response to growth factor stimulus,Jan-60,129/15833,0.388460285,0.443308988,0.307057589,Pmepa1,1,
GO:0072594,establishment of protein localization to organelle,Feb-60,354/15833,0.389372672,0.444115341,0.307616109,Nfkbia/Hsp90aa1,2,
GO:0010821,regulation of mitochondrion organization,Jan-60,130/15833,0.390796785,0.444799294,0.308089848,Ier3,1,
GO:0031099,regeneration,Jan-60,130/15833,0.390796785,0.444799294,0.308089848,Hmox1,1,
GO:0050680,negative regulation of epithelial cell proliferation,Jan-60,130/15833,0.390796785,0.444799294,0.308089848,Apoe,1,
GO:0062013,positive regulation of small molecule metabolic process,Jan-60,130/15833,0.390796785,0.444799294,0.308089848,Il1b,1,
GO:0006333,chromatin assembly or disassembly,Jan-60,131/15833,0.393124505,0.446741802,0.309435324,H3f3b,1,
GO:0008643,carbohydrate transport,Jan-60,131/15833,0.393124505,0.446741802,0.309435324,Il1b,1,
GO:0009267,cellular response to starvation,Jan-60,131/15833,0.393124505,0.446741802,0.309435324,Atf3,1,
GO:0006865,amino acid transport,Jan-60,132/15833,0.395443479,0.448196968,0.310443244,Il1b,1,
GO:0035023,regulation of Rho protein signal transduction,Jan-60,132/15833,0.395443479,0.448196968,0.310443244,Apoe,1,
GO:0035296,regulation of tube diameter,Jan-60,132/15833,0.395443479,0.448196968,0.310443244,Apoe,1,
GO:0046887,positive regulation of hormone secretion,Jan-60,132/15833,0.395443479,0.448196968,0.310443244,Spp1,1,
GO:0097746,regulation of blood vessel diameter,Jan-60,132/15833,0.395443479,0.448196968,0.310443244,Apoe,1,
GO:0009127,purine nucleoside monophosphate biosynthetic process,Jan-60,133/15833,0.397753739,0.450342376,0.311929259,Ier3,1,
GO:0009168,purine ribonucleoside monophosphate biosynthetic process,Jan-60,133/15833,0.397753739,0.450342376,0.311929259,Ier3,1,
GO:0051053,negative regulation of DNA metabolic process,Jan-60,134/15833,0.400055317,0.451999672,0.313077184,Dusp1,1,
GO:0071772,response to BMP,Jan-60,134/15833,0.400055317,0.451999672,0.313077184,Vsir,1,
GO:0071773,cellular response to BMP stimulus,Jan-60,134/15833,0.400055317,0.451999672,0.313077184,Vsir,1,
GO:1901991,negative regulation of mitotic cell cycle phase transition,Jan-60,134/15833,0.400055317,0.451999672,0.313077184,Ier3,1,
GO:0010675,regulation of cellular carbohydrate metabolic process,Jan-60,135/15833,0.402348245,0.453877425,0.314377807,Ier3,1,
GO:0030178,negative regulation of Wnt signaling pathway,Jan-60,135/15833,0.402348245,0.453877425,0.314377807,Apoe,1,
GO:2001251,negative regulation of chromosome organization,Jan-60,135/15833,0.402348245,0.453877425,0.314377807,H3f3b,1,
GO:0009142,nucleoside triphosphate biosynthetic process,Jan-60,136/15833,0.404632556,0.455977574,0.315832474,Ier3,1,
GO:0071383,cellular response to steroid hormone stimulus,Jan-60,136/15833,0.404632556,0.455977574,0.315832474,Zfp36,1,
GO:0009314,response to radiation,Feb-60,367/15833,0.406802147,0.457586278,0.316946742,Junb/Id2,2,
GO:0001824,blastocyst development,Jan-60,137/15833,0.40690828,0.457586278,0.316946742,Junb,1,
GO:0009156,ribonucleoside monophosphate biosynthetic process,Jan-60,137/15833,0.40690828,0.457586278,0.316946742,Ier3,1,
GO:0010634,positive regulation of epithelial cell migration,Jan-60,137/15833,0.40690828,0.457586278,0.316946742,Hmox1,1,
GO:0019933,cAMP-mediated signaling,Jan-60,138/15833,0.40917545,0.459263172,0.318108241,Cxcl10,1,
GO:0030010,establishment of cell polarity,Jan-60,138/15833,0.40917545,0.459263172,0.318108241,Hsp90aa1,1,
GO:0045017,glycerolipid biosynthetic process,Jan-60,138/15833,0.40917545,0.459263172,0.318108241,Lpl,1,
GO:0006914,autophagy,Feb-60,369/15833,0.409463551,0.459263172,0.318108241,Tlr2/Hmox1,2,
GO:0061919,process utilizing autophagic mechanism,Feb-60,369/15833,0.409463551,0.459263172,0.318108241,Tlr2/Hmox1,2,
GO:0046496,nicotinamide nucleotide metabolic process,Jan-60,139/15833,0.411434098,0.461233654,0.319473093,Ier3,1,
GO:0006606,protein import into nucleus,Jan-60,140/15833,0.413684254,0.463034554,0.320720485,Nfkbia,1,
GO:0009566,fertilization,Jan-60,140/15833,0.413684254,0.463034554,0.320720485,H3f3b,1,
GO:0051302,regulation of cell division,Jan-60,140/15833,0.413684254,0.463034554,0.320720485,Il1b,1,
GO:0019362,pyridine nucleotide metabolic process,Jan-60,141/15833,0.415925951,0.465061244,0.322124271,Ier3,1,
GO:1903169,regulation of calcium ion transmembrane transport,Jan-60,141/15833,0.415925951,0.465061244,0.322124271,Cxcl10,1,
GO:0009124,nucleoside monophosphate biosynthetic process,Jan-60,142/15833,0.418159219,0.466109295,0.322850202,Ier3,1,
GO:0010950,positive regulation of endopeptidase activity,Jan-60,142/15833,0.418159219,0.466109295,0.322850202,Vsir,1,
GO:0050657,nucleic acid transport,Jan-60,142/15833,0.418159219,0.466109295,0.322850202,Zfp36,1,
GO:0050658,RNA transport,Jan-60,142/15833,0.418159219,0.466109295,0.322850202,Zfp36,1,
GO:0060402,calcium ion transport into cytosol,Jan-60,142/15833,0.418159219,0.466109295,0.322850202,Cxcl10,1,
GO:1904064,positive regulation of cation transmembrane transport,Jan-60,142/15833,0.418159219,0.466109295,0.322850202,Cxcl10,1,
GO:0044770,cell cycle phase transition,Feb-60,377/15833,0.420052978,0.467864294,0.3240658,Ier3/Id2,2,
GO:0035150,regulation of tube size,Jan-60,143/15833,0.42038409,0.467864294,0.3240658,Apoe,1,
GO:0050880,regulation of blood vessel size,Jan-60,143/15833,0.42038409,0.467864294,0.3240658,Apoe,1,
GO:0006323,DNA packaging,Jan-60,144/15833,0.422600594,0.468639302,0.324602609,H3f3b,1,
GO:0008360,regulation of cell shape,Jan-60,144/15833,0.422600594,0.468639302,0.324602609,Ccl3,1,
GO:0009913,epidermal cell differentiation,Jan-60,144/15833,0.422600594,0.468639302,0.324602609,Zfp36,1,
GO:0043271,negative regulation of ion transport,Jan-60,144/15833,0.422600594,0.468639302,0.324602609,Il1b,1,
GO:0051170,import into nucleus,Jan-60,144/15833,0.422600594,0.468639302,0.324602609,Nfkbia,1,
GO:0051494,negative regulation of cytoskeleton organization,Jan-60,144/15833,0.422600594,0.468639302,0.324602609,Tlr2,1,
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,Jan-60,144/15833,0.422600594,0.468639302,0.324602609,Rpl23,1,
GO:0051236,establishment of RNA localization,Jan-60,145/15833,0.424808763,0.470846076,0.326131129,Zfp36,1,
GO:0072524,pyridine-containing compound metabolic process,Jan-60,146/15833,0.427008628,0.473041385,0.327651708,Ier3,1,
GO:0030833,regulation of actin filament polymerization,Jan-60,148/15833,0.431383566,0.477397813,0.330669184,Tlr2,1,
GO:0051291,protein heterooligomerization,Jan-60,148/15833,0.431383566,0.477397813,0.330669184,Cd74,1,
GO:0051606,detection of stimulus,Jan-60,149/15833,0.4335587,0.479559034,0.332166152,Tlr2,1,
GO:0031644,regulation of neurological system process,Jan-60,150/15833,0.435725652,0.481462344,0.333484478,Cst7,1,
GO:1901988,negative regulation of cell cycle phase transition,Jan-60,150/15833,0.435725652,0.481462344,0.333484478,Ier3,1,
GO:0048732,gland development,Feb-60,390/15833,0.43706055,0.482690209,0.334334957,Id2/Hmox1,2,
GO:0007088,regulation of mitotic nuclear division,Jan-60,151/15833,0.437884452,0.483105648,0.334622711,Il1b,1,
GO:0010952,positive regulation of peptidase activity,Jan-60,151/15833,0.437884452,0.483105648,0.334622711,Vsir,1,
GO:0015672,monovalent inorganic cation transport,Feb-60,391/15833,0.438358164,0.483381153,0.33481354,Cd63/P2ry12,2,
GO:0030534,adult behavior,Jan-60,152/15833,0.44003513,0.484487659,0.33557996,Id2,1,
GO:0034404,nucleobase-containing small molecule biosynthetic process,Jan-60,152/15833,0.44003513,0.484487659,0.33557996,Ier3,1,
GO:0050796,regulation of insulin secretion,Jan-60,152/15833,0.44003513,0.484487659,0.33557996,Il1b,1,
GO:0035303,regulation of dephosphorylation,Jan-60,154/15833,0.444312241,0.488449218,0.33832393,Ppp1r15a,1,
GO:0060401,cytosolic calcium ion transport,Jan-60,154/15833,0.444312241,0.488449218,0.33832393,Cxcl10,1,
GO:1903034,regulation of response to wounding,Jan-60,154/15833,0.444312241,0.488449218,0.33832393,Apoe,1,
GO:0034767,positive regulation of ion transmembrane transport,Jan-60,155/15833,0.446438732,0.490537059,0.339770072,Cxcl10,1,
GO:0006575,cellular modified amino acid metabolic process,Jan-60,156/15833,0.448557222,0.492613987,0.341208654,Ckb,1,
GO:0006733,oxidoreduction coenzyme metabolic process,Jan-60,157/15833,0.450667738,0.494428561,0.342465517,Ier3,1,
GO:0045931,positive regulation of mitotic cell cycle,Jan-60,157/15833,0.450667738,0.494428561,0.342465517,Il1b,1,
GO:0007416,synapse assembly,Jan-60,158/15833,0.452770311,0.496482892,0.343888448,Tlr2,1,
GO:0022613,ribonucleoprotein complex biogenesis,Feb-60,403/15833,0.453805988,0.497365831,0.344500015,Rpl10a/Hsp90aa1,2,
GO:0065004,protein-DNA complex assembly,Jan-60,159/15833,0.45486497,0.498273404,0.345128644,H3f3b,1,
GO:0006109,regulation of carbohydrate metabolic process,Jan-60,160/15833,0.456951745,0.500051656,0.346360349,Ier3,1,
GO:2001242,regulation of intrinsic apoptotic signaling pathway,Jan-60,160/15833,0.456951745,0.500051656,0.346360349,Cd74,1,
GO:0001659,temperature homeostasis,Jan-60,161/15833,0.459030664,0.502072059,0.347759779,Il1b,1,
GO:0006479,protein methylation,Jan-60,162/15833,0.461101756,0.503688526,0.348879424,Btg2,1,
GO:0008213,protein alkylation,Jan-60,162/15833,0.461101756,0.503688526,0.348879424,Btg2,1,
GO:0032386,regulation of intracellular transport,Feb-60,409/15833,0.461442176,0.503688526,0.348879424,Ier3/Hmox1,2,
GO:0034765,regulation of ion transmembrane transport,Feb-60,409/15833,0.461442176,0.503688526,0.348879424,Cd63/Cxcl10,2,
GO:0030041,actin filament polymerization,Jan-60,163/15833,0.463165051,0.505058201,0.349828128,Tlr2,1,
GO:0042180,cellular ketone metabolic process,Jan-60,163/15833,0.463165051,0.505058201,0.349828128,Il1b,1,
GO:0003205,cardiac chamber development,Jan-60,164/15833,0.465220577,0.506276352,0.350671879,Id2,1,
GO:0008064,regulation of actin polymerization or depolymerization,Jan-60,164/15833,0.465220577,0.506276352,0.350671879,Tlr2,1,
GO:0009743,response to carbohydrate,Jan-60,164/15833,0.465220577,0.506276352,0.350671879,Il1b,1,
GO:0051262,protein tetramerization,Jan-60,164/15833,0.465220577,0.506276352,0.350671879,Cd74,1,
GO:0007219,Notch signaling pathway,Jan-60,165/15833,0.467268364,0.507992508,0.351860573,Nfkbia,1,
GO:0030832,regulation of actin filament length,Jan-60,165/15833,0.467268364,0.507992508,0.351860573,Tlr2,1,
GO:0000082,G1/S transition of mitotic cell cycle,Jan-60,166/15833,0.469308439,0.509696835,0.353041074,Id2,1,
GO:0006403,RNA localization,Jan-60,166/15833,0.469308439,0.509696835,0.353041074,Zfp36,1,
GO:0007409,axonogenesis,Feb-60,418/15833,0.472783188,0.513212334,0.355476081,Apoe/Hsp90aa1,2,
GO:0000075,cell cycle checkpoint,Jan-60,168/15833,0.47336557,0.513586174,0.355735021,Ier3,1,
GO:0006006,glucose metabolic process,Jan-60,170/15833,0.477392197,0.51717488,0.358220735,Atf3,1,
GO:0016051,carbohydrate biosynthetic process,Jan-60,170/15833,0.477392197,0.51717488,0.358220735,Atf3,1,
GO:0030307,positive regulation of cell growth,Jan-60,170/15833,0.477392197,0.51717488,0.358220735,Apoe,1,
GO:0009108,coenzyme biosynthetic process,Jan-60,171/15833,0.479394142,0.51908307,0.359542442,Ier3,1,
GO:0015931,nucleobase-containing compound transport,Jan-60,173/15833,0.483375436,0.522869269,0.362164949,Zfp36,1,
GO:0061136,regulation of proteasomal protein catabolic process,Jan-60,173/15833,0.483375436,0.522869269,0.362164949,Apoe,1,
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,Jan-60,174/15833,0.48535484,0.524747368,0.363465812,Cd74,1,
GO:0048839,inner ear development,Jan-60,175/15833,0.487326787,0.526615526,0.364759791,H2-K1,1,
GO:0048568,embryonic organ development,Feb-60,431/15833,0.488917606,0.527945316,0.365680869,Junb/Id2,2,
GO:1903305,regulation of regulated secretory pathway,Jan-60,176/15833,0.489291303,0.527945316,0.365680869,Hmox1,1,
GO:2001235,positive regulation of apoptotic signaling pathway,Jan-60,176/15833,0.489291303,0.527945316,0.365680869,Atf3,1,
GO:0006364,rRNA processing,Jan-60,177/15833,0.491248416,0.529527514,0.366776776,Rpl10a,1,
GO:0051668,localization within membrane,Jan-60,177/15833,0.491248416,0.529527514,0.366776776,Apoe,1,
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,Jan-60,178/15833,0.493198154,0.531098611,0.367864996,Apoe,1,
GO:0051783,regulation of nuclear division,Jan-60,178/15833,0.493198154,0.531098611,0.367864996,Il1b,1,
GO:0051186,cofactor metabolic process,Feb-60,437/15833,0.496263246,0.534132711,0.369966562,Ier3/Hmox1,2,
GO:0044843,cell cycle G1/S phase transition,Jan-60,180/15833,0.497075613,0.534740365,0.370387453,Id2,1,
GO:0010817,regulation of hormone levels,Feb-60,439/15833,0.498697372,0.536217703,0.37141073,Spp1/Il1b,2,
GO:0016458,gene silencing,Jan-60,181/15833,0.499003388,0.536279537,0.37145356,Zfp36,1,
GO:0008406,gonad development,Jan-60,182/15833,0.500923896,0.537807845,0.372512141,H3f3b,1,
GO:0050773,regulation of dendrite development,Jan-60,182/15833,0.500923896,0.537807845,0.372512141,Apoe,1,
GO:0002429,immune response-activating cell surface receptor signaling pathway,Jan-60,183/15833,0.502837165,0.539057427,0.373377663,Tlr2,1,
GO:0046434,organophosphate catabolic process,Jan-60,183/15833,0.502837165,0.539057427,0.373377663,Ier3,1,
GO:0099173,postsynapse organization,Jan-60,183/15833,0.502837165,0.539057427,0.373377663,Apoe,1,
GO:0006820,anion transport,Feb-60,443/15833,0.503543802,0.539546934,0.373716719,Apoe/Il1b,2,
GO:0030073,insulin secretion,Jan-60,184/15833,0.50474322,0.539768243,0.373870009,Il1b,1,
GO:0050679,positive regulation of epithelial cell proliferation,Jan-60,184/15833,0.50474322,0.539768243,0.373870009,Hmox1,1,
GO:0071103,DNA conformation change,Jan-60,184/15833,0.50474322,0.539768243,0.373870009,H3f3b,1,
GO:0007005,mitochondrion organization,Feb-60,444/15833,0.504750841,0.539768243,0.373870009,Ier3/Hsp90aa1,2,
GO:0023061,signal release,Feb-60,445/15833,0.505956045,0.540789076,0.374577088,Spp1/Il1b,2,
GO:0030522,intracellular receptor signaling pathway,Jan-60,185/15833,0.50664209,0.540986457,0.374713804,Nfkbia,1,
GO:0090276,regulation of peptide hormone secretion,Jan-60,185/15833,0.50664209,0.540986457,0.374713804,Il1b,1,
GO:0045137,development of primary sexual characteristics,Jan-60,186/15833,0.508533799,0.542737853,0.375926907,H3f3b,1,
GO:0001666,response to hypoxia,Jan-60,187/15833,0.510418376,0.544479909,0.37713354,Hmox1,1,
GO:0001701,in utero embryonic development,Feb-60,449/15833,0.510758442,0.544573477,0.37719835,Junb/Klf2,2,
GO:0120031,plasma membrane bounded cell projection assembly,Feb-60,451/15833,0.51314854,0.546851629,0.37877631,P2ry12/Hsp90aa1,2,
GO:0007160,cell-matrix adhesion,Jan-60,189/15833,0.514166236,0.547311367,0.379094747,Cd63,1,
GO:0008154,actin polymerization or depolymerization,Jan-60,189/15833,0.514166236,0.547311367,0.379094747,Tlr2,1,
GO:0061564,axon development,Feb-60,452/15833,0.514340802,0.547311367,0.379094747,Apoe/Hsp90aa1,2,
GO:0016049,cell growth,Feb-60,453/15833,0.515531202,0.548027469,0.379590754,Apoe/Hsp90aa1,2,
GO:0007266,Rho protein signal transduction,Jan-60,190/15833,0.516029572,0.548027469,0.379590754,Apoe,1,
GO:0030324,lung development,Jan-60,190/15833,0.516029572,0.548027469,0.379590754,Klf2,1,
GO:0048863,stem cell differentiation,Jan-60,190/15833,0.516029572,0.548027469,0.379590754,Vsir,1,
GO:0007623,circadian rhythm,Jan-60,191/15833,0.51788588,0.548940087,0.380222879,Id2,1,
GO:0036293,response to decreased oxygen levels,Jan-60,191/15833,0.51788588,0.548940087,0.380222879,Hmox1,1,
GO:0048639,positive regulation of developmental growth,Jan-60,191/15833,0.51788588,0.548940087,0.380222879,Apoe,1,
GO:0090407,organophosphate biosynthetic process,Feb-60,455/15833,0.517906403,0.548940087,0.380222879,Ier3/Ckb,2,
GO:0030323,respiratory tube development,Jan-60,193/15833,0.521577516,0.552559784,0.382730059,Klf2,1,
GO:0002768,immune response-regulating cell surface receptor signaling pathway,Jan-60,194/15833,0.523412897,0.55396029,0.383700118,Tlr2,1,
GO:0009152,purine ribonucleotide biosynthetic process,Jan-60,194/15833,0.523412897,0.55396029,0.383700118,Ier3,1,
GO:0050770,regulation of axonogenesis,Jan-60,195/15833,0.525241353,0.555622961,0.384851765,Apoe,1,
GO:0009952,anterior/posterior pattern specification,Jan-60,196/15833,0.527062911,0.557276708,0.385997232,Btg2,1,
GO:0030031,cell projection assembly,Feb-60,463/15833,0.527332098,0.55728828,0.386005247,P2ry12/Hsp90aa1,2,
GO:0051099,positive regulation of binding,Jan-60,197/15833,0.528877595,0.558647993,0.386947052,Apoe,1,
GO:0005975,carbohydrate metabolic process,Feb-60,465/15833,0.52966963,0.559210891,0.387336942,Atf3/Ier3,2,
GO:0010810,regulation of cell-substrate adhesion,Jan-60,198/15833,0.530685433,0.559735662,0.387700424,Spp1,1,
GO:0019318,hexose metabolic process,Jan-60,198/15833,0.530685433,0.559735662,0.387700424,Atf3,1,
GO:0030258,lipid modification,Jan-60,201/15833,0.536068114,0.564585158,0.391059424,Apoe,1,
GO:0032984,protein-containing complex disassembly,Jan-60,201/15833,0.536068114,0.564585158,0.391059424,Rpl23,1,
GO:0048762,mesenchymal cell differentiation,Jan-60,201/15833,0.536068114,0.564585158,0.391059424,Il1b,1,
GO:0009260,ribonucleotide biosynthetic process,Jan-60,203/15833,0.539622794,0.567774738,0.393268684,Ier3,1,
GO:0070482,response to oxygen levels,Jan-60,203/15833,0.539622794,0.567774738,0.393268684,Hmox1,1,
GO:0007264,small GTPase mediated signal transduction,Feb-60,474/15833,0.540094181,0.567993783,0.393420404,Apoe/Hmox1,2,
GO:0034764,positive regulation of transmembrane transport,Jan-60,204/15833,0.541390077,0.568525443,0.393788659,Cxcl10,1,
GO:0043583,ear development,Jan-60,204/15833,0.541390077,0.568525443,0.393788659,H2-K1,1,
GO:0060348,bone development,Jan-60,204/15833,0.541390077,0.568525443,0.393788659,Tmem119,1,
GO:0060828,regulation of canonical Wnt signaling pathway,Jan-60,205/15833,0.543150688,0.57009688,0.394877113,Apoe,1,
GO:0002064,epithelial cell development,Jan-60,208/15833,0.54839274,0.574760336,0.398107252,Il1b,1,
GO:0016072,rRNA metabolic process,Jan-60,208/15833,0.54839274,0.574760336,0.398107252,Rpl10a,1,
GO:0090150,establishment of protein localization to membrane,Jan-60,208/15833,0.54839274,0.574760336,0.398107252,Hsp90aa1,1,
GO:0022618,ribonucleoprotein complex assembly,Jan-60,209/15833,0.550126912,0.576018377,0.398978633,Hsp90aa1,1,
GO:0046390,ribose phosphate biosynthetic process,Jan-60,209/15833,0.550126912,0.576018377,0.398978633,Ier3,1,
GO:0006164,purine nucleotide biosynthetic process,Jan-60,210/15833,0.551854535,0.576987445,0.399649857,Ier3,1,
GO:0046034,ATP metabolic process,Jan-60,210/15833,0.551854535,0.576987445,0.399649857,Ier3,1,
GO:2000116,regulation of cysteine-type endopeptidase activity,Jan-60,210/15833,0.551854535,0.576987445,0.399649857,Cst7,1,
GO:0043588,skin development,Jan-60,211/15833,0.553575634,0.578506643,0.400702128,Zfp36,1,
GO:0007163,establishment or maintenance of cell polarity,Jan-60,213/15833,0.556998355,0.581801767,0.402984493,Hsp90aa1,1,
GO:0072522,purine-containing compound biosynthetic process,Jan-60,215/15833,0.560395269,0.585066759,0.405245987,Ier3,1,
GO:0060541,respiratory system development,Jan-60,216/15833,0.562084108,0.586546182,0.406270708,Klf2,1,
GO:0044089,positive regulation of cellular component biogenesis,Feb-60,496/15833,0.564918316,0.589218814,0.408121904,P2ry12/Hsp90aa1,2,
GO:0005996,monosaccharide metabolic process,Jan-60,219/15833,0.567112437,0.591221565,0.409509108,Atf3,1,
GO:0001763,morphogenesis of a branching structure,Jan-60,220/15833,0.568775896,0.592669427,0.410511969,Il1b,1,
GO:0007423,sensory organ development,Feb-60,500/15833,0.569330351,0.592674818,0.410515702,H2-K1/Crybb1,2,
GO:0022604,regulation of cell morphogenesis,Feb-60,500/15833,0.569330351,0.592674818,0.410515702,Apoe/Ccl3,2,
GO:0071826,ribonucleoprotein complex subunit organization,Jan-60,221/15833,0.57043307,0.593536434,0.4111125,Hsp90aa1,1,
GO:0048738,cardiac muscle tissue development,Jan-60,222/15833,0.57208398,0.594967339,0.412103615,Id2,1,
GO:0051188,cofactor biosynthetic process,Jan-60,223/15833,0.573728651,0.59639038,0.413089283,Ier3,1,
GO:0046578,regulation of Ras protein signal transduction,Jan-60,224/15833,0.575367106,0.597805592,0.414069529,Apoe,1,
GO:0007281,germ cell development,Jan-60,226/15833,0.57862546,0.600901704,0.416214048,H3f3b,1,
GO:0030072,peptide hormone secretion,Jan-60,228/15833,0.581859224,0.603969315,0.418338826,Il1b,1,
GO:0043393,regulation of protein binding,Jan-60,229/15833,0.583466942,0.605346953,0.419293046,Apoe,1,
GO:0017157,regulation of exocytosis,Jan-60,230/15833,0.585068582,0.606716963,0.420241982,Hmox1,1,
GO:0006260,DNA replication,Jan-60,233/15833,0.589837253,0.611368296,0.423463724,Cst3,1,
GO:0003007,heart morphogenesis,Jan-60,235/15833,0.592986384,0.613159855,0.424704645,Id2,1,
GO:0009126,purine nucleoside monophosphate metabolic process,Jan-60,235/15833,0.592986384,0.613159855,0.424704645,Ier3,1,
GO:0009167,purine ribonucleoside monophosphate metabolic process,Jan-60,235/15833,0.592986384,0.613159855,0.424704645,Ier3,1,
GO:0009205,purine ribonucleoside triphosphate metabolic process,Jan-60,235/15833,0.592986384,0.613159855,0.424704645,Ier3,1,
GO:0048705,skeletal system morphogenesis,Jan-60,235/15833,0.592986384,0.613159855,0.424704645,Tmem119,1,
GO:0008544,epidermis development,Jan-60,239/15833,0.599213488,0.618117929,0.428138851,Zfp36,1,
GO:0009161,ribonucleoside monophosphate metabolic process,Jan-60,239/15833,0.599213488,0.618117929,0.428138851,Ier3,1,
GO:0009199,ribonucleoside triphosphate metabolic process,Jan-60,239/15833,0.599213488,0.618117929,0.428138851,Ier3,1,
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,Jan-60,239/15833,0.599213488,0.618117929,0.428138851,Cd74,1,
GO:0110053,regulation of actin filament organization,Jan-60,239/15833,0.599213488,0.618117929,0.428138851,Tlr2,1,
GO:0045055,regulated exocytosis,Jan-60,240/15833,0.600755568,0.619412573,0.429035585,Hmox1,1,
GO:0006605,protein targeting,Jan-60,241/15833,0.602291813,0.620403691,0.429722082,Hsp90aa1,1,
GO:0045165,cell fate commitment,Jan-60,241/15833,0.602291813,0.620403691,0.429722082,Id2,1,
GO:0009144,purine nucleoside triphosphate metabolic process,Jan-60,242/15833,0.603822244,0.621683399,0.430608471,Ier3,1,
GO:0140014,mitotic nuclear division,Jan-60,243/15833,0.605346885,0.622955926,0.431489886,Il1b,1,
GO:0061448,connective tissue development,Jan-60,245/15833,0.608378877,0.6257777,0.433444385,Id2,1,
GO:0009123,nucleoside monophosphate metabolic process,Jan-60,246/15833,0.609886271,0.626730749,0.434104514,Ier3,1,
GO:0060485,mesenchyme development,Jan-60,246/15833,0.609886271,0.626730749,0.434104514,Il1b,1,
GO:0009165,nucleotide biosynthetic process,Jan-60,251/15833,0.617338081,0.634086425,0.439199416,Ier3,1,
GO:0044262,cellular carbohydrate metabolic process,Jan-60,252/15833,0.618811558,0.634995407,0.439829022,Ier3,1,
GO:0060070,canonical Wnt signaling pathway,Jan-60,252/15833,0.618811558,0.634995407,0.439829022,Apoe,1,
GO:0001822,kidney development,Jan-60,253/15833,0.620279455,0.635896942,0.44045347,Id2,1,
GO:0051056,regulation of small GTPase mediated signal transduction,Jan-60,253/15833,0.620279455,0.635896942,0.44045347,Apoe,1,
GO:0034504,protein localization to nucleus,Jan-60,255/15833,0.623198594,0.638586213,0.442316191,Nfkbia,1,
GO:0045926,negative regulation of growth,Jan-60,257/15833,0.626095662,0.640946129,0.443950784,Tlr2,1,
GO:1901293,nucleoside phosphate biosynthetic process,Jan-60,257/15833,0.626095662,0.640946129,0.443950784,Ier3,1,
GO:0009141,nucleoside triphosphate metabolic process,Jan-60,258/15833,0.627535972,0.642115992,0.444761089,Ier3,1,
GO:0009416,response to light stimulus,Jan-60,262/15833,0.633242852,0.647341579,0.448380588,Id2,1,
GO:0043414,macromolecule methylation,Jan-60,262/15833,0.633242852,0.647341579,0.448380588,Btg2,1,
GO:0042254,ribosome biogenesis,Jan-60,264/15833,0.63606396,0.649917626,0.450164884,Rpl10a,1,
GO:0045927,positive regulation of growth,Jan-60,269/15833,0.643023709,0.656718014,0.454875167,Apoe,1,
GO:0044282,small molecule catabolic process,Jan-60,273/15833,0.64849713,0.661994705,0.458530063,Apoe,1,
GO:0072001,renal system development,Jan-60,274/15833,0.64985254,0.663064672,0.459271174,Id2,1,
GO:0048562,embryonic organ morphogenesis,Jan-60,278/15833,0.655222972,0.668228343,0.462847786,Id2,1,
GO:0016358,dendrite development,Jan-60,279/15833,0.656552874,0.669268352,0.463568148,Apoe,1,
GO:0043010,camera-type eye development,Jan-60,284/15833,0.663127088,0.675650735,0.4679889,Crybb1,1,
GO:0018108,peptidyl-tyrosine phosphorylation,Jan-60,294/15833,0.675906454,0.688346451,0.476782576,Cd74,1,
GO:0006732,coenzyme metabolic process,Jan-60,295/15833,0.677157861,0.689295597,0.477440002,Ier3,1,
GO:0018212,peptidyl-tyrosine modification,Jan-60,297/15833,0.679646438,0.691502599,0.47896868,Cd74,1,
GO:0009100,glycoprotein metabolic process,Jan-60,306/15833,0.690613592,0.702329939,0.486468228,Cst3,1,
GO:0032259,methylation,Jan-60,307/15833,0.691809134,0.703214371,0.487080829,Btg2,1,
GO:0001655,urogenital system development,Jan-60,313/15833,0.698887573,0.710075039,0.491832864,Id2,1,
GO:0032956,regulation of actin cytoskeleton organization,Jan-60,319/15833,0.705806085,0.716429695,0.496234411,Tlr2,1,
GO:0034470,ncRNA processing,Jan-60,319/15833,0.705806085,0.716429695,0.496234411,Rpl10a,1,
GO:0003002,regionalization,Jan-60,322/15833,0.709206481,0.719542824,0.498390718,Btg2,1,
GO:0001654,eye development,Jan-60,326/15833,0.713680288,0.72374157,0.501298976,Crybb1,1,
GO:0006091,generation of precursor metabolites and energy,Jan-60,328/15833,0.715891741,0.725643202,0.502616139,Ier3,1,
GO:0010769,regulation of cell morphogenesis involved in differentiation,Jan-60,329/15833,0.71699116,0.726416396,0.503151691,Apoe,1,
GO:0033044,regulation of chromosome organization,Jan-60,333/15833,0.721347155,0.730486702,0.505970985,H3f3b,1,
GO:0022411,cellular component disassembly,Jan-60,339/15833,0.727757807,0.736632902,0.510228146,Rpl23,1,
GO:0010976,positive regulation of neuron projection development,Jan-60,343/15833,0.731950774,0.740529662,0.512927233,Apoe,1,
GO:0060562,epithelial tube morphogenesis,Jan-60,344/15833,0.732989054,0.741232604,0.513414125,Cxcl10,1,
GO:0006887,exocytosis,Jan-60,349/15833,0.738121423,0.746073083,0.516766878,Hmox1,1,
GO:0048638,regulation of developmental growth,Jan-60,361/15833,0.75004662,0.757771819,0.524869998,Apoe,1,
GO:0032970,regulation of actin filament-based process,Jan-60,363/15833,0.751981548,0.759371166,0.525977784,Tlr2,1,
GO:0000280,nuclear division,Jan-60,366/15833,0.754856355,0.761917687,0.52774163,Il1b,1,
GO:0009150,purine ribonucleotide metabolic process,Jan-60,369/15833,0.757698389,0.764428762,0.529480924,Ier3,1,
GO:0007015,actin filament organization,Jan-60,374/15833,0.762363278,0.76877568,0.532491813,Tlr2,1,
GO:0009259,ribonucleotide metabolic process,Jan-60,379/15833,0.766939826,0.773029493,0.535438213,Ier3,1,
GO:0001558,regulation of cell growth,Jan-60,386/15833,0.773201705,0.778977254,0.539557924,Apoe,1,
GO:0006163,purine nucleotide metabolic process,Jan-60,390/15833,0.77670533,0.782141905,0.541749917,Ier3,1,
GO:0019693,ribose phosphate metabolic process,Jan-60,395/15833,0.781010091,0.78610997,0.544498394,Ier3,1,
GO:0007265,Ras protein signal transduction,Jan-60,406/15833,0.790195363,0.794613976,0.550388686,Apoe,1,
GO:0007389,pattern specification process,Jan-60,406/15833,0.790195363,0.794613976,0.550388686,Btg2,1,
GO:0048285,organelle fission,Jan-60,409/15833,0.792633982,0.796694985,0.551830095,Il1b,1,
GO:0072521,purine-containing compound metabolic process,Jan-60,428/15833,0.807443968,0.811203018,0.561879072,Ier3,1,
GO:0034660,ncRNA metabolic process,Jan-60,429/15833,0.808193943,0.811578655,0.562139257,Rpl10a,1,
GO:0045666,positive regulation of neuron differentiation,Jan-60,431/15833,0.809685286,0.812698068,0.562914617,Apoe,1,
GO:0010498,proteasomal protein catabolic process,Jan-60,434/15833,0.811900945,0.814543114,0.564192587,Apoe,1,
GO:0006281,DNA repair,Jan-60,446/15833,0.820512722,0.822800397,0.569911987,Ier3,1,
GO:0051656,establishment of organelle localization,Jan-60,448/15833,0.821909822,0.823818577,0.570617228,Hmox1,1,
GO:0001501,skeletal system development,Jan-60,468/15833,0.835305687,0.836856858,0.579648182,Tmem119,1,
GO:0009117,nucleotide metabolic process,Jan-60,491/15833,0.849489002,0.850671585,0.589216941,Ier3,1,
GO:1903827,regulation of cellular protein localization,Jan-60,494/15833,0.851248089,0.852037744,0.59016321,Hsp90aa1,1,
GO:0002009,morphogenesis of an epithelium,Jan-60,495/15833,0.851829947,0.852224861,0.590292816,Cxcl10,1,
GO:0006753,nucleoside phosphate metabolic process,Jan-60,498/15833,0.853562124,0.853562124,0.59121907,Ier3,1,